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SUMMARY
This work investigates the effects of the anticholinesterases 
physostigmine and pyridostigmine and the cholinergic antagonists 
atropine and homatropine on the human visual system. The antagonism 
between these classes of drug is also assessed.
Anticholinesterases cause pupillary constriction and an increase 
in accommodation. As a means of simulating their effects in a 
controlled situation, a systematic study was performed to determine the 
effects of artificial pupils and defocusing lenses on visual 
performance. This was assessed by measuring contrast sensitivity for the 
detection of sinusoidal grating patterns. Contrast sensitivity was 
measured in 12 subjects for a range of spatial frequencies (0.5-38 
c/deg), for pupil diameters 2 - 8imi and for defocuses of +1 to +4 D, 
following homatropine eyedrops. Changes in pupil diameter, without any 
compensation for the change in retinal illumination, had no significant 
effect cn contrast sensitivity, except at 0.5 and 1 c/deg when a 
significant reduction occurred with the 2mm pupil. This suggests that 
the expected improvement in optical quality associated with smaller 
pupil diameters had been annulled by the accompanying reduction in 
retinal illumination. On the other hand, defocus caused an appreciable 
reduction in contrast sensitivity at spatial frequencies higher than the 
peak of the contrast sensitivity function (3 c/deg) and a smaller 
reduction below the peak. With increasing defocus a downwards parallel 
shift of the contrast sensitivity function above the peak was observed. 
Each dioptre of defocus reduced contrast sensitivity by about 50% at 
spatial frequencies higher than peak and 19% at spatial frequencies 
lower than peak in the hcmatropinised eye. The decrements were slightly 
less in the natural eye.
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An oral dose of 60mg pyridostigmine bromide which causes at least 
a 20% inhibition of blood cholinesterase, caused a small but significant 
increase of 7% in contrast sensitivity to stationary oscilloscope­
generated grating patterns over 3-38 c/deg, for a group of 13 subjects. 
This m s  attributed to an increase in ocular quality due to the small 
reduction in pupil diameter. Contrast sensitivity to laser interference 
fringes observed in the Maxwellian view, were unchanged after 
pyridostigmine. It is concluded that pyridostigmine may be used as a 
pre-treatment against organophosphorus anticholinesterases without 
adverse effects on stationary visual function.
Instillation of 0.25% physostigmine sulphate eyedrops in 12 
subjects caused a sustained miosis, a transient increase of near point 
acoonmodation and amplitude of involuntary accommodation. This last 
effect was maximal at 30 min and subsided by 90 min, though its 
amplitude varied greatly between subjects from +0.5D to +10D. 
Comparisons between two families of three siblings suggested involvement 
of a genetic trait in the amplitude of response of the ciliary body to 
physostigmine. Contrast sensitivity to externally-viewed oscilloscope 
grating patterns was transiently reduced after physostigmine and 
correlated with the increase in amplitude of accommodation. 
Physostigmine had a transient deleterious effect on contrast sensitivity 
to laser interference fringes, particularly at higher spatial 
frequencies, which was not affected by defocus of the image. 
Physostigmine also caused a prolonged reduction in contrast sensitivity 
to low spatial frequency grating patterns. Since the control eye showed 
no miosis, systemic absorption of physostigmine seems improbable. This 
suggests that there is a direct effect from trans-comeal absorption of 
physostigmine on the retinal neurones.
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The effects of a single intramuscular injection of 2mg atropine 
sulphate on visual performance were studied in 13 subjects. The well 
known actions of atropine on heart rate, secretion of saliva, dilatation 
of pupils and reduction in the amplitude of accommodative range, were 
observed. However, visual acuity, stereoacuity, red-green colour balance 
and reaction time to a visual stimulus were unaffected by atropine, 
although extra-ocular muscle balance was transiently changed. There was 
no significant change in contrast sensitivity to stationary sinusoidal 
gratings of spatial frequencies 1-30 c/deg for oscilloscope-generated 
patterns and laser interference fringes. However, contrast sensitivity 
to lew spatial frequency (1-5 c/deg) grating patterns phase-reversed at 
5.5 Hz showed a sustained reduction over six hours post-injection. 
Thus, it is concluded that atropine has an adverse effect on movement 
detection but not on stationary visual function.
An intramuscular injection of 2mg atropine sulphate was given at 
either 8 min or 124 min prior to 0.25% physostigmine eyedrops. The 
maximum increase in acoonmodation expected with physostigmine would thus 
coincide with the peak plasma concentration of atropine or with the 
fully developed mydriasis and reduction in near point accommodation 
caused by atropine. Atropine applied at either time had no affect on 
the miosis, the increase in near point accommodation, the increase in 
involuntary accommodation or the resulting reduction in contrast 
sensitivity caused by physostigmine. The reduction in contrast 
sensitivity to a phase-reversed grating pattern of 3 c/deg caused by 
physostigmine, was actually exacerbated by atropine although this was 
not statistically significant. Thus, the standard intramuscular dose of 
atropine is ineffective against an anticholinesterase. This was due 
primarily to insufficient delivery of atropine to ocular tissues 
following intramuscular injection as shown by the effectiveness of 
topically applied homatropine against physostigmine.
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Homatropine hydrobromide eyedrops (2%) were applied 100 min prior 
to physostigmine eyedrops, so that antagonism of the muscarinic 
receptors vrould be optimal prior to exposure to physostigmine. Pupil 
diameter was still reduced by physostigmine, but to a much smaller 
extent than that seen with physostigmine alone. Although physostigmine 
transiently reversed the homatropine-induced paralysis of near point 
accommodation, no large increase in involuntary accommodation was 
induced and the marked reduction in contrast sensitivity was effectively 
antagonised by homatropine at all spatial frequencies.
Thus, pre-treatment with homatropine eyedrops prior to exposure to 
anticholinesterases vrould be far more effective, as far as the visual 
system is concerned, than intramuscular injection of atropine, 
especially since atropine itself may have adverse effects on perception 
of moving objects.
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PTOCTOCTICN
The work presented in this thesis is a study of the effects of the 
anticholinesterases pyridostigmine and physostigmine and the cholinergic 
antagonists homatropine and atropine on the human visual system. The 
possible antagonism between these two classes of drug was also 
investigated. Throughout this work, the principal test of visual 
performance was to measure contrast sensitivity to sinusoidal grating 
patterns, which will be described first in this introductory section.
Measurement of visual function; contrast sensitivity
Contrast sensitivity was measured as the ability to detect a 
grating pattern of a specified spatial frequency. In a sinusoidal 
grating pattern, the luminance varies sinusoidally across the horizontal 
axis producing a repeated sequence of light and dark cycles as shown in 
Fig. 1. The two important variables to consider are spatial frequency 
and contrast. The number of cycles per degree of visual angle is the 
spatial frequency and the difference in luminance between light and dark 
half cycles is the contrast, being conventionally defined as
^  = kmax ~ ^ in in  /  ^hnax + ^ in in  
where and are the maximum and minimum luminance of the cycles
of the grating pattern.
If the contrast of the grating pattern is increased from below 
visibility to where the grating is just seen, then the grating is said 
to have reached threshold contrast. Contrast sensitivity is the 
reciprocal of this threshold contrast. Gratings of different spatial 
frequencies require different contrasts to reach threshold and 
collectively give the contrast sensitivity function (CSF) which relates 
contrast sensitivity to spatial frequency. The CSF thus describes a 
person's ability to detect an object across the range of object sizes.
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Fig. 1. A sinusoidal grating pattern generated on a Tektronix 606B 
oscilloscope as used in this study.
The CSF of the human visual system was first measured by Schade 
(1956). He found that contrast sensitivity is highest for spatial 
frequencies of 3-5 c/deg with a decline in performance at both higher 
and lower spatial frequencies. Schade's technique was subsequently used 
by F.W. Campbell and colleagues. Campbell & Green (1965) determined the 
modulation transfer function (MTF) of the human eye by comparing 
contrast sensitivity measured to oscilloscope generated grating patterns 
which are focused by the eye and represent an assessment of the overall 
visual system, with that for the neural component alone. The latter 
assessment consisted of measurement of contrast sensitivity to a pattern 
formed directly on the retina by the interference of two laser beams. 
Interference fringes have been used as stimuli for psychophysical 
measurements since the work of LeGrand (1935). As the interference 
fringes were formed by coherent light and were observed in the 
Maxwellian view, they were unrefracted by the optical media and gave a 
measure of retinal/central sensitivity. Campbell & Green demonstrated 
that the resolution limit of the visual system was set by the retina and 
not by the optical media of the eye. Campbell, Kulikowslci & Levinson, 
(1966) showed that the visual system is sensitive to the orientation of 
a grating pattern, as contrast sensitivity to vertical or horizontal 
patterns was greater than for oblique orientations. This was not due to 
any optical factors as it was also valid for interference fringe 
patterns. The CSF is believed to reflect the contributions of a series 
of independent channels each detecting over a limited range of spatial 
frequencies. The presence of these channels was first suggested by 
Campbell & Robson (1964; 1968) because they found the contrast
sensitivity for the fundamental frequency of a square waveform (of low 
spatial frequency) was lower than predicted from a model based on the 
CSF of the whole visual system measured with sine waves. Thus, the
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mechanism detecting low fundamental frequencies had a lower sensitivity 
to high frequency harmonics than would be supposed from the CSF. 
Complex waveforms could only be recognised as distinct from sine waves 
when the higher harmonic components of the waveform reached their own 
thresholds, indicating that the channels operate independently. 
Blakemore & Campbell (1969) showed that there was an indeterminate 
number of individual spatial channels with peak sensitivities closely 
spaced through the range of frequencies 3-20 c/deg. Each channel had a 
band-width of about an octave. Recent studies suggest the presence of 
six or seven discrete spatial frequency channels in central vision 
(Wilson, McFarlane & Phillips, 1983; Watson & Robson, 1981 
respectively). These frequency-selective channels are not only involved 
in the detection of contrast, but also in the suprathreshold perception 
of spatial frequency (Blakemore & Sutton, 1969). Campbell & Kulikowski 
(1966) also demonstrated the presence of narrow orientationally 
selective channels, thus, it seems that each of the channels which 
transmit visual spatial information filters a narrow band of both 
orientations and frequencies: these channels are believed to be
cortically located (Braddick, Campbell & Atkinson, 1978; Maffei, 1978).
Contrast sensitivity is influenced by many factors. Decreasing 
the mean retinal luminance reduces the peak sensitivity and shifts the 
high frequency cut-off of the CSF to lower frequencies. Also, the low 
spatial frequency decline in contrast sensitivity is absent for scotopic 
luminances (Patel, 1966; van Meeteren & Vos, 1972). Contrast 
sensitivity to a grating may also depend on the number of cycles visible 
(McCann et al., 1974; Hoekstra et al., 1974) and the presence of a dark 
or an illuminated surround (Estevez & Cavonius, 1976). Due to the
anatomical and functional specialisation of central retina for spatial 
resolution, the part of the retina which is tested is also important
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(Daitch & Green, 1969; Hilz & Cavonius, 1974; Skrandies, 1985). Focus 
and pupil size also affect the CSF but they will be discussed in detail 
later. Finally, the temporal modulation of the grating can also affect 
the shape of the CSF. At very lew spatial frequencies there is an 
increased sensitivity to moving and flickering gratings (Robson, 1966; 
Tolhurst, 1973). It seems that two distinct CSFs can be determined for 
the detection of pattern and movement corresponding to two different 
detection mechanisms. Tolhurst has suggested that the movement- 
independent mechanism may be analagous to the "X" or "sustained" class, 
and the movement-dependent mechanism to the "Y" or "transient" class of 
cat retinal ganglion cells (Enroth-Cugell & Robson, 1966).
Hie fundamental advantage of measuring contrast sensitivity for a 
range of spatial frequencies is that it gives a more complete 
description of the visual system1s functional range than, for example, 
the Snellen test which measures only the resolution limit. The 
importance of this has been demonstrated by Ginsburg et al., (1982), who 
found a correlation between the ability to detect a target and the peak 
of the CSF, but not with Snellen acuity. Also, contrast sensitivity 
measurements are often more sensitive to visual disturbances than other 
means of visual assessment (Arden, 1978; Comerford, 1983). Contrast 
sensitivity has been useful in assessing visual abnormalities in cases 
of amblyopia (Gstalder & Green, 1971; Hess & Howell, 1977), myopia 
(Fiorentini & Maffei, 1976), cataract (Hess & Woo, 1978), macular 
degeneration (Hyvarinen, Laurinen & Rovamo, 1983), glaucoma (Arden & 
Jacobson, 1978) and in multiple sclerosis (Regan, Silver & Murray, 1977; 
Ginsburg, 1981) and Parkinson's disease (Skrandies & Gottlob, 1986). 
Contrast sensitivity measurements have also been used to study changes 
in the visual system associated with normal ageing (McGrath & Morrison, 
1981; Morrison & McGrath, 1985; Owsley, Sekuler & Siemsen, 1983) and to
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study the effects of dopaminergic drugs on normal vision (Dcmenici et 
al., 1985).
Factors affecting the retinal image
The size of the pupil is an important factor in determining the 
final image quality as not only does it control the amount of light 
which reaches the retina, it also limits which rays from the object form 
the image. Pupil diameter determines the amount of geometrical 
aberration, diffraction and depth-of-focus available. Even in a perfect 
optical system, with a round pupil, the image of light from a point 
object is spread into an Airy disc on the retina, known as the point- 
spread function. Theoretically, for two incoherent point objects to be 
resolvable, the maximum of the Airy disc of one object should fall on 
the first minimum of the second. The minimum angular separation (9, in 
radians) is given by the Rayleigh criterion of
0 = 1.22 X / a, where X^ is wavelength and a, pupil diameter 
Relating this to the Fourier theory of optical images, for a 
diffraction-limited optical system, in monochromatic light, image 
contrast declines approximately linearly with spatial frequency (this 
relationship is the MIF), until the cut-off frequency determined by 
a / X (cycles/rad) is reached (Westheimer, 1964).
In the human eye, the performance of the ocular media is poorer 
than that of a diffraction limited system. The eye may be approximated 
as an optical system made up of spherical surfaces and is thus subject 
to the five Seidel monochromatic aberrations; spherical aberration, 
coma, oblique astigmatism, field curvature and distortion (details in 
Fincham & Freeman, 1980). The latter two are compensated for by the 
curvature of the retina and in the higher centres of the visual system 
respectively, and are not thought to significantly degrade the final
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image (Charman, 1983). Of the three remaining Seidel aberrations, only 
spherical aberration will produce blurring of the image on the
optical axis. This results from the formation of a blur circle due to 
marginal and paraxial rays coming to slightly different foci. However, 
in the human eye, on average only 0.5 D of positive spherical 
aberration exists (Millodot, 1978), as the eye is made aspheric by the 
flattening of the peripheral cornea (Westheimer, 1963). The lens also 
corrects its own spherical aberration by means of the gradients of 
refractive indices from its centre to the periphery (Nakao & Qno, 1969), 
and also by flattening of its surfaces towards the periphery (Howcroft & 
Parker, 1977). The optical axis and visual axis are misaligned in the 
living eye by 5-10 deg. In the past, off-axis aberrations were 
thought to have little effect as the peripheral retina is not capable of 
good resolution (Bennett & Francis, 1962). Recent measurements of the 
overall monochromatic wavefront aberration of the eye, however, suggest 
that off-axis aberrations dominate (Howland & Howland, 1976, 1977; Walsh 
& Charman, 1985). In Howland & Howland's original study, the subject 
monocularly viewed a point source of light through a crossed-cylinder 
lens and grid assembly, and drew a picture of the retinal shadow of the 
grid. Since each individual aberration produces a characteristic 
deformation, the contribution of each to the overall wavefront 
aberration could be calculated. Walsh & Charman repeated this approach 
but objectively measured the aberrations by photography of the retinal 
image and measured the phase relationship as well as the amplitude 
change. The general conclusions from the two groups were essentially 
the same; spherical aberrations are often limited to one meridian (i.e. 
a "cylindrical" aberration) and that coma (an off-axis aberration which 
causes point objects to appear as a core of light with a spreading tail) 
was the dominant aberration at all pupil sizes. They also concluded
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that aberrations vary from subject to subject and are usually 
asymmetrical.
The final Seidel aberration to consider is oblique ray astigmatism 
which causes blurring in a plane either through or perpendicular to the 
image, this will then either blur horizontal lines and sharpen vertical 
lines or vice versa. However, no difference in peripheral visual acuity 
was found in a study made both with and without correction for this 
peripheral refractive error (Millodot et al., 1975). Other functions of 
the peripheral retina such as motion threshold or absolute threshold 
were reduced by off-axis aberrations (Millodot, 1978).
In white light, aberrations due to chromatic differences in focus 
are important (van Meeteren, 1974), since the eye can be in focus for 
only one wavelength, the retinal image formed by the other wavelengths 
must be blurred. The longitudinal chromatic aberration of the human eye 
(distance along optical axis of foci for the different wavelengths) is 
approximately 2D over the whole visible spectrum (Charman, 1983). 
Transverse chromatic aberration or chromatic difference in magnification 
may also be present, due to the misalignment of the optical and visual 
axes (van Meeteren, 1974). However, the overall effect of chromatic 
aberration on the retinal image is not generally considered to be large, 
although contrast sensitivity to medium spatial frequencies was reduced, 
contrast sensitivity to high spatial frequencies (and hence cut-off 
frequency) was little changed (Campbell & Gubisch, 1967). Chromatic 
aberration also increases the threshold for out-of-focus blurring, which 
leads to a greater depth-of-focus (Campbell, 1957). Bour (1980) found 
that monochromatic MTFs were generally no better than those for white 
light, suggesting that the monochromatic aberrations dominate over 
chromatic aberrations.
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Further degradation of the retinal image results from intraocular 
scatter of light, due to small heterogeneities in the ocular media, 
particularly in the cornea and lens. The combined effects of all these 
aberrations become progressively more important as the pupil size 
increases. However, under photopic conditions the visual system 
partially compensates for this due to the narrow acceptance angle at the 
cone photoreceptors (Stiles-Crawford effect). Light entering the 
periphery of the pupil falls obliquely on the cones and is not reflected 
or "trapped" by the cone inner segments which then funnel the rays to 
the outer segments which contain the light sensitive pigment (Miller & 
Snyder, 1977). This reduces the "effective" pupil diameter for large 
pupils and results in an increased depth-of-focus.
Experimental measurements of the ocular quality of the human eye 
for a range of pupil sizes fall into two categories. The first is 
objective assessments of the MTF of the ocular media by measuring the 
line spread function of the faintly reflected fundal image of a thin 
line of light (Campbell & Gubisch, 1966; Charman & Jennings, 1976). 
Second, subjective assessments have been made of the effect of pupil 
size on visual acuity, as measured by discrimination of parallel 
vertical lines (Campbell & Gregory, 1960), the Landolt C (Jenkins, 
1963) and Snellen letters (Tucker & Charman, 1975) and on contrast 
sensitivity (Campbell & Green, 1965; Charman, 1979). Generally, ocular 
quality is found to increase as pupil diameter decreases, with maximal 
quality at around 3mm; below this it again declines due to increased 
diffraction. Experimental measurements of the effects of pupil diameter 
(with constant retinal illumination) on the MTF of the eye agree closely 
with theoretical predictions based on the combined effects of 
aberrations and diffraction (van Meeteren, 1974). However, in studies 
where no compensation has been made for the changes in retinal
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illumination with pupil size, less variation in visual acuity with pupil 
diameter was seen (Jenkins, 1963). Previously, no significant change in 
contrast sensitivity was reported over a range of spatial frequencies 
between the natural pupil (8mm) or a 3imi artificial pupil (Morrison & 
McGrath, 1985).
So far, we have been considering optical quality for an eye in 
optimal focus. Defocus, however, will cause further degradation of the 
image due to the formation of a blur circle around the true focus of a 
point source. The size of the blur circle is directly related to the 
pupil diameter. Out-of-focus imaging improves at smaller pupil 
diameters when the depth-of-focus increases (Campbell, 1957; Tucker & 
Charman, 1975). Errors of refraction are commonplace especially since 
the refractions required to bring different spatial frequencies into 
focus differ viz. high spatial frequencies require an additional +0.8D 
compared with lew spatial frequencies for large pupil diameters, due to 
the effects of spherical aberration (Green & Campbell, 1965). Also 
errors of accommodation are common even in the natural eye, for the 
resting state of accommodation is not at 0 D but at 1.0 -1.5 D (Morgan, 
1944; Hennessy et al., 1976) and visual resolution is closely related to 
accommodation accuracy over a wide range of luminances and stimulus 
distances (Johnson, 1976). Viewing a brightly illuminated field like a 
featureless blue sky leads to an involuntary accommodative effort of 
some 1.7D which is referred to as empty-field or space myopia 
(Whiteside, 1952). Accommodation also increases in twilight when the eye 
becomes myopic by 1.5-2.0D (Campbell & Primrose, 1953), though there is 
an element of 0.5-1 . 5D in this case due to increased spherical 
aberration resulting from dilation of the pupil (Koomen, Scolnik & 
Tousey, 1951). Another condition related to the resting state of 
accommodation is instrument myopia, where subjects overaccommodate by
26
2D when viewing through an optical instrument like a microscope 
(Hennessy, 1975).
The visual system is able to tolerate a degree of defocus blur, 
this has been measured psychophysically to be 0.20-0.25D (Whiteside, 
1957; Campbell & Westheimer, 1958). Theoretically however, appreciable 
degradation should occur when the Rayleigh criterion of X / 4 (i.e. 
greater than only 0.03D) is exceeded (Hopkins, 1962). Hopkins has also 
calculated the MTFs for a diffraction limited optical system 
corresponding to different levels of defocus. In theory, the changes in 
retinal image quality associated with defocus lead to an accelerated 
fall in image contrast with increasing spatial frequency as shown in 
Fig. 2. which is taken from Hopkins (1955). When defocus reaches a 
certain level (n = 2 in Fig. 2.), the contrast ratio becomes negative 
for certain spatial frequencies. This is known as spurious resolution 
and results in an image of a grating with reversed contrast and occurs 
at a lower spatial frequency for greater amounts of defocus.
Measurements for the human eye show that defocus broadens the 
line-spread function and reduces its central amplitude. For a given 
amount of defocus, image quality deteriorates more rapidly with a larger 
pupil (Westheimer & Campbell, 1962). Optical performance measured in 
this way is comparable to that which would be predicted from geometrical 
optics provided the errors of focus are greater than 0.5D (Charman & 
Jennings, 1976). However, contrast sensitivity and ocular quality 
measured for various amounts of defocus are generally higher than 
predicted from theory (Campbell & Green, 1965; Charman, 1979), due to 
geometrical aberrations which reduce the MTF at optimal focus relatively 
more than at out-of-focus positions. In practice, defocus has a severe 
effect on contrast sensitivity at medium and high spatial frequencies, 
but a much higher tolerance of defocus exists at low spatial frequencies
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(Campbell & Green, 1965; Green & Campbell, 1965). Defocus lias less 
effect on contrast sensitivity at small pupil diameters (Charman, 1979).
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Fig. 2. Computations by Hopkins (1955) of the effects of defocus on the 
MTF for a diffraction-limited optical system. Spatial frequency is 
normalised so that the value of 2.0 corresponds to the cut-off value for 
the system [this cut-off is given by (1 .746 x 10^a)A c/deg for the eye, 
where a is pupil diameter in nxn and A  is wavelength in nm]. The figures 
on the curves give the defocus terms of the parameter n, where the 
corresponding wavefront aberration is ~  (iV tt)A. A value of
n = 1 corresponds to a defocus of approximately 0.125 D when the eye has 
a pupil diameter of 3.3 mm and the wavelength is 555 nm. Note the 
expanded abscissa on the right hand graph. Reproduced with permission 
from Hopkins (1955).
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Influence of cholinergic drugs on visual function
Cholinergic drugs influence visual function largely because o f  
their effects on the parasympathetically innervated ciliary muscles and 
sphincter pupillae of the iris leading to changes in a c c o m m o d a t i o n  
(focus) and pupil diameter, respectively. There may also be an action 
via the sympathetic nervous system through an effect on the sympathetic 
ganglia. Topical and systemic administration of cholinergic drugs may 
also affect central visual function (Alpem & Jampel, 1959; Trussov, 
1962). Before considering the pharmacology of the cholinergic drugs 
investigated in this work, the role of cholinergic transmission in 
central visual processing will be discussed.
Cholinergic mechanisms in the retina
It is now well established that acetylcholine is a 
neurotransmitter in the vertebrate retina: the evidence for this has 
been recently reviewed by Neal (1983) and Hutchins (1987). 
Histochemical studies have shown that the retina contains significant 
quantities of the enzymes cholineacetyltransferase (ChAT) which 
catalyses the synthesis of acetylcholine from choline and acetyl- 
coenzyme A, and acetylcholinesterase (AChE) which hydrolyses 
acetylcholine not bound to receptors and thus terminates its 
physiological action (Graham, 1974). Both enzymes are mainly confined 
to the inner retinal layers with the highest activity in the inner 
plexiform layer (IFL) (Neal, 1983). ChAT activity lias also been found 
in human retinal homogenates (Hutchins & Hollyfield, 1986) and AChE 
activity has been reported in the human IPL (Hutchins & Hollyfield, 
1987a).
The identity of the cholinergic cells was first established in the 
rabbit retina using autoradiography (Masland & Mills, 1979). Two
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populations of amacrine cells were found to synthesise acetylcholine; 
one in the inner nuclear layer and one in the ganglion cell layer, which 
were later identified as displaced amacrine cells (Hayden, Mills & 
Masland, 1980). ChAT-like imnunoreactivity has also been demonstrated 
in the retinae of rat (Voight, 1986), cat (Schmidt, Wassle & Humphrey, 
1985; Bourcho & Osman, 1986), monkey (Mariani & Hersch, 1988) and human 
(Hutchins & Hollyfield, 1987b). In each case the reactivity was located 
in specific types of amacrine cells. Morphologically, these cholinergic 
amacrine cells have "starburst" dendritic fields in rabbit (Famiglietti, 
1983; Masland & Tauchi, 1986), rat (Voight, 1986) and cat retinae 
(Schmidt, Humphrey & Wassle, 1987). Starburst amacrine cells have also 
been found in human retinae (Golgi stain; Rodieck, 1986) but they have 
not yet been shown to be cholinergic.
Both muscarinic and nicotinic acetylcholine receptors have been 
reported in the retina of many species. The localisation of nicotinic 
receptors has been studied using alpha bungarotoxin (BTX) although the 
binding of this molecule may not be totally selective for this receptor 
(Neal, 1983). For muscarinic receptors, however, the binding of [JH]qui-
o
nuclidinylbenzylate and [ H] propylbenzilylcholine is generally accepted 
to be specific. In human retina, binding sites for both muscarinic 
markers and BTX have been found in the IPL (Hutchins & Hollyfield, 1985; 
Zarbin et al., 1986). The cellular localisation of receptors has been 
determined in chick retina; BTX binding sites occur on ganglion, bipolar 
and amacrine cells, whereas muscarinic receptors occur only on amacrine 
and/or bipolar cells (Morgan & Mundy, 1982). In rat retina, Redbum et 
al., (1984) proposed that muscarinic receptors occur on amacrine cells 
but that BTX binding sites occur only on ganglion cells and Lipton, 
Aizenman & Loring (1987) have shown pharmacologically that cholinergic 
receptors on isolated rat retinal ganglion cells are nicotinic.
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Physiological evidence that acetylcholine is a retinal 
neurotransmitter has come from several sources. Masland & Livingstone 
(1976) first demonstrated that rabbit retina, in vitro, synthesises 
acetylcholine from labelled precursors, which has also been reported in 
human retina (Hutchins & Hollyfield, 1986). More importantly, Masland & 
Livingstone showed that rabbit retina released acetylcholine in response 
to stimulation by light and that rapid changes of illumination were 
most effective in producing this release. Masland and his co-workers 
have shown that there is a burst of acetylcholine released at light 
onset and a second burst of acetylcholine after the off stimulus. It has 
been suggested that displaced cholinergic amacrine cells are responsible 
for the "ON" response and the conventionally placed amacrines for the 
"OFF" release of acetylcholine (Masland & Tauchi, 1986). Other 
neurotransmitters can affect the release of acetylcholine from the 
retina (Neal, 1983). Glycine reduces the light-evoked release of 
acetylcholine as does the cholinergic agonist muscarine, whereas the 
muscarinic antagonist, atropine increases the release (Cunningham, 
Dawson & Neal, 1983). Strychnine, a glycinergic antagonist blocked the 
effects of both atropine and muscarine, suggesting .that they may have 
been acting via an inhibitory glycinergic amacrine cell (ibid).
The functional postsynaptic effects of cholinergic amacrine cells 
have been studied principally by the effects of cholinergic agonists and 
antagonists on the activity of retinal ganglion cells.
In the rabbit, Masland & Ames (1976) showed that most CJN-centre or 
directionally selective and many OFF-centre ganglion cells were excited 
by acetylcholine and their spontaneous and light evoked activity was 
enhanced by anticholinesterases and depressed by cholinergic 
antagonists: nicotinic antagonists having greater efficacy than 
muscarinic antagonists. Ariel & Daw, (1982a) found that all ganglion
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cells with complex receptive fields received a light-driven cholinergic 
input. Furthermore, the light evoked response of directionally 
selective cells were, of all ganglion cell types studied, the most 
affected by cholinergic drugs (Ariel & Daw, 1982b) which may reflect a 
stronger cholinergic excitatory input to these cells (from cholinergic 
amacrine cells) compared with other ganglion cells.
In the cat retina, Ikeda & Sheardown (1982) showed that 
ionophoresis of acetylcholine enhanced both the spontaneous and 
visually-driven activity of "transient" ganglion cells (with the 
periphery effect). This response was blocked by dihydro-ft-erythroidine 
(dHRE), a nicotinic antagonist but not by atropine. However, Schmidt 
et al., (1987) showed that acetylcholine excited both "transient" and
"sustained" ganglion cells and that hyoscine, a muscarinic antagonist, 
blocked the effects of ionophoretically applied acetylcholine in both 
cases, whereas dHRE only blocked the effect of acetylcholine on OFF- 
centre cells. Despite the apparent difference in results between these 
two groups of workers, there appears to be unequivocal evidence of the 
involvement of cholinergic inputs to at least one class of retinal 
ganglion cell.
Cholinergic influences in other parts of the visual pathway
The optic nerve is notable for its absence of ChAT (Hebb & Silver, 
1956) and neither atropine nor dHRE greatly affect the response of 
lateral geniculate nucleus (LGN) relay neurones to stimulation of the 
optic tract, indicating that acetylcholine is not the neurotransmitter 
released by the axon terminals of retinal ganglion cells (Phillis, 
Tebecis & York, 1967). Nevertheless, there is a large amount of AChE 
present in the LGN which seems to be associated with terminals 
originating from the pontine and mesencephalic reticular formation and
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may be involved in the arousal response (Singer, 1979). Indeed Phillis 
et al., (1967) found that many LGN neurones were excited by
acetylcholine and stimulation of the reticular formation facilitated the 
response of these cells. Sillito, Kemp & Berardi (1983) have shown 
ionophoresis of acetylcholine has a strong excitatory action on neurons 
of the dorsal lateral geniculate nucleus (dLGN) and suggest that the 
function of the cholinergic input may be to enhance stimulus-specific 
inhibitory interactions within the dLGN. More recently, McCormick & 
Prince (1987) showed that application of acetylcholine can result in 
both excitation and inhibition of dLGN and medial geniculate cells in 
the cat and guinea pig. Three separate responses could be demonstrated: 
a rapid depolarisation due to activation of nicotinic receptors which in 
some cells was followed by a hyperpolarisation; this was then followed 
by a slew depolarisation above the resting potential in some cells. The 
latter two responses were due to activation of muscarinic receptors. 
Such mechanisms may not exist in all species, however, for in the rat 
dLGN only a very few cells respond with a hyperpolarisation (Crunelli et 
al., 1988). In cat, the only difference reported between "X" and "Y" 
dLGN cells' responses following ionophoresis of acetylcholine has been a 
specific enhancement of the late part of the "Y" cell "shift" response 
(elicited by stimulation outside the conventional receptive field): this 
was presumed to be a disinhibition effect (Eysel, Pape & van Schayck, 
1987).
There is also some evidence for cholinergic neurotransmission in 
the superior colliculus due to the presence of AChE and a high affinity 
choline uptake mechanism in rabbit (Wichmann, Illing & Stark, 1987).
The visual cortex also receives a cholinergic input and the 
reticular formation again appears to be the source (Singer, 1979). 
However, the visual cortex has the lowest concentration of ChAT in the
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entire cerebral cortex (Hebb & Silver, 1956). Anticholinesterases are 
known to reduce the cortical visual evoked response (VER) in cat 
(Harding, Wiley & Kirby, 1983; Harding, Kirby & Wiley, 1985; DeBruyn, 
Gajewski & Bonds, 1986) and this effect can be reversed by atropine, 
suggesting that muscarinic receptors are involved.
Ionophoretically applied anticholinesterases also affect the 
responses of single cells in the primary visual cortex of cat (DeBruyn & 
Bonds, 1987). Physostigmine, for example, caused an increased firing to 
visual stimulation in 61% of cells and a decreased firing in 30% of 
cells; 9% of cells were unaffected. Similarly, Sillito & Kemp (1983) 
found 92% of striate cortex cells exhibited a modification in their 
visual response during ionophoresis of acetylcholine; 61% of responses 
being facilitated and 31% depressed. The effect was antagonised by 
atropine. Sato et al., (1987) suggested that the responses of striate 
cortical cells may be tonically modulated by acetylcholine, to maximise 
the signal to noise ratio of visual signals.
Cholinergic Pharmacology
Nature and function of cholinesterase
The duration and magnitude of a response to acetylcholine, as with 
other neurotransmitters, depends not only on release but also on the 
removal of the neurotransmitter from the region of the receptor. For 
example, at the skeletal neuromuscular junction, if acetylcholine is not 
removed rapidly from the synaptic cleft then the sub-synaptic membrane 
remains depolarised and hence unresponsive to further stimuli. Removal 
of acetylcholine from the neuromuscular synaptic cleft is accomplished 
by the enzyme acetylcholinesterase and also by diffusion of the 
transmitter away from the receptor area. In fact, two kinds of 
cholinesterase enzyme are found in mammals, acetylcholinesterase
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(AChE, true cholinesterase) and butyryl-cholinesterase (BuChE, 
pseudocholinesterase). AChE is found largely in the post-synaptic 
membranes at cholinergic synapses, and in red blood cells (where its 
function is not known; Day, 1979). BuChE is found in mammalian plasma, 
the intestine and in many glial cells in the central nervous system. The 
function of BuChE is not clear but may include a role in active sodium 
transport (Hobbiger, 1968) and in regulating the proposed action of 
acetylcholine on intestinal tone (Day, 1979). BuChE is little involved 
with the hydrolysis of endogenous acetylcholine (Culluiribine, 1963).
The AChE molecule has two active sites for combination with 
acetylcholine; the anionic site which bears a negative charge and the 
esteratic site which bears a positive charge (Fig. 3a). AChE combines 
with acetylcholine and forms a reversible enzyme-substrate complex as 
the positively charged head of acetylcholine attaches to the anionic 
site of AChE. This hydrolyses the ester linkage of the acetylcholine 
molecule and free choline is released. The acetyl group is then thought 
to covalently bind with the esteratic site of AChE. Acetylated AChE is 
very unstable, with a half-life of less than 1ms, and is rapidly 
hydrolysed to form acetic acid and unbound enzyme which is then ready to 
combine with another acetylcholine molecule (Fig. 3b).
Mechanism of action of anticholinesterases
Anticholinesterases preserve acetylcholine at sites of cholinergic 
transmission by preventing its hydrolysis by cholinesterases (diffusion 
away from the receptor still takes place). The actions of 
anticholinesterases are almost entirely attributable to the inhibition 
of AChE since inhibition of BuChE at most sites produces no apparent 
functional change (Hobbiger, 1968). Anticholinesterases are classified 
into two groups, reversible and irreversible.
35
(a)
Anionic Hislidine Serine 
Si,e Eslerotic Site 
Acelylcholineslerose
(b) Acetylcholine Choline Acetic Acid
H3CN / CHNA
H-C CH
N— H
EnzymeSubslrole
Inlermediole
/ * \
H.,C CH,
CH.,
CH;,
Acelyloled
Enzyme
+ H ,0
HO-C
CH..
Regenerated
Enzyme
(c)
Physostigmine
CH,CH,
•O— H
P "
,CH.
CH, CH.CH,CH,
„N— H O
Enzyme-lnhibitor
Inlermediole
Carbamylated
Enzyme
N— melhylcorbomic Acid
HO— C
(d) DFP Diisopfopylphosphoric Acid
H,C.O OC,H
N— H Qj
Eniyme-lnhibilor
Intermediate
4h 7c , o  o c , h 7
— >n : \ ^ 4
Phosphorylaled
Enzyme
HOW °P
H jC ,0  x o c , h 7
Heavy, light, and dashed arrows represent extremely rapid, intermediate, and extremely slow or 
insignificant reaction velocities, respectively.
Fig. 3. Representation of the AChE molecule and its active sites (a). 
The steps involved in the hydrolysis of acetylcholine by AChE (b) and 
in the inhibition of AChE by physostigmine (c) and by the 
organophosphorus anticholinesterase DFP (d). Adapted from Taylor, 1980.
A. Reversible anticholinesterases
Examples are physostigmine, neostigmine and pyridostigmine which 
contain a carbamyl ester group (a condensation product of a carboxylic 
acid and an amine) and form a reversible complex with AChE in 
essentially the same way as acetylcholine (Fig. 3c). The carbamylated 
enzyme is more stable than the acetylated enzyme (Fig. 3b) and is 
hydrolysed at a much slower rate. Thus, the anticholinesterase competes 
with acetylcholine for binding sites on the AChE enzyme thereby 
protecting acetylcholine from hydrolysis. The time course of the 
inhibition of AChE depends on the structure of the anticholinesterase. 
For example, neostigmine is longer lasting than physostigmine as its 
ammonium group provides greater binding stability at the anionic site of 
AChE, whereas edrophonium, a similar compound to neostigmine but without 
a carbamyl group is less potent and much shorter acting (Taylor, 1980). 
A full account of the structure and activity of reversible 
anticholinesterases is given by Long (1963).
B. Irreversible anticholinesterases
These substances are mainly organic compounds containing 
pentavalent phosphorus and are extremely long-lasting and potent 
anticholinesterases. They can be described by the general formula which 
was first given in 1937 by Schrader (Holmstedt, 1963).
R1 and R2 are almost infinitely variable, e.g. alcohols, phenols, 
amides or alkyl groups (Holmstedt, 1963). Common X radicals include
R1 O (or S)
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fluorine (e.g. in diisopropyl fluorophosphate, DFP) and phosphates (e.g. 
tetraethyl pyrophosphate, TEPP). Detailed tables with the structure, 
activity and toxicity of numerous organophosphate anticholinesterases 
are given by Holmstedt (1959; 1963).
Many organophosphorus compounds do not have a quarternised 
nitrogen to react with the anionic site of AChE (as is the case for 
physostigmine) and are thought to react oily with the esteratic site of 
the enzyme (Fig.3d). The stages of the interaction of these compounds 
with AChE are generally similar to those of- the reversible inhibitors. 
The enzyme and inhibitor again form a complex which is still capable of 
dissociation. The group X is then removed by hydrolysis leaving the 
esteratic site of AChE phosphorylated. The phosphorylated enzyme is 
extremely stable and secondary (as in DFP) or tertiary alkyl groups 
further enhance this stability. Removal of the phosphoryl group from the 
enzyme may take weeks or months and thus for most practical purposes the 
complex is irreversible. The return of cholinesterase activity depends 
on the synthesis of new enzyme.
Actions of anticholinesterases in vivo
Anticholinesterases allow acetylcholine to accumulate at 
cholinergic receptor sites and thus enhance and prolong the effects 
produced by stimulation of pre- and postganglionic autonomic cholinergic 
nerves. The symptoms of acute poisoning by anticholinesterases in man 
are quite well documented for both local and systemic absorption and 
consist of so-called muscarinic and nicotinic components (Table 1; 
reviewed by Grob, 1963).
At the neuromuscular junction, the persistence of acetylcholine 
leads to fasciculation of the muscle due to prolongation of the endplate 
currents and even antidromic firing of the motor nerve fibres due to
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binding of acetylcholine to cholinergic receptors on the motor nerve 
terminal. (Brown, Dale &  Feldberg, 1936; Morrison, 1977). With 
sufficient inhibition of AChE at the endplate a depolarisation block may 
develop, which, if in the respiratory muscles, will result in death. 
The spontaneous, quantal release of acetylcholine from nerve terminals 
which cause miniature endplate potentials (Fatt & Katz, 1952) can in the 
presence of an anticholinesterase, lead to stimulation of post-synaptic 
cells as they can lead to the build up of an effective concentration of 
acetylcholine in the synaptic cleft under these conditions (Katz, 1966). 
If the anticholinesterase is lipid soluble it can cross the blood-brain 
barrier and affect the central nervous system. Central effects are
characterised by stimulation at low concentrations, followed by
depression at higher concentrations, which can lead to changes in the 
EEG and respiration (Grob & Harvey, 1953; Dille & Smith, 1964).
The most frequent causes of systemic anticholinesterase poisoning 
are inhalation of sprays or dust of insecticides or contamination of the 
skin in the case of agricultural workers (Wolf^ Durham & Armstrong, 
1967), contamination of crops or food (Hayes, 1967) and direct ingestion
(Toivonen, Ohela & Kaipaieu, 1965). However, the development of
organophosphorus nerve agents has produced another potential risk of 
anticholinesterase poisoning (see p. 45)
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Table 1. Signs and symptoms of anticholinesterase poisoning in man. 
Reproduced, with permission, from Grob (1963).
Silc of notion Signs and symptoms
Muscarinic 
Pupils...................................
Ciliary b o d y ......................
Conjunctivac......................
Nasal mucous membranes 
Bronchial t r e e .................
Sweat glands......................
Nicotinic 
Striated muscle.................
Muscarinic
Bronchial t r e e .................
Gastrointestinal
Sweat glands. . 
Salivary glands. 
Lacrimal glands
H e a r t .................
Pupils..................
Ciliary body . . 
Bladder . . . .  
Nicotinic 
Striated muscle.
Sympathetic ganglia 
Central nervous system.
Folloiving Local Exposure
Miosis, marked, usually maximal (pin-point), sometimes 
unequal
Prontal headache; eye pain on focusing; slight dimness of 
vision; occasional nausea and vomiting 
Hyperemia
Bhinorrhea; hyperemia
Tightness in chest, sometimes with prolonged, wheezing ex­
piration suggestive of bronchoconstriction or increased 
secretion; cough 
Sweating at site of exposure to liquid
Fasciculation at site of exposure to liquid
Following Systemic Absorption
Tightness in chest, with prolonged, wheezing expiration sug­
gestive of bronchoconstriction or increased secretion; dys­
pnea; slight pain in chest; increased bronchial secretion; 
cough; pulmonary edema; cyanosis 
Anorexia; nausea; vomiting; abdominal cramps; epigastric 
and substcrnal tightness ( ? cardiospasm) with "heartburn” 
and eructation; diarrhea; tenesmus; involuntary defecation 
Increased sweating 
Increased salivation 
Increased lacrimation 
Slight bradycardia
Slight miosis, occasionally unequal; later, more marked miosis 
Blurring of vision
Frequency; involuntary micturition
Easy fatigue; mild weakness; muscular twitching; fascicula­
tion; cramps; generalized weakness, including muscles of 
respiration, with d}’spnea and cj'anosis 
Pallor; occasional elevation of blood pressure 
Giddiness; tension; anxiety; jitterincss; restlessness; emo­
tional lability; excessive dreaming; insomnia; nightmares; 
headache; tremor; apathy; withdrawal and depression; 
bursts of slow waves of elevated voltage in EJCG, espe­
cially on ovcrvcntilation; drowsiness; difficulty in concen­
trating; slowness of recall; confusion; slurred speech; 
ataxia; generalized weakness; coma, with absence of re­
flexes; Chcync-Stokes respiration; convulsions; depression 
of respiratory and circulatory centers, with dyspnea, 
cyanosis, and fall in blood pressure
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Historical review of physostigmine
Daniell, a British Army medical officer, stationed in West Africa 
first reported in 1840 the use of the "ordeal bean of Calabar" , in 
native judicial procedure. Those on trial were made to swallow a 
solution containing the crushed bean and then to walk continuously until 
it took effect. If, however, after the lapse of a predetermined period 
the accused vomited the poison, his innocence was considered vindicated 
and he was set free. Following Daniell's report of this to the 
Edinburgh Ethnological Society, a botanist at Edinburgh University, 
Balfour, became interested in the tall woody vine which produced the 
Calabar beans, identified it as a member of the pea family, and named it 
Physostigma venenosum.
Christison, a toxicologist also of Edinburgh University, was first 
to experiment with the use of the Calabar bean on animals and also on 
man. Indeed, Christison ate a small amount of the bean himself and 
found it caused a great feeling of weakness with sane giddiness and 
nausea and a weak, irregular pulse. Thomas Fraser, an assistant of 
Christison, continued the study of the Calabar bean and isolated the 
active principle, an alkaloid, which became known as eserine, fran the 
native name for the ordeal poison. Fraser (1863) was first to observe 
the constriction of the pupil associated with the use of physostigmine 
in man, and noted that the pupil constricted within a few minutes if 
physostigmine was applied either to the eyeball or to the skin around 
the eye. He also noted that the immediate reaction to placing a drop of 
the physostigmine solution onto the eyeball was a copious discharge of 
tears. Ten minutes after application, the pupil had constricted to 1/16 
inch diameter (1.6 mm) and vision was described as being imperfect. By 
30 minutes, however, vision was almost lost and there was redness of the 
eye and tenderness on exposure to light. These uncomfortable symptoms
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lasted for 1-2 hours, the dimness of vision lasted for 4 hours and the 
pupil remained fully constricted for 24 hours after which it slowly 
returned to normal over a period of 5 days.
Douglas Argyll Robertson, a practising ophthalmologist, also 
experimented with physostigmine on his own eye. He wished to find a 
drug which would produce an effect on the pupil exactly opposite to that 
of belladonna (atropine). He confirmed that physostigmine constricted 
the pupil and increased accommodation to cause indistinct distance 
vision which was relieved by concave glasses. He then repeated the 
experiment with one drop of physostigmine followed by a drop of atropine 
30 minutes later. Following physostigmine, the pupil had constricted 
and the near point had moved closer to a distance of 5 inches (~13 cm) 
from the eye. A concave lens of 8 inches negative focus (- 5.0 D) was 
required for distant objects to be clearly seen. The atropine solution 
then caused the pupil to dilate and all objects beyond 3 feet could then 
be distinctly viewed unaided. These experiments led Robertson to 
propose that physostigmine and atropine were antagonistic in their 
action on the eye (Argyll Robertson, 1863). Shortly after this, 
physostigmine was first used as a treatment for systemic atropine 
poisoning by another ophthalmologist, Kleinwachter, in Prague in 1864 
(translated by Nickalls & Nickalls, 1988). Nowadays, physostigmine is 
used as an antidote for poisoning by over 600 varieties of cholinergic 
antagonists (Daunderer, 1980). Conversely, Fraser (1870) in an animal 
study, demonstrated that the lethal effect of physostigmine could be 
prevented by atropine. Atropine is still used today to treat 
anticholinesterase poisoning (see p. 55).
Argyll Robertson did not realise the value of the Calabar bean 
extract as a miotic in glaucoma, but suggested that it be applied after 
atropine eyedrops given as a mydriatic prior to ophthalmological
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examination of the eyes. He also proposed its use for the relief of 
photophobia and paralysis of the ciliary muscles. Ludwig Laqueur (1876) 
was the first ophthalmologist to use physostigmine therapeutically in 
glaucoma and Weber first measured the reduction in intraocular pressure 
caused by physostigmine in 1876. The development of physostigmine as a 
miotic agent has been reviewed by several authors (Rodin, 1947; 
Lebensohn, 1963; Kronf. .eld, 1970; Holmstedt, 1972).
Finally, in this historical review of physostigmine, the work of 
Anderson (1905), which advanced the understanding of its mechanism of 
action, should be mentioned. He demonstrated that physostigmine can 
constrict the pupil in normal cats but not in cats in which the ciliary 
ganglion has been removed and time allowed for degeneration of the post­
ganglionic fibres. After post-ganglionic nerve fibre degeneration there 
are no nerve terminals present to release acetylcholine and hence 
anticholinesterases are without effect.
Effects of topically instilled physostigmine
Physostigmine, instilled into the conjunctival sac is absorbed 
through the cornea and reaches the intraocular smooth muscle of the 
sphincter pupillae and the ciliary body. These muscles are innervated 
by parasympathetic cholinergic fibres arising from the ciliary ganglion 
and physostigmine acts by preserving the tonic and reflex release of 
acetylcholine from the parasympathetic nerve endings. This leads to a 
sustained contraction of the sphincter pupillae (pupil constriction or 
miosis) and of the ciliary muscles (which may lead to a spasm of 
accommodation). As the ciliary muscle fibres contract, the diameter of 
the ciliary ring reduces and the ciliary body is pulled forwards. This 
reduces the tension on the suspensory ligaments and the elasticity of 
the lens capsule causes it to become more spherical to diminish its
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focal length resulting in optimal focus for near vision.
The minimum concentration of physostigmine which will produce 
pupillary constriction in humans is of the order of 0.01% (Leopold, 
1961 ). The extent and duration of the miosis depends on the dose 
administered and the viewing conditions under which measurements are 
made. In rabbits, after instillation into the conjunctival sac, 
physostigmine can be demonstrated in the iris for 7-8 hours which 
corresponds to the duration of miosis (Schumacher, 1956). At low 
concentrations, physostigmine enhances the pupil's contraction to light, 
because the extra acetylcholine at cholinergic terminals allows each 
light flash to elicit a contraction which is faster, stronger, and 
longer lasting than normal. High frequency repeated light flashes lead 
to a tetanic contraction of the pupil. Under the influence of 
physostigmine, the iris sphincter becomes tetanically contracted at a 
lower than normal stimulation rate. Higher doses of physostigmine 
reduce the light reflex, as only little further contraction (although 
longer lasting than normal) can be elicited from the already constricted 
pupil (Loewenfeld, 1963).
The increase in accommodation starts at about the same time as the 
miosis but is of a much shorter duration. Any intense accommodative 
spasm tends to disappear in about 2 hours, but may remain irritable so 
that the slightest effort of accommodation for looking at a near object 
results in a spasm of accommodation (O'Connor Davies, 1981). 
Physostigmine also increases the amplitude of voluntary near point 
accommodation (Fincham, 1955). Again, in rabbits, physostigmine can be 
demonstrated in the ciliary body for 4 hours, which corresponds to the 
duration of the effects on accommodation (Schumacher, 1956).
Although the blurring of far vision associated with the 
accommodative spasm was measured by Argyll Robertson in 1863, very
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little quantitative work has been reported since that time. Mattila, 
Takki & Idanpaan-Heikkila, (1967) studied the effects of one drop of 
0.5% physostigmine salicylate and found that two thirds of the subjects 
reported impaired vision, a decrease in Snellen visual acuity from 6/4 
to 6/36 was not uncommon. Rengstorff (1970) investigated the effects of 
one or two drops of 0.5% physostigmine salicylate, which was instilled 
into one or both eyes. Two drops were more effective than one. He found 
that accommodation could increase by up to 7.75D, 30 min after
instillation, although there was large variation between subjects as to 
the extent of the increase in accommodation. Visual acuity decreased 
from 6/6 to as little as 6/120. No consensual effect was present; 
physostigmine applied to one eye had no effect on the pupil size or 
refractive state of the contralateral eye.
Hie electrical and motor activity of extraocular muscles are also 
greatly enhanced by physostigmine and may show spontaneous contraction 
(Brown & Harvey, 1941).
As mentioned previously, topical application of physostigmine 
decreases intraocular pressure. Although in most cases, there is first 
a slight rise in intraocular pressure due to dilatation of the blood 
vessels and engorgement of the vascular supply of the iris and ciliary 
body. This is then followed by a decrease in intraocular pressure once 
the pupil has constricted allowing increased aqueous outflow at the 
sinus venosus sclerae (canal of Schlemm) (Leopold, 1961).
Flicker sensitivity of human eyes is reduced by about 1-2 Hz 
following 1% physostigmine and this is independent of pupil size 
(Alpem & Jampel, 1959). The authors believed that the effect was 
retinal and probably on nicotinic receptors because pilocarpine 
(muscarinic agonist) did not change the flicker fusion frequency. 
However, prior administration of homatropine (muscarinic antagonist)
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effectively blocked the response, whereas homatropine itself had no 
measurable effect on the critical flicker frequency, suggesting that 
muscarinic receptors must in fact be involved. Also, Alpem & Jampel 
found a reduction in visual sensitivity, independent of pupil size, 
following topical physostigmine, although small intramuscular (i.m.) 
doses of physostigmine improved light sensitivity and accelerated dark 
adaptation (Trussov, 1962).
Development of organophosphorus nerve agents -
Organic phosphorus compounds such as TEPP have been known since 
the middle of the last century. In fact, as Holmstedt (1963) points out, 
it was remarkable that De Clermont, the chemist who first synthesised 
TEPP, was not poisoned in 1854, for he reported tasting the compound he 
had made. It was not until 1932 that a vigorous interest in their 
chemistry occurred when Lange and Kruegar gave the first indication of 
the extreme toxicity of these compounds. During the synthesis of 
dimethyl and diethyl phosphorofluoridate, the workers found that 
inhalation of the vapours caused a persistent choking sensation and 
blurred vision (Holmstedt, 1963). This discovery led directly to the 
long sequence of synthetic organophosphates with insecticidal and toxic 
properties. It also led to the synthesis in Germany of chemical warfare 
agents, chiefly by Schrader at Farbenfabriken Bayer, and also prompted 
the first synthetic and toxicological work with these compounds in 
Britain (these studies were carried out during the Second World War but 
only reported afterwards - Kilby & Kilby, 1947; Aldridge et al., 1947). 
During the war Schrader is said to have synthesised around 2000 
organophosphorus compounds, though most were kept secret by the German 
Government. Among these compounds were the fluorine-containing compounds 
including DFP and the pyrophosphorus derivatives including TEPP, and
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also the nerve agents Tabun or GA (ethyl N-dimethyl- 
phosphoramidocyanidate), Sarin or GB (isopropyl methylphosphono- 
fluoridate) and Soman or GD (pinacolyl rnethylphosphonofluoridate). 
The nerve agents are among the most toxic of the chemical warfare agents 
and are particularly dangerous as they act very rapidly and may be 
absorbed through any body surface. The so-called "V" agents, e.g. VX 
(0-ethyl-S-(2-diisopropylaminoethyl) methylphonothiolate) are most 
persistent as they do not disperse but remain over the area of release.
Effects of organophosphorus compounds on visual function
The first reported systematic study of the effects of 
organophosphorus compounds involved the exposure of volunteers to low 
concentrations of DFP (Kilby & Kilby, 1947). A long lasting pupillary 
constriction and a small increase in near point accommodation was 
observed. Blurring of far vision was also reported and later quantified 
by Scholz & Wallen (1946) at 1D to 6D which began 3 hours after exposure 
and lasted for several days. Aldridge et al. (1947) then went on to 
investigate the effects of DFP vapour (but at a lower concentration than 
that tested by Scholz & Wallen) on visual function when just the eyes 
were exposed (while the volunteer breathed uncontaminated air). They 
again observed a marked (though sometimes unequal) pupillary 
constriction and an increase in near point accommodation; however, 
Snellen visual acuity was unchanged. The scotopic visual threshold 
increased by a factor of, at most, ten which is slightly less than would 
have been expected from the changes in pupil diameter which occurred.
The visual effects accompanying the miosis induced by TEPP, which 
is used as an insecticide, have also been studied in some detail (Upholt 
et al., 1956). Doses of TEPP sufficient to give a maximal miosis also 
resulted in an increase in accommodation and a decrease in sensitivity
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to light. When miosis was induced in only one eye, subjects complained 
of an inability to perceive distance properly and experienced some 
stumbling or other sensorimotor accidents. The authors point out that 
these effects are the same as the Pulfrich effect, which causes the 
subject with unequal light intensities in the two eyes to perceive 
moving objects falsely; thus a pendulum appears to rotate in an ellipse 
instead of moving in one plane. Any change in accommodation may also 
cause a change in vergence of the eyes since accommodation and 
convergence are linked by a common neural mechanism which activates the 
two together and to which pupil diameter is also related (Davson, 1980), 
although sane people can sever this link (Morrison & Whiteside, 1984). 
Thus, any change in vergence may add to the difficulties in depth 
perception.
Pilots engaged in aerial application of organophosphorus 
insecticides have an accident rate which is very much higher than that 
of other commercial flyers (Smith, Stavinoha & Ryan, 1968) and visual 
disturbances may be an important factor leading to pilot-error (Wood et 
al., 1971). Chronic exposure to organophosphorus insecticides can also 
produce various central effects and psychiatric symptoms such as 
depression, confusion, dizziness and an inability to perform familiar 
tasks (Dille & Smith, 1964). A case of accidental exposure to two
organophosphorus insecticides in 19 farm workers reported that all 
experienced blurred vision on the day of exposure. Also, that 12 of the 
workers still reported problems of blurred vision, discomfort on reading 
and photophobia 4 months later (Whorton & Orbinsky, 1983).
The organophosphorus substance which has received the most 
attention as far as the visual system is concerned is the nerve agent 
Sarin. At the lowest effective dose of Sarin, miosis which lasts for 
about 24 hours and a general feeling of heaviness in and behind the eyes
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is produced. After four times this dose, extreme miosis is seen which 
diminishes gradually over a period of 3 to 14 days. Considerable aching 
in and behind the eyes is also felt with difficulty in focusing and 
frontal headache vtfiich may last up to 2 to 5 days (Grob, 1956). In cases 
of accidental exposure to Sarin, the miosis may last for many weeks; the 
time course for pupil recovery and plasma cholinesterase are similar but 
was not complete for several months (Sidell, 1974).
Stewart, Madill & Dyer (1968) found that a Sarin solution 
instilled into the eye reduced sensitivity to light in proportion to the 
decrease in area of the pupil. The miosis reduced visual performance (on 
an eyesight test) in dim light and the reduction was greater as the 
visual threshold was approached. However, Sarin may also have some 
central visual effects, for experiments in which retinal illumination 
was held constant using a 2mm artificial pupil have indicated that low 
doses of Sarin vapour elevates both the time course of dark adaptation 
and the absolute scotopic threshold (Rubin & Goldberg, 1957). The 
recovery of photopic vision was complete after 4 hours, but scotopic 
vision was impaired for more than 24 hours. Topical instillation of 
Sarin solution did not elevate the absolute visual threshold despite a 
marked miosis (Rubin, Krop & Goldberg, 1957) and protecting both eyes, 
with goggles, from direct contact with Sarin vapour prevented the miosis 
but not the action on visual threshold. The authors concluded that 
Sarin was acting on central visual processing. In a further experiment, 
Rubin & Goldberg (1958) showed that 2mg atropine sulphate (i.m.) 
significantly reduced the elevation of threshold whereas 2mg atropine 
methylnitrate (i.m.) which does not cross the blood-brain barrier had no 
significant effect, thus providing additional support for some central 
effect of Sarin.
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Gazzard & Thomas (1975) compared the effects of Sarin vapour to 
those of physostigmine eyedrops on visual function. A trend was found 
for visual thresholds for stimuli presented within the central visual 
field to be higher after exposure to Sarin vapour compared with those 
measured after physostigmine eyedrops. However, these differences were 
very small and may have been due to slight differences in the miosis 
(Sarin, 1.5mm compared to 1.5-2.Omm for physostigmine) or from defocus 
of the retinal image. Since inhibition of AChE occurred in the retina 
of guinea pigs after exposure to Sarin (Harris, Fleisher & Yamamura, 
1971), this further suggests an action at the retina.
More recently, Rengstorff (1985) has studied the visual effects 
following accidental exposure to small doses of Sarin vapour in two men. 
Despite miotic pupils of 1mm diameter lasting for up to 45 days, and an 
increase in near point accommodation, Snellen acuity actually improved 
after exposure for both men who were hypermetropic, which was attributed 
to increased depth-of-focus. In more severe cases of accidental exposure 
to Sarin, visual effects (save the miosis) are not detailed, as 
immediate treatment must be given to save life (Sidell, 1974).
So, it appears that the visual effects of organophosphorus 
anticholinesterases are largely due to miosis and an increase in 
accommodation, the severity of which depends on the dose and method of 
administration. Anticholinesterases like DFP have been used 
therapeutically to correct hypermetropia and accommodative esotropia 
(Gellman, 1963), since they enhance the amplitude of accommodation 
without reflexly inducing convergence.
Protection of cholinesterase against irreversible inactivation
The reversible anticholinesterases, physostigmine and neostigmine, 
have been used as pre-treatments against the irreversible
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organophosphorus anticholinesterases. In experiments on cat, Koster, 
(1946) showed that a pre-treatment with physostigmine had a marked 
protective action against the toxic effects of subsequent doses of DFP. 
The best protection was obtained when small doses of physostigmine were 
given just prior to exposure to DFP. When physostigmine was given after 
DFP, the toxic effects were enhanced. This additive action of 
physostigmine has also been seen after parathion exposure (Salerno & 
Coon, 1950). The probable mechanism of physostigmine1s protection 
against DFP was revealed in an investigation by Koelle (1946); 
physostigmine protected serum cholinesterase from inactivation by DFP in 
an in vitro rat brain preparation. The degree of protection varied 
directly with the concentration of physostigmine. Similarly, in vivo, 
the cholinesterase activity of serum from cats pre-treated with 
physostigmine showed a smaller reduction after exposure to DFP than 
serum from control cats. The recovery of cholinesterase activity was 
more rapid in the physostigmine treated cats (Koster, 1946).
Pyridostigmine is also being considered as a possible pre­
treatment against organophosphorus poisoning in man. Dimhuber et al., 
(1979) found pretreatment with pyridostigmine resulted in toleration of 
a dose of Soman 28 times greater than normal in rhesus monkeys and 15 
times in marmosets. These levels of protection were higher than any 
reported in non-primate species and therefore suggested that this 
treatment might also be effective in man.
The protective action of physostigmine/pyridostigmine against 
organophosphorus anticholinesterases depends upon the ability of these 
compounds to inhibit AChE forming a semi-stable enzyme-complex which can 
spontaneously break down to free the enzyme. This fraction of the enzyme 
would therefore be protected against phosphorylation in subsequent 
poisoning by an organophosphate. Rapid excretion of the free
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organophosphate along with spontaneous breakdown of the carbaniate-AChE 
complex would provide sufficient free AChE to support vital functions.
Cholinergic antagonists; atropine and homatropine
Atropine (hyoscyamine), the classical antagonist to the action of 
acetylcholine at muscarinic receptors, is a naturally occurring alkaloid 
obtained from the deadly nightshade plant Atropa belladonna. 
Preparations of belladonna were known to the ancient Hindus and have 
been used by physicians for many centuries. During the time of the Roman 
Empire and again during the Middle Ages the deadly nightshade plant was 
frequently used as a poison. It also became popular in Renaissance Italy 
as both a poison and a cosmetic (to dilate the pupils), after which 
Linnaeus named the plant in the 18th century.
Atropine was first isolated in pure form by Mein in 1831 and its 
characteristic effect in blocking the cardiac effects of vagal 
stimulation was reported by Bezold & Bloebaum in 1867 (quoted by Weiner, 
1980). Atropine is an ester of trophic acid and the complex organic 
base tropine. Homatropine, another muscarinic antagonist similar to 
atropine but with about one tenth the potency, has a much shorter 
duration of action. It is used clinically as a topical mydriatic 
(dilates the pupil) and cycloplegic (paralyses accommodation). 
Homatropine is a semi-synthetic compound produced by combining the base 
tropine with mandelic acid and acts in essentially the same manner as 
atropine. Hie structural formulae of atropine and homatropine are given 
in Fig. 4.
Combination of atropine with muscarinic receptors
Atropine and related compounds compete with acetylcholine for 
identical binding sites on muscarinic receptors. Although there are two
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subtypes of muscarinic receptor; Ml and M2, these are equally sensitive 
to atropine and hyoscine (Hammer et al., 1980). First, the binding of 
acetylcholine with the muscarinic receptor must be considered. The 
acetylcholine molecule consists of three parts, each of which is 
involved in the combination with the muscarinic receptor (Fig. 5). 
First, the qua ternary nitrogen moiety is the centre of the "cationic 
head" bearing a strong positive charge and fits into a depression in the 
receptor surface, the anionic site, which bears a negative charge. 
Second, the acetyl group of the acetylcholine molecule which bears an 
overall negative charge binds with the receptor at the positively 
charged esteratic site. Third, the alkylamine chain of acetylcholine 
provides a bridge between the cationic head and the acetyl group and 
allows both ends to "fit" into the receptor. The overall binding is 
therefore a combination of electrostatic attraction and spatial fit 
(Day, 1979).
Similarly, the combination of atropine with the muscarinic 
receptor results from at least three points of attachment. Atropine 
also contains a nitrogen moiety which may be attracted to the anionic 
site of the muscarinic receptor. The hydroxyl group and the benzene 
ring of the trophic acid moiety of atropine are the other proposed 
active sites.
Atropine binding with the muscarinic receptor prevents access of 
the acetylcholine molecule. The antagonism is competitive and can be 
overcome by increasing the concentration of acetylcholine at the 
receptor sites. The selectivity of antagonism is very high at 
muscarinic receptors of smooth muscle, cardiac muscle and exocrine 
glands. However, very large doses of atropine may also partially block 
the nicotinic actions of acetylcholine at ganglia and in skeletal muscle 
(Weiner, 1980). Also, very lew concentrations of atropine, below those
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needed to block muscarinic receptors, have been shown to stimulate 
muscarinic receptors and cause contraction of isolated gut, showing that 
atropine can act as a partial agonist (Bowman & Band, 1980).
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Fig. 4. Structural formulae of atropine and homatropine.
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Fig. 5. Hypothetical mechanism involved in the combination of an 
acetylcholine molecule at three sites with the muscarinic receptor (from 
Day, 1979).
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Pharmacological effects of atropine
As muscarinic receptors occur throughout the body, the effects of 
systemic atropine are very widespread (Martindale, 1982). Atropine 
causes a tachycardia due to diminished vagal tone and reduces 
gastrointestinal motility and salivary, bronchial and gastric 
secretions. The sweat glands of the skin are also inhibited and, at 
high doses, an increase in body temperature occurs. Micturition is also 
inhibited and the parasympathetic tone of the bronchi and bronchioles is 
reduced which leads to a dilation of the airways. In the sulphate form, 
atropine crosses the blood-brain barrier to cause central effects such 
as giddiness and ataxia. Finally, and most importantly as far as this 
work is concerned, atropine causes dilation of the pupils by antagonism
smooth muscle of the iris, and paralysis of accommodation by blocking 
the excitation of the ciliary muscles. Photophobia and increased 
intraocular pressure also occur due to the mydriasis caused by atropine.
Clinical uses of atropine
In adults, one drop of 1% atropine produces mydriasis which is 
maximal within 30 to 40 min and may last for as long as 12 days (pupil 
diameter increased from 3.4mm to 8.3mm). Atropine cycloplegia is 
attained within a few hours and constitutes, on average, an 80% loss of 
accommodation which may last 2 weeks or longer (Wolfe & Hodge, 1946). 
In comparison, in the same study one drop of 1% homatropine produced 
maximal nydriuls in 10 to 30 min with recovery in from 6 hours to 4 
days (pupil diameter increased from 3.4mm to 5.9mm). Homatropine caused 
a 45% loss of accommodation which was maximal at 30 to 90 min after 
instillation with recovery in 10 to 48 hours. A greater degree of 
cycloplegia can be obtained by the repeated administration of one drop
of acetylcholine, thus relaxing the circular
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of 2% homatropine solution given at 10 minute intervals for one hour 
(Thornt& Murph^, 1939).
Clinically, atropine eyedrops are used routinely in children to 
produce mydriasis and cycloplegia in preparation for examination of the 
retina or for refraction. Cycloplegic refraction is important in 
children because of their very strong accommodative reserve which can, 
in the case of hypermetropes, mask a large part of their refractive 
error (O’Connor Davies, 1981). Atropine eyedrops are used 
therapeutically for certain diseases characterised by inflammation of 
the iris (iritis) since the prolonged immobilisation of the ciliary 
muscle and iris help to prevent the formation of adhesions and post- 
operatively after cataract extractions (details in Havener, 1983). 
Systemic atropine is also used as a premedication in surgery to obviate 
vagal inhibition of the heart and to inhibit salivary, gastro-intestinal 
and pulmonary secretions.
Atropine as an antidote to organophosphorus poisoning
The antagonism between atropine and physostigmine has been known 
since the work of Argyll Robertson (1863) and Fraser (1870) and since 
this time, atropine lias become the drug of choice for all cases of 
anticholinesterase poisoning including that of organophosphorus agents. 
However, skeletal muscle neuromuscular block will still occur, thus the 
effective treatment for organophosphorus poisoning combines atropine 
sulphate with artificial respiration and general supportive therapy 
(Gordon & Fry , 1955). More recently, a number of specific oximes have 
been investigated which act by freeing AChE from its combination with 
the inhibitor (by removing the phosphoryl group from the phosphorylated 
ACHE) and thus reactivate the AChE (Durham & Hayes, 1962). These agents 
are now used in conjunction with atropine therapy and are particularly
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effective in reversing the neuromuscular block of skeletal muscle 
(Anon., 1972, Headley, 1982).
Atropine should not be given for preventive purposes prior to an 
anticipated exposure to nerve agents (Durham & Hayes, 1962; Grob & 
Harvey, 1953) as it might mask the early occurrence of symptoms of 
poisoning and allow the patient to expose himself to dangerous levels of 
the toxicant without realising it. Furthermore, Wills (1959) noted that 
animals given atropine before respiratory exposure to Sarin vapour were 
somewhat more susceptible to the anticholinesterase than control animals 
given no antidote. The bronchoconstriction which otherwise occurs to 
sane degree after inhalation of nerve gas vapour had been prevented by 
the prior administration of atropine, thus allowing greater inhalation 
and absorption from the respiratory tract.
The standard first aid measure in cases of organophosphorus 
poisoning is a 2mg i.m. dose of atropine sulphate Though this may seem 
large by comparison with the usual therapeutic dose of 0.4 to 0.6mg, it 
represents no hazard to an adult man (Gordon & Frye, 1955). Also, there 
is a marked tolerance for atropine in the presence of anticholinesterase 
poisoning (Grob & Harvey, 1958) and in severe cases doses of 24-48 mg of 
atropine may be needed in a day (Grob, 1963). U.K. servicemen carry, as 
part of their standard equipment, 3 self-inject syringes each containing 
2mg atropine sulphate in 1ml saline. There arises the question of what 
would be the effects of premature injection of atropine. The 
possibility of inappropriate or untimely antidote usage would only occur 
in a military setting and much of the early work concentrated on the 
effects of atropine on physical performance and military tasks with less 
attention paid to visual function.
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Effects of atropine on physical performance
Moylan-Jones (1969) showed that 6mg atropine (i.m.) impaired 
soldiers' physical work rate (digging) but shooting ability was 
unimpaired. Subjects had little difficulty in completing a light 
exercise protocol after 2mg atropine but in a more severe test 
atropinised subjects were less likely to complete the exercise than were 
control subjects (Miles, 1955). The environmental temperature and 
humidity can limit the amount of work possible after atropine 
(Cullumbine & Miles, 1956). This would be ^ especially relevant if any 
form of protective clothing was being worn.
Symptoms of giddiness, lightheadedness and dizziness are also 
experienced after atropine (Cullumbine, McKee & Creasey, 1955) and 
soldiers often require very strong motivation from their superiors in 
order to overcome the lassitude caused by the drug (Headley, 1982).
Following 1mg atropine sulphate (i.m.), the plasma concentration 
rises to a peak after 30 minutes and then declines gradually with a 
measurable amount still present at 240 minutes post-injection (Berghem 
et al., 1980). Similar results were reported for 2mg (i.m.) monitored 
over 60 minutes and a close correlation was found between plasma 
atropine concentration and heart rate (Kaiser and McLain, 1970). The 
initial effect is a bradycardia, beginning at 2 minutes post-injection 
for a 2mg i.m. dose (Cullumbine et al,, 1955). The main effect, 
however, is a tachycardia which reaches a maximum at 30 minutes 
(Cullumbine et al., 1955; Kaiser & McLain, 1970) or 1 hour (Mirakhur, 
1978; Baker et al., 1983).
Effects of intramuscular atropine on visual performance
The ocular effects of atropine viz. paralysis of accommodation 
and dilatation of the pupil, develop rather slowly and remain pronounced
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beyond 6 hours post-injection for a 2mg i.m. dose (Mirakhur, 1978; 
Rozsival & Ciganek, 1978; Baker et al., 1983), making close tasks 
requiring accommodation very difficult (Moylan-Jones, 1969; Rozsival & 
Ciganek, 1978). Atropine sulphate (2mg i.m.) has no effect on the course 
of dark adaptation nor on the absolute scotopic visual threshold (Rubin, 
1956). Distance vision, assessed by the Snellen test, was also 
unaffected by atropine i.m. (Cullumbine, et al., 1955; Miles, 1955; 
Rozsival & Ciganek, 1978). Performance of two complex tasks of visual 
function: a visual search task and a task requiring repeated
accommodative changes to identify high and low contrast targets was also 
unaffected by atropine i.m. Recently, however, 2mg and 4mg atropine 
sulphate i.m. have been shown to impair visual tracking of a moving 
stimulus (Penetar & Beatrice, 1986; Baegerstrom-Portnoy et al., 1987).
AIMS OF THIS STUDY
Part 1: A quantitative investigation of the effects of defocus, pupil 
diameter and spatial frequency on contrast sensitivity.
As a first stage in this work, the well-known effects of 
anticholinesterases on the pupil and accommodation were reproduced by 
the use of artificial pupils and defocusing lenses. Contrast 
sensitivity was measured over a wide range of spatial frequencies of 
sinusoidally modulated grating patterns. Sinusoidal stimuli are 
particularly useful in a study of defocus since the fundamental 
frequency remains constant regardless of the optical blur while the 
amplitude and phase of the modulation are altered. Thus, the 
psychophysical judgements of threshold are always made for a 
sinusoidally modulated image.
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The effects of defocus and pupil size on contrast sensitivity have 
been investigated before on only a small number of subjects viz. two by 
Campbell & Green (1965) and one by Charman (1979). In the present 
study, the responses of a relatively large sample of 12 subjects were 
investigated to allow for individual variations in response. 
Furthermore, this study differs from previous work in that, as for 
natural viewing, the changes in retinal illumination which result from 
changes in pupil diameter were not compensated.
The eye was homatropinised in order to remove the fluctuations in 
accommodation and pupil diameter which normally occur under steady 
viewing conditions for a near target (Campbell, Robson & Westheimer,
1959). However, in the event of homatropine itself exerting an effect 
on contrast sensitivity, the study was also repeated with the natural 
eye.
The results of this work have been reported in Kay & Morrison 
(1985; 1987a).
Part 2: The effects of a single oral dose of pyridostigmine bromide on 
contrast sensitivity.
The effects of an oral dose of pyridostigmine bromide on the 
visual system were of interest for two reasons. First, because
pyridostigmine is a reversible anticholinesterase and second, because 
this dose and route of administration is being considered as a possible 
pre-treatment against organophosphorus anticholinesterases. A 60mg oral 
dose of pyridostigmine bromide causes a 20% inhibition of blood 
cholinesterase, which gives optimal prophylactic effect at between 1 and 
5 hours post-ingestion (Dr. R.I. Gleadle, personal communication). 
Thus, measurements of visual performance were made during this period.
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In order to exclude any psychological overlay to the effects of 
pyridostigmine, the experiments were performed on a double-blind basis, 
which meant that the control and test trials were performed on different 
days. To reduce any diurnal variations in the measurements the tests 
were carried out at the same time of day. Also, several practice runs 
were performed during the one hour period allowed for drug absorption to 
cover any learning effects on first acquaintance with the measurements.
Pyridostigmine bromide is a qua ternary compound and crosses the 
blood-brain barrier with difficulty but although central effects are 
unlikely they cannot be excluded. Thus, contrast sensitivity to laser 
interference fringes was measured to assess any change in 
retinal/central vision.
These results have been reported in Kay & Morrison (1988a).
Part 3: The effects of topical application of 0.25% physostigmine 
sulphate on visual performance.
The effects of topical application of the reversible 
anticholinesterase, physostigmine sulphate, were studied to simulate the 
effects of organophosphorus anticholinesterases. Since many aspects of 
visual function were investigated, the experiments had to be performed 
in three separate parts. Also, because of the transient nature of the 
acccmraodation response to physostigmine eyedrops (Rengstorff, 1970), the 
protocol was designed to consist of short series of measurements which 
could be repeated at intervals to follow the time course of the 
response.
Pupil diameter, near point accommodation and the increase in 
accommodation caused by the eyedrops were monitored for 3 hours post­
administration, along with other aspects of visual function (different
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for each of the three parts). Contrast sensitivity was measured to 
stationary sinusoidal gratings of spatial frequencies of 3, 10, 20 and 
30 c/deg to assess stationary pattern function. To assess movement 
sensitivity, contrast sensitivity was measured in response to a phase- 
reversed sinusoidal grating pattern, which provides an adequate stimulus 
to the "movement detectors", at the temporal and spatial frequencies 
most sensitive to movement, viz. 5.5 Hz and low spatial frequencies 
belcw 5 c/deg (Kulikowski & Tolhurst, 1973). Topical application of 
physostigmine has previously been shown to affect critical fusion 
frequency (Alpem & Jampel, 1959). Thus, a more detailed study of 
retinal/central vision, involving measurement of contrast sensitivity to 
laser interference fringes along with the critical fusion frequency, was 
performed in the present study.
These results have been reported in Kay & Morrison (1988b).
Part 4: Tie effect of an intramuscular dose of 2mg atropine sulphate on 
visual performance.
Due to the increasing importance of rapid detection of objects, 
for example, on radar displays or in flying an aircraft, even the 
smallest decrement in visual function may be significant. As the 
possibility exists of premature injection of atropine sulphate a 
comprehensive investigation was made of the effects of a 2mg i.m. 
injection of atropine sulphate per se, on visual function. In one set 
of experiments the general changes in heart rate, pupil diameter and 
accommodation were followed over 6 hours post-injection. The study also 
included other aspects of visual function, viz.. extraocular muscle 
balance, colour perception, reaction time and choice reaction time to a 
visual stimulus, stereoacuity, contrast sensitivity to a moving grating
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pattern and visual acuity. Movement sensitivity at low spatial 
frequencies was of particular interest for in the cat, after intravenous 
(i.v.) administration of physostigmine, visual evoked responses to low 
spatial frequencies were often abolished whilst responses to higher 
spatial frequencies were only minimally affected (Harding et al., 1983). 
These effects were reversed by atropine sulphate indicating the 
involvement of cholinergic neurones. In this study, the effect of 
atropine per se on contrast sensitivity to lew spatial frequency phase- 
reversed grating patterns was investigated.
In the second set of experiments, contrast sensitivity was 
measured over an extended range of spatial frequencies to oscilloscope 
generated stationary grating patterns: this was a substantial
undertaking vhich required a separate study in itself. To take account 
of atropine sulphate crossing the blood-brain barrier to stimulate the 
central nervous system, the response of the retina/brain was assessed 
directly by measuring contrast sensitivity .in response to laser 
interference fringes.
Although contrast sensitivity measurements are widely used, little 
work has been done on the reproducibility of such measurements in an 
extended recording session on a given day, bar one assessment of the 
variability of measurements as part of a study comparing three different 
methods of determining threshold (Ginsburg & Gannon, 1983). To resolve 
this question of reproducibility and to establish control levels, each 
individual first underwent a full "dummy" run of the test procedure 
without atropine.
The results of this part of the study have been reported in Kay & 
Morrison (1986; 1987b).
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Pa^t JL*. f^ e effectiveness of prior administration of an intramuscnl a-r
inj ection of atropine sulphate or instillation of homatropine eyedrops 
against physostigmine eyedrops.
It was of interest to find out whether the prior administration of 
atropine (i.m.) would provide any protection against the topical 
application of an anticholinesterase. Atropine sulphate ( 2mg i.m.) was 
given at two different time intervals:
(a) 8 min prior to physostigmine so that peak plasma concentration of 
atropine (Berghem et al., 1980) would coincide with the peak defocus.
(b) 120 min prior to physostigmine so that the ocular effects of 
atropine viz. cycloplegia and mydriasis, could be fully developed before 
physostigmine was applied.
To investigate if a higher dose of a cholinergic antagonist would 
afford any protection against topical application of an 
anticholinesterase, a third test of the effects of physostigmine was 
performed:
(c) Homatropine hydrobromide eyedrops were instilled 100 min prior to 
physostigmine eyedrops.
The topical application of a cholinergic antagonist was preferred 
to a higher dose of atropine (i.m.) due to the possible risk to the 
volunteer subjects. Homatropine eyedrops were preferred to atropine 
eyedrops which have a much more persistent action.
Control runs of the following tests were made prior to atropine or 
homatropine and were repeated every 20-30 min following physostigmine. 
Contrast sensitivity to stationary grating patterns of 10, 20 and 30 
c/deg and to a phase-reversed pattern of 3 c/deg, together with pupil 
diameter, accommodation and near-point were measured.
These results have been reported in Kay & Morrison (1987c; 1988c).
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METHODS
In the course of this work contrast sensitivity was measured in 
response to vertical sinusoidal grating displays generated by both 
cathode ray tube (CRT) and laser interferometer.
Apparatus
(1)CRT Display
In parts 1 and 2 of this study the display used was generated by a 
Telequipment DM53S oscilloscope with a P-^-j phosphor, peak wavelength 
520nm, with the time base running at 1ms/div. A triangular wave, peak- 
to-peak voltage of 12V and frequency 220 kHz was fed into the vertical 
amplifiers of both beams of the oscilloscope, which had been 
superimposed, to produce a uniform green raster. The grating pattern was 
produced by feeding a sine wave of variable voltage and variable 
frequency into the z-modulation of the oscilloscope. The sine wave was 
obtained from a Feedback sine square oscillator SS0603, the output of 
which could be amplified to a maximum of 70V peak-to-peak by a control 
unit. The amplitude of this sine wave was varied by adjustment of either 
the oscillator output or the ten-turn potentiometer which attenuated the 
output of the control unit, and was monitored on a Tektronix 5103 
oscilloscope.
The luminance of the grating pattern remains constant as the depth 
of modulation is varied, and was measured with a Pentax Spotmeter V as 
1.4 cd/m^. Psychophysical determinations showed luminance to be 3.83 
log units above foveal threshold i.e. in the mesopic range where both 
rod and cone pathways may be operational. To exclude the distortions 
which occurred at the edges of the screen, the display was viewed 
through a window in a surround of green card. The surrounding card was 
not illuminated except for the background room lighting of circa 0.5 
metre-candela at the level of the subject. The horizontal aspect of the 
viewing aperture subtended 1.5 deg when viewed from 3m and 4.5 deg when
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viewed from 1m. These two viewing distances were used in order to 
obtain a sufficiently wide range of spatial frequencies without 
exceeding the limit (of number of cycles of the grating) at which the 
performance of the CRT declined (Morgan & Watt, 1982) and without going 
below the limit at which contrast sensitivity was determined by the 
number of grating cycles rather than by the spatial frequency itself 
(i.e. 3 cycles for this display luminance; Hoekstra et al., 1974).
Thus spatial frequencies of 8 c/deg and above were measured from 3m and 
spatial frequencies of belcw 8 c/deg were measured from 1m. The 
combination of measurements from near and far viewing distances into a 
common CSF had previously been established by Campbell & Robson (1968).
The psychophysical method described by Campbell & Green (1965) was 
used to determine the relation between z-modulation voltage and 
contrast. One cycle of a square wave grating, located in a narrow 
window, was viewed from 1m. A calibrated neutral density filter was 
placed in the window covering the brighter half of the cycle and the z- 
modulation voltage was increased until the twc half-cycles were judged 
to be of equal luminance. At this point, the z-modulation voltage was 
numerically equivalent to the transmissivity of the neutral density 
filter. This m s  repeated at cycle widths corresponding to 5, 10 and 20 
c/deg at 3m by two observers. Contrast was linearly related to z- 
modulation voltage with a slope of 0.022 contrast units/V peak-to-peak 
up to 25V, attaining a maximum contrast of 0.85 at 70V.
Contrast thresholds were measured for one eye only with the other 
being covered either by the subject's hand or more usually by an 
occluder placed in a trial frame over the appropriate eye. For the 
experiments on the homatropinised eye in part 1, thresholds were 
measured by an ascending method in which the experimenter steadily 
increased the contrast of the grating pattern from zero contrast until
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the subject was just able to detect the grating in the centre of the 
screen and no mere. This measure, in fact, agrees very closely with the 
contrast threshold based upon 50% detection (Morrison & Reilly, 1986). 
Furthermore, Ginsburg & Cannon (1983) demonstrated that an ascending 
method of measuring contrast threshold produced more conservative values 
with less variance between subjects, than methods of adjustment which 
incorporated descending contrast measurements which may be confounded by 
after-images. The experimenter controlled procedure for measuring 
contrast was adopted since, in these experiments, the majority of 
subjects were recruited from outside the academic world and 
unfortunately did not prove to be completely reliable in their 
objectivity. In the second experiment in part 1 for the natural eye 
and, in fact, for all remaining parts of this study, the method used was 
again ascending but new under the subject's control. This was possible 
due to the employment of subjects who were better motivated to cooperate 
to produce objective results. In this case, the experimenter still had 
independent control of the z-modulation voltage, the sensitivity of the 
control unit could be varied between determinations so that the subject 
could not arrive at the same threshold simply by counting the number of 
turns of the potentiometer. Throughout this study contrast sensitivity 
was calculated as the mean of five contrast threshold determinations at 
each spatial frequency measured.
In all experiments from part 3 onwards, the sinusoidal grating 
pattern was generated on a Tektronix 606B monitor, which also had a 
phosphor, peak wavelength 520 nm. The raster was now produced by 
feeding a 770 kHz triangular wave into the Y-plates, whilst the time- 
sweep was driven by a saw-tooth waveform from the X-output of the 
Tektronix 5103 oscilloscope with time base running at 0.2 ms/div. This 
oscilloscope also monitored the frequency and amplitude of the z-
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modulation which was produced by a sine wave oscillator. The z- 
modulation signal was connected via a 1:2 or 1:10 attenuator to the 
control unit with an adjustable ten-turn potentiometer; the attenuation 
ensured the subj ect had a reasonable number of turns of the 
potentiometer in cases where contrast was very lew.
The 606B display was viewed through a windcw 10 x 8 cm in a green 
card screen. This subtended 2 deg at 2.86m and 4 deg at 1.43m, these 
being the two distances used to obtain a sufficiently wide range of 
spatial frequencies without the number of cycles limiting contrast 
sensitivity as mentioned earlier. Contrast sensitivity was measured from 
2.86m for spatial frequencies of 8 c/deg and above and from 1.43m for 
spatial frequencies belcw 8 c/deg. The luminance of this display was 
considerably greater than that of the previous oscilloscope and was 
measured as 10.2 cd/m^, equivalent to 4.89 log units above foveal 
threshold in the upper mesopic range. The surrounding card was not 
illuminated other than by a background illumination provided by two 
spotlamps of combined intensity 0.5 metre-candela measured at the 
location of the subject with a Lightmaster Photometer (Diffusion Systems 
Ltd.).
The relationship between the z-modulation voltage and contrast was 
determined as described for the other CRT. The calibration was repeated 
several times for a range of contrasts with three observers. Contrast 
was linearly related to z-modulation voltage with a slqpe of 0.253 
contrast units/V peak-to-peak up to 3V, levelling off to a maximum of 
0.85 at 5V.
In some experiments, contrast thresholds were also measured to 
"moving" sinusoidal grating patterns of low spatial frequencies ranging 
from 0.5 to 5 c/deg. These were generated by a 180 deg phase-reversal 
(with the positions of the light and dark bars of the grating being
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continuously exchanged) at 5.5 Hz of a sinusoidal grating pattern giving 
rise to an apparent movement of the pattern (Kulikowski, 1971) known as 
the phi-phenomenon, which is an effective stimulus for movement 
detection (Kulikowski & Tolhurst, 1973). Thresholds were measured by an 
ascending method with the subject increasing the contrast of the grating 
until the temporal modulation or flicker was just seen, irrespective of 
whether or not the form of the pattern was perceived.
(2) Laser Display
The method used was that described by .Morrison & McGrath (1985), 
based on that of Westheimer (1960) and Campbell & Green (1965). Vertical 
sinusoidal fringes were generated by the interference of two laser beams 
consisting of polarised coherent monochromatic light observed in the 
Maxwellian View (Fig. 6). Maxwellian viewing is the procedure of imaging 
a light source in the plane of the eye's pupil, instead of viewing it 
directly (Westheimer, 1960).
Beam 1
In t e r f e r e n c e
Fr i n g e s £H![Beam 2Posterior
Nodal
Plane
Eye Objective Lens
Fig. 6. Schematic representation of the formation of laser interference 
fringes on the retina from Morrison & McGrath (1985).
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Normally, rays of light entering the eye are focused by the ocular 
media onto the retina. Instead, in the Maxwellian View, the rays of 
light are focused by a microscope objective onto a plane passing through 
the posterior nodal point of the eye which is about 17rrm in front of the 
retina, approximately at the level of the pupil. As coherent rays pass 
unrefracted through this point the effects of standard geometrical 
aberrations associated with any optical system, viz. chromatic 
aberration (in the case of white light), spherical aberration, coma and 
cylindrical aberration are avoided. It should be noted that wide-angle 
scattering of light by small particles in the ocular media may still 
occur. Since the two beams overlap and interfere behind the posterior 
nodal point the exact position of the eye is not as critical as it may 
at first seem. One can move forward or backward a few millimetres 
without changing the spatial frequency of the pattern. Nevertheless, the 
head was kept as stable as possible by the subject placing his chin on a 
rest or a cushioned pad whichever was the more comfortable. Care was 
taken to reduce vibrations of the optical table on which the apparatus 
were mounted with four Barry Mount stabilisers as movement of the 
stimulus might influence the threshold being measured.
Hie vertical sinusoidal interference fringes were generated by a 
Mach-Zehnder interferometer (Bom & Wolf, 1980) and their production has 
been given in detail in Morrison & McGrath (1985). Briefly, a beam of 
polarised coherent light from a He-Ne laser (wavelength 632 nm) is split 
into two and made to travel different paths before recombining and 
interfering so as to produce light maxima and minima. The two parameters 
of the interference fringes which were important to this study are 
spatial frequency and contrast.
The spatial frequency of the fringes is directly related to 
difference in path length of the two beams. The path length was altered
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by translation of a front silvered mirror, mounted on a Beck rotation 
stage, placed in the path of one beam. The deflected beam was then 
realigned by rotation of the Beck stage until the beam was brought back 
onto the centre of the Maxwellian lens which consisted of a x2 Leitz 
objective. When the realigned beam was subsequently combined with the 
fixed beam, interference fringes of the required spatial frequency were 
obtained. The arrangement of the optical table was such that it allowed 
the formation of a second pair of laser beams vhich combined to form a 
second set of interference fringes (see Morrison & McGrath, 1985). These 
were used to measure the spatial frequency of the display in the x2 
objective by counting the number of cycles within the phase ring of a 
xlOO Vickers objective. This was multiplied by a correction factor of 
0.75 which had been obtained by comparing the number of cycles in the 
x100 objective with those in the x2 objective lens obtained by 
photography of the image over the range of spatial frequencies studied 
(and counting the cycles on the negative under low power magnification). 
This correction factor remained constant despite dismantling the 
apparatus three times during the course of this work.
Variable contrast of the interference fringes was achieved by 
superimposing the laser beams on a diffuse beam from a tungsten source 
(Vickers microscope lamp), passed through a narrow band red interference 
filter with peak transmission 630 nm and bandwidth 5 nm (Barr & Stroud 
Ltd), but polarised at 90 deg. It was important that the two laser 
beams and the diffuse beam were of the same intensity and this was 
arranged using a photodiode operational amplifier unit (RS 305-462). 
First, the intensity of the two laser beams were measured separately 
and the brighter beam attenuated by placing the appropriate neutral 
density filter in its path. The recombined beams were then measured and 
matched for intensity with the diffuse beam. The laser beams and
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diffuse beam all passed through a Glan-Thompson calcite polariser, with 
extinction circa 10“^ (J. Phillips Ltd) mounted within a Beck rotation 
stage. By rotating the polariser from 0 to 90 deg, the contrast of the 
interference fringes increases from zero (only diffuse beam passing) to 
1.0 (only laser light passing). The angle of rotation 9 is read directly 
from a scale on the rotation stage and as 9 increases the contrast of 
the grating increases according to the sine-squared law (Westheimer,
1960). The intensity of the combined beams remained constant upon 
rotation of the polariser as determined photometrically and was 
determined psychophysically, in three observers, to be about 2.5 log 
units above foveal threshold. This intensity was chosen empirically for 
long term viewing as anything brighter was found to be uncomfortable. 
The field size used was 7 deg and the ambient background illumination 
was as for the CRT unless stated otherwise.
Thresholds were measured by an ascending method. In part 1, the 
experimenter slowly increased the contrast until the subject indicated 
that the grating was just visible in the centre of the field. In all 
other experiments in this study the subject increased the contrast 
himself until the grating was just visible and no more. For each 
threshold determination the rotation stage was placed at a different 
subthreshold position by the experimenter in order that the observer 
could not reach threshold by counting the number of turns of the dial. 
Five determinations of threshold were made at each spatial frequency and 
then averaged, similar to CRT measurements.
Other visual measurements
Throughout the study pupil diameter and near point accommodation 
were measured. Pupil diameter was measured by photography (Olympus 0M- 
1 single lens reflex body with Tamron 80mm macro lens) under moderate
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illumination (30 metre-candela). Both eyes were photographed, with a 10 
mm scale bar placed just belcw one eye, from a distance of about 0.5m. 
Two frames were taken for each measurement and the pupil diameter in the 
horizontal plane averaged. Near point accommodation was measured, in 
dioptres, with a RAF Near Point Rule: the subject viewed the fine print 
chart and brought the slide towards himself to locate the point at which 
blurring was first detected. This was repeated five times and averaged.
The experiments were usually of a demanding nature and regular 
breaks were taken to avoid subject fatigue. No tea, coffee, drinks with 
additives or cigarettes were allowed, but refreshments were taken at 
appropriate intervals.
Subjects
The subjects who participated in this study were all volunteers 
(ages 18-42 years) recruited in the early part of the study from local 
Territorial Army units with some staff and post-graduate students from 
the Institute of Physiology. In later experiments volunteers were almost 
entirely post-graduate students and friends (ages 18-28 years). They 
each gave their written consent to the experiments after an explanation 
of the likely effects and hazards of the procedure to be used and were 
advised of their right to withdraw from the experiment at any time 
irrespective of having signed the consent form.
Exclusions
All subjects were to be of good health and those receiving any 
medication were excluded from the study. Undergraduate students 
receiving tuition within the Institute of Physiology were also excluded. 
In addition no subjects with over 2.5 D myopia were allowed to 
participate in the experiments involving physostigmine eyedrops (because
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of the increased risk of retinal detachment in severely myopic patients 
from the use of miotic agents; Alpar, 1979).
Ethical consent
The work described in this thesis had received the prior approval 
of the Ethical Committee of The Greater Glasgow Health Board (Western 
District) which evaluates projects undertaken within the University of 
Glasgow.
Experiments performed
Prior to every experimental period each subject viewed the Snellen 
test and astigmatism fan and were optimally refracted to within 0.25 D 
(to within 0.12 D for part 1). Visual acuity was always 6/5 or 6/4 for 
parts 1 and 2. For the remainder of the experiments, visual acuity was 
measured from 5m and all subjects were corrected to 5/4. Additional 
lenses were worn if necessary for optimal acuity when viewing the CRT 
display but were not necessary for the laser display. For both stimulus 
displays the subject viewed monocularly with the same eye. Prior to the 
study proper, each subject underwent a familiarisation run consisting of 
spatial frequencies of 10, 20 and 30 c/deg. This process usually took 
longer with the laser display. It was found that once a subject had 
successfully practised the highest spatial frequency, he became attuned 
to the method and was reasonably consistent in judgements thereafter. 
The consistency of repeated contrast sensitivity measurements to the CRT 
was tested in a series of experiments described in part 4.
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Part 1; A quantitative investigation of the effects of defocus, pupil 
diameter and spatial frequency on contrast sensitivity.
A total of 10 male and 2 female subjects ages 18-40 years 
participated in the first experiment in this section involving 
hcmatropine eyedrops. Of this group, eight also completed the second 
experiment for the natural eye.
CRT Display; The same standard protocol was followed by all subjects. 
Contrast thresholds for stationary sinusoidal gratings were measured at 
each of-10, 20, 30, 38, 35, 25, 15 and 10 c/deg viewed at 3m and 8, 3, 
1, 0.5 and 5 c/deg at 1m, in this order. These were collected for the 
following conditions.
(1) Natural pupil diameter and optimal accommodation.
(2) Viewing with a 3.0mm artificial pupil and optimal accommodation.
(3) 2.0mm artificial pupil and optimal accommodation.
(4) 2.0mm artificial pupil and +2.0 D additional defocus.
(5) 3.0mm artificial pupil and +2.0 D additional defocus.
(6) 3.0mm artificial pupil and +4.0 D additional defocus.
(7) 3.0mm artificial pupil and +1.0 D additional defocus.
(8) Repeat measurements at 10, 20 and 30 c/deg with natural pupil 
and accommodation.
The artificial pupil was worn in a trial frame in the slot 
directly in front of the eye, additional lenses were also placed in this 
frame when required.
In the first set of experiments, one drop of 2% homatropine 
hydrobromide solution (Kirby-Warrick Pharmaceuticals Ltd.) was
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instilled, prior to condition (2), which maximally dilated the pupil and 
paralysed accommodation after 20-30 minutes. The subject was then 
optimally refracted with a Snellen chart to within 0.12 D for viewing at 
1m and 3m, as Charman (1979) has demonstrated the importance of accurate 
refraction for spatial frequencies of 10 c/deg and over (Charman found 
for a spatial frequency of 20 c/deg and a 3mm pupil that a defocus of 
only 0.5D caused a fall in relative contrast sensitivity by a factor of 
0.6). These corrections were typically +0.75 D for 1m and +0.25 for 3m. 
Condition (8) was omitted but two repeat measurements were taken for the 
homatropinised pupil at 3 and 20 c/deg. These experiments were carried 
out by Dr. J.D. Morrison and subsequently analysed by myself.
In the second set of experiments the protocol was followed exactly 
as stated, thus repeating the measurements for the natural eye. The 
experimental measurements usually lasted for some 6 hours, with an 
additional 1-1.5 hours allowed for breaks.
Laser Display; Contrast thresholds were measured for a range of spatial 
frequencies from 1 to 50 c/deg. When setting the spatial frequency of 
the display it was not always possible to obtain exactly the intended 
spatial frequency without an undue amount of re-adjustment. Hence, the 
spatial frequencies measured do not always correspond exactly to those 
measured for the CRT display; however, the spatial frequency that was 
obtained was, of course, known very precisely. The spatial frequencies 
were studied in the following order; 9.5, 20.5, 30, 41 , 45, 50, 33, 36, 
26, 15, 9.5, 5, 1, 2.5, 7.5, 17.5 and 23 c/deg. The measurements were 
made in a darkened room in which the pupil would be dilated thus 
presenting no problem in viewing the two laser sources even at their 
widest separation. Even at 50 c/deg, the subjects were able to make 
reproducible measurements of contrast threshold without difficulty. In
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cases of uncertainty, they were advised to look away from the display 
for a few moments and then review before making a decision, since high 
spatial frequency fringes readily disappear from view due to adaptation. 
Measurements usually lasted for 3 hours and were made on a different day 
from the CRT measurements.
Part 2: The effects of a single oral dose of pyridostigmine bromide on 
contrast sensitivity.
Thirteen male subjects, ages 18-40 years participated in this 
experiment. The effect of a single oral dose of 60mg pyridostigmine 
bromide on contrast sensitivity was investigated on a double-blind 
basis, with lactose as the control. Each subject made two visits to the 
laboratory at the same time of day. At least 1 hour, usually 2 hours 
after a light meal, the volunteer ingested one of two capsules, prepared 
by the Pharmacy, Western Infirmary Glasgow, which contained 60mg 
pyridostigmine bromide (Roche) or 60 mg lactose. Neither the subject nor 
myself nor Dr. Morrison was aware of the order in which the capsules 
were given until after the experiments had been completed and analysed.
The time course of the experiments was dictated by the 
pharmacokinetics of pyridostigmine absorption. At least 20% inhibition 
of whole blood cholinesterase is known to occur between 1 and 4.5 hours 
after ingestion of this dose (Dr. R.I. Gleadle, personal communication). 
The contrast sensitivity measurements were, therefore, made during this 
interval. Each volunteer underwent the following procedure after 
ingestion of the tablet.
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(1)0 - 1 h Rest period while pyridostigmine was absorbed.
(2) 1 - 1.5 h Familiarisation with laser and CRT displays, practice
measurements at 10, 20 and 30 c/deg for each display.
(3) 1.5 - 2.25h Contrast sensitivity measurements to CRT display at 10,
20, 30, 35, 38, 25, 15, 8 and 10 c/deg in that order
from 3m and 5, 3, 1, 6 and 8 c/deg at 1m.
(4) 2.25 - 2.5h Short break for refreshments (water/milk/decaffeinated
coffee offered with the same on the second day).
(5) 2.5 - 4.25h Contrast sensitivity measurements to laser
interference fringes at a range of spatial frequencies 
from 1 to 40 c/deg with approximately the same values 
as for the CRT display.
(6) 4.25 - 4.5h Repeat measurements were made for the CRT display at
10, 20 and 30 c/deg.
Throughout this study, starting with control measurements prior to 
ingestion of the tablets, pupil diameter was taken by photography, under 
dim illumination, every 30 min. After completion of the tests, and 
ascertaining that the subject was fit and well, he was allowed to go 
home, but requested not to drive until the following day.
Part 3: The effects of topical application of 0.25% physostigmine 
sulphate on visual performance
A total of 12 subjects completed this part of the study, 7 male 
and 5 female, ages 18 to 28 years. In this and all subsequent studies, 
subjects were first optimally refracted to within 0.25D by viewing an 
illuminated Snellen chart. As the increase in accommodation caused by 
physostigmine eyedrops is fairly transient (Rengstorff, 1970), the
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visual tests consisted of short series of measurements which were 
repeated continuously for the first one and a half hours, and then once 
every half hour until 3 hours post-administration.
Each subj ect completed three separate experiments covering 
different aspects of visual function. Prior to the eyedrops two control 
series of measurements were taken on each of the three separate days. 
Following this on each occasion the subject received two drops of 0.25% 
physostigmine sulphate (Evans Medical Ltd.) into the lower conjunctival 
sac (of the same eye). The head was held back for 2 to 3 min so that the 
drug would be absorbed without being blinked away. Measurements then 
began at 5 min after instillation.
Every series of measurements commenced with a Snellen test and 
then the increase in accommodation caused by the eyedrops was measured 
by finding the strength of negative lens required to bring the bottom 
line of the Snellen chart bade into sharp focus. Following this, near 
point accommodation was measured using the RAF rule for the natural 
pupil (and also for viewing through a 2nm artificial pupil in the 
initial control measurements). Contrast sensitivity was then measured in 
response to one of the following on a separate day.
(1) Stationary patterns of 10, 20, and 30 c/deg generated on a CRT 
measured from 2.86m and 3 c/deg from 1.43m. These measurements were 
repeated approximately every 15 min.
(2) Moving patterns (sinusoidal gratings phase-reversed at 5.5 Hz.) of 
0.5, 1, 2 and 3 c/deg, from 1.43m. These measurements were repeated 
approximately every 20 min.
(3) Stationary patterns generated by the laser interferometer at 4, 15 
and 25 c/deg. These measurements were preceded by a test for critical 
fusion frequency, which measures the lowest frequency of repetition at 
which a flickering object appears stationary. This was determined using
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a U.S. Air Force Portable Visual Function Tester (Genco & Task, 1984). 
This is a hand-held device with which the subject views a target 
arranged to be at infinity at the centre of his visual field through a 
collimating eyepiece. Viewing was, of course, monocular and through an 
appropriate lens to bring an object at infinity into sharp focus as 
measured just prior to this test for the Snellen chart. Control 
measurements prior to administration of the eyedrops were made through a 
2mm artificial pupil. This group of measurements was repeated every 30 
min.
There may be some genetic factor involved in determining the 
strength of a person's response to physostigmine eyedrops. Twd brothers 
were involved in the initial series of experiments just described, and 
so a third brother from this family was later tested with physostigmine 
eyedrops (and, in fact, vrent on to participate in part 5 of this study). 
Two siblings (twins, male and female) of another male member of the 
original 12 subjects were also tested with the same dose of 
physostigmine and their accommodation (near point and amplitude of 
defocus) and pupil diameter responses were assessed, and compared to 
that of their brother.
Part 4: The effect of an intramuscular dose of 2 mg atropine sulphate on 
visual performance
General Procedure
A total of 13 male subjects ages 21-40 years participated in this 
part of the study. In all experiments, following routine medical 
screening, the subject received an i.m. injection into the upper arm of 
2mg atropine sulphate in 1 ml saline (McCarthys Ltd) from the Medical 
Officer in attendance. He also remained on-call for the duration of the
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experiment and discharged the subject after the experiment had been 
completed. Two complications could arise from an injection of atropine. 
First, immediately after the injection the subject may become 
susceptible to a vaso-vagal attack resulting in fainting. Thus a rest 
period of 15 min was allowed before measurements commenced. During this 
period, heart rate was monitored continually by palpation until it 
started to rise; thereafter, heart rate was taken every half hour. 
Second, a possible risk existed in those subjects with an abnormality of 
the ventricular conducting system, e.g. with the accessory bundle of 
Kent when an increased risk of ventricular fibrillation existed. In the 
one case where some doubt of a subject's cardiac health existed, an 
electrocardiogram was taken prior to the experiment. In fact, no adverse 
effects other than those anticipated were encountered and all subjects 
were discharged as satisfactory after the experiment.
Throughout the study the subject was asked to describe any 
symptoms as they occurred. Viewing was binocular for this study and if 
additional lenses were necessary for optimal control acuity then they 
were worn throughout. Pupil diameter was measured every 30 min.
Two experiments were performed, the first was completed by 8 
subjects and the second by 13 subjects.
Experiment 1^
Prior to the injection, the subject was made familiar with the 
procedures to be used and two control runs were completed. Each test 
period consisted of the following seven procedures in the order given, 
and lasted for about 45 min. These were performed at hourly intervals up 
to 6 hours post-injection. The tests were performed under normal room 
lighting (30 metre-candela), except for tests 4,6 and 7, which required 
subdued lighting (0.5 metre-candela).
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(1) Reaction time and choice reaction time
A simple reaction time unit was used to measure the time between 
the signal and the response. A Digitimer provided a pulse to illuminate 
a small light emitting diode (LED) and also start the counter (Digital 
Latency-meter) which was accurate to the nearest 0.1ms. The subject held 
a console with three coloured LEDs and three push-button switches and 
was asked to press the button adjacent to the illuminated LED. This 
stopped the counter and the reading was noted. Reaction time was 
measured as the time to respond to illumination of the red LED. An 
additional unit allowed the experimenter to select at random which of 
the three LEDs would be illuminated, requiring that a decision be made 
by the observer thus allowing a choice reaction time to be measured. 
The latencies of ten consecutive tests were averaged for each period.
(2) Extraocular muscle balance
These measurements were determined with the portable Visual 
Function Tester as used previously for critical fusion frequency 
measurements. For these determinations of extraocular muscle balance, 
the subject viewed the target at infinity binocularly through 
collimating eyepieces.
Lateral and vertical heterophoria. The relative positions of the eyes 
referenced to the X and Y axes were measured. The stimulus for the left 
eye was a short duration flash and for the right a grid calibrated 
vertically and horizontally in prism dioptres. On pressing a button the 
flash of light appeared in the left visual field and the subject gave 
the coordinates of the square in which the flash was seen. Thus perfect 
orthophoria would be coordinates H4.
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Cyclophoria. This describes the relative position of the eyes along 
the Z axis, i.e. the rotation of one eye with respect to the other. The 
torsional phoria stimulus was an arrow in the left eye and a numbered 
scale calibrated in degrees in the right. Both eyes also viewed a 
bullseye pattern to allow fusion of the targets. The subject identified 
the position to which the arrow pointed. The amount of cyclophoria was 
given by the reading on the scale.
For both tests the mean of four readings were taken.
(3) Accommodation
Near Point Acconxnodation was measured with the RAF rule whilst 
viewing with both eyes and natural pupils.
(4) Colour-matching
A Pickford-Nicolson Anomaloscope was used to find the Red/Green 
matching range as described by Pickford and Lakowski (1960). The 
instrument is a simple colorimeter with two integrating boxes such that 
light from each box illuminates a separate half of the screen which 
measured 5cm in diameter. The light to one half passes through a yellow 
filter whilst that to the other half passes through red and green 
filters. The proportion of red and green was varied by adjusting a 
scale from 0 to 80 until the subject matched the hue with that on the 
other half of the screen. Brightness was always made equal before any 
judgement of colour was accepted. The test was carried out until a 
steady matching range was obtained, usually within four to six 
determinations. For normal subjects, the range lies between 33.6 - 41.2 
(99% confidence limits).
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(5) Stereoacuity
(i) Measurements to extended line stimuli based upon the method 
of Anderson and Weymouth (1923) were made. The subject, chin in rest, 
viewed three white vertical needles in an aperture from a distance of 2 
metres. The needles were approximately 1mm thick, 30imi long and 
positioned 20mm apart. The central needle was mounted on a micrometer 
and could be positioned at varying distances in front and behind the two 
lateral needles: viz. 3.25mm in front and 3.75mm behind in 0.5mm steps. 
Each position was tested three times giving a total of 45 positions in 
all. The subject's stereoacuity was calculated as half the distance 
between the two 100% "hits" points (i.e. where 3 out of 3 correct scores 
were made) in front and behind and converted into visual angle. An 
overall assessment of performance on the test was also computed as the 
number of correct decisions expressed as a percentage of the 45 trials.
(ii) An alternative test of stereopsis based on a matrix of 4 dots 
was also performed on the portable Visual Function Tester. The subject 
viewed each test matrix in turn and identified which dot appeared 
closer to him than the others. The smallest stereoscopic disparity 
testable was 10 seconds of arc.
(6) Visual Acuity
Visual acuity was measured as the highest spatial frequency 
visible for a stationary sinusoidal grating generated on the CRT and 
viewed with both eyes from 2.86m. The subject m s  asked to say whether 
or not a high spatial frequency grating at full contrast was visible, 
giving him the option to turn the contrast down and then back up again 
to aid a decision. The cut-off frequency was taken as the highest 
spatial frequency detected on two or more of four trials. This is
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related to Snellen acuity since 30 c/deg is equivalent to 6/6 vision, 36 
c/deg to 6/5 vision and 45 c/deg to 6/4 vision.
(7) Contrast sensitivity to a moving stimulus
Contrast sensitivity was measured to sinusoidal grating patterns 
of 1, 2, 3 and 5 c/deg phase-reversed at 5.5 Hz, as described earlier.
Experiment 2
In this experiment each subject was tested on two separate days. 
On their first visit to the laboratory, each subject completed a full 
"dummy" run of the experiment consisting of four consecutive series of 
measurements, lasting for four hours, to determine the consistency of 
repeated contrast sensitivity measurements. The test day consisted of a 
further control run followed by the injection and three test runs.
Contrast sensitivity was measured monocularly to vertical 
sinusoidal grating patterns generated on both the CRT and the laser 
interferometer. Each series of measurements consisted of the following:
(1) CRT contrast sensitivity determinations for stationary patterns at 
10, 20, 30, 25, 15, 8, 10, 5, 3, 1, and 8 c/deg in that order, of 
duration 30 min.
(2) Laser contrast sensitivity determinations at 8, 15, and 26 c/deg in 
variable order, of duration 15 min.
(3) Rest period during which heart rate, near point and pupil diameter 
were measured, of duration 15 min.
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Part 5; The effectiveness of prior administration of an intramuscular 
injection of atropine sulphate or instillation of homatropine eyedrops 
against physostigmine eyedrops.
Those six subjects who were most markedly defocused by 
physostigmine eyedrops were then twice more tested with physostigmine, 
but this time preceded by 2mg of atropine sulphate (i.m.) at different 
intervals. Five of these subjects also completed a third experiment in 
Which physostigmine eyedrops were preceded by homatropine hydrobromide 
eyedrops. Each subject first underwent two control series of tests of 
visual function before each of the following treatments.
(a) Intramuscular injection of 2mg atropine sulphate 8 min prior to two 
drops of 0.25% physostigmine sulphate eyedrops.
Following the atropine injection a rest period was allowed as the 
bradycardia experienced at this time may cause syncope. Two drops of 
0.25% physostigmine sulphate were instilled into one eye as soon as the 
heart rate began to increase. Tests of visual function were recommenced 
5 min after physostigmine and were made continuously until 1.5 hours 
after administration, thereafter one complete series was made every half 
hour until 3 hours.
(b) Intramuscular injection of 2mg atropine sulphate at 120 min prior to 
tvro drops of 0.25% physostigmine sulphate eyedrops.
Two series of tests of visual function were made following the 
atropine injection. After physostigmine, three series of tests were 
made in the first hour, followed by two further series, until 2 hours.
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(c) Ocular instillation of three drops of 2% homatropine hydrobromide at 
100 min prior to two drops of 0.25% physostigmine sulphate eyedrops.
Each subject first performed three control series of tests on this 
occasion. The subject then received three single drops of 2% 
homatropine hydrobromide (Kirby-Warrick Pharmaceuticals Ltd.) at 5 min 
intervals, instilled into the lower conjunctival sac. This dose is used 
clinically to induce cycloplegia. After an
interval of approximately 30 min, the first series of tests was made, 
followed closely by a second series before a short break was taken for 
lunch at approximately 60 min after homatropine administration. A third 
series of tests was made, then at 100 min after homatropine 
administration the subject received two drops of 0.25% physostigmine 
sulphate into the same eye. Ihe effects of which were followed for 3 
hours as in part (a).
Each series of tests of visual function consisted of the following:
(1) Snellen test and measurement of the amount of myopia caused by the 
eyedrops as previously described for part 3.
(2) Near point accommodation and pupil diameter.
(3) Critical fusion frequency was measured using the portable Visual 
Function Tester (also as described for part 3) for the 8 min atropine 
pre-treatment only.
(4) Contrast sensitivity measurements were made for stationary 
sinusoidal grating patterns generated on a COT at 10, 20, and 30 c/deg 
and at 3 c/deg for a grating pattern phase-reversed at 5.5 Hz.
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Data analysis
The statistical tests used in this thesis were made, in the main, 
with the Minitab package (Ryan, Joiner & Ryan, 1985) on the University 
Mainframe computer although some analysis was also performed on an 
Amstrad personal computer using the Amstat One package. Comparisons 
between test and control periods for the same set of subjects were made 
with paired t-tests wherever possible. Other tests performed were 
unpaired t-tests, analysis of variance and calculations of best-fitting 
linear regression equations. Further comparisons of the slopes and 
intercepts of the best fitting regression equations were made manually 
according to Draper & Smith (1981).
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RESULTS
Part 1: A quantitative investigation of the effects of defocus, pupil 
diameter and spatial frequency on contrast sensitivity.
Contrast sensitivity to CRT display
The form of the CSF was the same for all individuals and, for the 
natural pupil (of some 6mm diameter), consisted of a peak at 3-5 c/deg 
with a decline at lcwer and higher spatial frequencies. A mean CSF was 
calculated for the 12 subjects and is shown in Fig. 7. The peak of 
this function occurred at 3 c/deg and had, a mean value of 81 units 
(range 62-182). The high frequency fall-off was best fitted by a 
logarithmic-linear plot with a cut-off frequency of 35-38 c/deg. The 
standard deviation bars show that there was quite large variation 
between subjects in their absolute contrast sensitivity values.
Pupil Diameter
Homatropine eyedrops increased the pupil diameter from 
approximately 6mm (natural pupil under these illumination conditions) to 
8mm without having an effect on contrast sensitivity after refraction 
for the two viewing distances. The regression equations for 3-38 c/deg 
for natural and homatropinised eyes did not differ significantly in 
intercept or slope (P>0.25). When paired t-tests were made for the 
highest spatial frequency detected, no significant difference was 
observed (P>0.25). Paired t-tests for the spatial frequencies less than 
peak, before and after homatropine, also failed to reveal a significant 
difference (P>0.25).
In the homatropinised eye, viewing with the 3mm artificial pupil 
marginally improved contrast sensitivity while the 2mm pupil had a 
tendency to slightly worsen it, compared with the fully dilated pupil 
(Fig. 8A). However, comparison of the regression equations of the 2mm
90
3 .0 —,
S p a t i a l  f r e q u e n c y  (c/deg)
Fig. 7. Contrast sensitivities (on logarithmic scale) to CRT showing 
the mean + S.D. of the logarithm contrast sensitivities (i.e. the 
geometric mean) for 12 subjects viewing with natural 6mm pupil.
and 3mm artificial pupils with that of the fully dilated pupil revealed 
that neither the slopes nor intercepts were significantly different 
(P>0.25). At 0.5 and 1.0 c/deg, the paired t-test showed that contrast 
sensitivities for the 3mm pupil were not significantly different from 
those for the dilated pupil (P>0.25); however those for the 2mm pupil 
were significantly reduced (P<0.01 for each spatial frequency).
In the repeat experiments for the natural eye without homatropine, 
similar results were obtained. The 3mm pupil marginally improved and the 
2mm pupil marginally worsened contrast sensitivity compared with the 
natural 6mm pupil (Fig. 8B). The regression equations for 3-38 c/deg 
were not significantly different with regard to slopes and intercepts 
(P>0.25). Contrast sensitivity was unaffected at 0.5 c/deg with the 2mm 
and 3mm pupils (paired t-test, P>0.25) but a significant reduction did 
occur with both 2mm and 3mm pupils at 1 c/deg (P<0.05). The details of 
the regression equations for the different pupil diameters are listed in 
Table 2.
Defocus
When viewing with the 3mm artificial pupil with which optical 
quality is said to be optimal (Campbell & Green, 1965), increasing 
defocus by positive spherical lenses had an increasingly detrimental 
effect on contrast sensitivity over 3-38 c/deg in both homatropinised 
(Fig. 9A) and natural eyes (Fig. 9B). In both cases there is a step-wise 
parallel downward shift of the 3-38 c/deg segment of the CSF, with a 
smaller decrease for spatial frequencies below 3 c/deg. A similarly 
deleterious effect was caused by a +2.0D lens when viewing through the 
2mm artificial pupil (Figs. 10A & B). The shifts in the CSF caused by 
defocus were examined by comparing the regression equations for 3-38 
c/deg under each of the experimental conditions. These regression
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Fig. 8. Effects of pupil diameter on mean logarithmic contrast 
sensitivities in the homatropinised (A) and natural eye (B). Each point 
shows the mean for 12 (A) or 8 (B) subjects. Pupil diameter in mm is 
indicated.
Table 2. Effect of pupil diameter on the regression equation of mean log 
contrast sensitivity (y) against spatial frequency (x) in the range 
3 - 3 8  c/deg.
Condition Regression SD of y r P
Pre-homatropine y  = 2.08 -  0.056* 0.08 -0 .9 9 2 <  0.001
Homatropine/8 mm y =  2.07 -  0.058* 0.05 -0 .997 <  0.001
Homatropine/3 mm y  = 2.06 -  0.052* 0.06 -0 .9 9 6 <  0.001
Homatropine/2 mm y = 1.94 -  0.052* 0.05 -0 .9 9 6 <  0.001
Natural/6 mm y =  2.15 -  0.057* 0.12 -0 .987 <  0.001
Natural/3 mm y =  2.07 -  0.053* 0.08 -0 .99 2 <  0.001
Natural/2 mm y = 2.00 -  0.052* 0.05 -0 .99 6 <  0.001
y  is logarithm contrast sensitivity and *  is spatial frequency.
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Fig. 9. Effects of positive defocusing lenses on mean logarithmic 
contrast sensitivities for viewing with the 3 inn artificial pupil in 
homatropinised (A) and natural (B) eyes. Each point shows the mean for 
12 (A) or 8 (B) subjects. Defocus in dioptres is given alongside the 
appropriate contrast sensitivity curves.
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Fig. 10. Effects of a +2 D defocusing lens on mean logarithmic contrast 
sensitivities for viewing with the 2 mm artificial pupil in 
homatropinised (A) and natural (B) eyes. Each point shows the mean for 
12 (A) or 8 (B) subjects.
equations are listed in Table 3. For 2D and 4D of defocus, there was a 
very marked reduction in the intercept of regression equations, which 
was significant when compared with optimal focus in the homatropinised 
and natural eyes (P<0.001). With the +1.0D lens, the decrease in 
intercept was significant only in the homatropinised eye (P=0.05) but 
not in the natural eye (P>0.25) where presumably relaxation of 
accommodation reduced the effects of defocus.
Inspection of the slopes of the regression lines shows an apparent 
increase in the negative slope with increasing defocus; however, 
statistical comparison of these slopes showed that the changes were not 
significant (P>0.25) in both homatropinised and natural eyes (Table 3). 
The same absence of a significant difference between slopes was also 
present in each one of the individual results listed in Table 4.
In the homatropinised eye, vhere defocus was precisely controlled, 
the subjects showed a range of effects with increasing defocus. 
Subjects 1 and 2 had slopes which were essentially unchanged with 
defocus. Subjects 10-12 had slopes which increased with increasing 
defocus in the same way as Campbell & Green's (1965) results, shown as 
"C and G" in Table 4. The remaining subjects (with the exception of 
subject 9) gave biphasic responses, in that the slope increased with 
+1.0D and then remained the same or decreased with greater defocus.
Viewing with the natural eye was subjectively reported as being 
difficult since continual shifts of focus occurred presumably as a 
result of the accommodation mechanism seeking optimal focus. The 
variability of the data was greater in the natural eye than in the 
homatropinised eye as shown for the mean data in Fig. 10B and Table 3. 
The individual results shown in Table 4 (right) again shew a range of 
behaviour with regard to the slope of the regression equation. Some 
subjects showed an increase in slope with increasing defocus whilst
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others showed an increase followed by a fall in slope at +4.0D. The data 
of Regan et al., (1977) shown as "R, S and M" also show an increase in 
slope for 1.0D. However, for all the data shown in Table 4 (right), 
including that of Regan et al., none of the regression equations for 
defocus were significantly different from optimal focus (P>0.25).
For spatial frequencies below peak of the CSF, the data were 
analysed using paired t-tests. Increased defocus in the homatropinised 
eye caused a significant reduction in contrast sensitivity at 0.5 and 
1.0 c/deg with the 3mm pupil (P<0.02) but not with the 2mm pupil 
(P>0.10). Contrast sensitivity at 3 c/deg was significantly reduced with 
defocus for both 2 and 3mm pupils (P<0.001). In the natural eye, defocus 
reduced contrast sensitivity to a lesser extent, which was not 
significant for +1.0D (P>0.1), but with greater defocus, contrast 
sensitivity was significantly reduced with the 3mm pupil (P<0.02) but 
not with the 2mm pupil (P>0.25).
At the end of this long experiment (which usually lasted for 8 
hours) repeat measurements were made for a range of spatial frequencies 
for the CRT display. For the homatropinised eye, repeat measurements 
were made at a lew spatial frequency, 3 c/deg and at a high spatial 
frequency, 20 c/deg. When compared to the initial measurements for the 
homatropinised pupil and optimal focus, no significant differences were 
found for either 3 c/deg (P>0.10) or 20 c/deg (P=0.89), despite the 
arduous experiment just completed. For the natural eye repeat 
measurements were made at 10, 20 and 30 c/deg. At 10 c/deg a small but 
significant decline in contrast sensitivity was seen when compared to 
the first series of measurements taken for the natural pupil (P=0.04). 
Those measurements at 20 and 30 c/deg, however, were not significantly 
different from the initial measurements (P=0.34 and P=0.51 
respectively).
94
Table 3. Effect of defocus with positive lenses on the regression 
equation of mean log contrast sensitivity (y) against spatial 
frequency (x) in the range 3 - 3 8  c/deg for the combinations of 
defocusing lens power and artificial pupil diameter indicated.
Condition Regression SD of y r P
After homatropine:
0.0 D /3  mm y - 2.06 -  0.052* 0.06 -0 .9 9 6 < 0.001
+ 1.0 D /3  mm y = 1.69 -  0.063* 0.10 -0 .9 8 0 < 0.001
+  2.0 D /3  mm y = 1.44 -  0.068* 0.07 -0 .9 8 6 < 0.001
+  4.0 D /3  mm y = 0.96 -  0.068* 0.04 -0 .9 8 6 < 0.01
0.0 D /2  mm y = 1.94 -  0.052* 0.05 -0 .9 9 6 < 0.001
+ 2.0 D /2  mm y = 1.56 -  0.076* 0.10 -0 .9 7 9 < 0.001
Natural eye:
0.0 D /3  mm y = 2.07 -  0.053* 0.08 -0 .9 9 2 < 0.001
+  1.0 D /3  mm y = 1.79 -  0.053* 0.15 -0 .9 6 8 < 0.001
+  2.0 D /3  mm y = 1.64 -  0.072* 0.19 -0 .9 5 0 < 0.001
+ 4.0 D /3  mm y = 1.26 -  0.077* 0.07 -0 .9 8 2 < 0.001
0.0 D /2  mm y = 2.00 -  0.052* 0.05 -0 .9 9 6 < 0.001
+  2.0 D /2  mm y = 1.71 -  0.072* 0.18 -0 .9 5 6 < 0.001
Table 4. Slopes of regression equations of log contrast sensitivity 
against spatial frequency (c/deg) for 12 individual subjects with a 3 mm 
artificial pupil under the various conditions of defocus indicated. 
Also given are the slope values obtained from Campbell & Green (1965) 
- (C and G) and Regan et al., (1977) - (R, S and M).
0.0 D
Homatropine 
+ 1 .0 D  + 2 .0  D + 4.0 D 0.0 D
Natural 
+ 1 .0 D  + 2 .0  D + 4.0 D
1. CDK -0 .0 5 4 -0 .0 5 8 -0 .0 5 9 -0 .0 5 4 -0 .0 6 3 -0 .0 7 8 -0 .0 9 5 -0 .0 5 4
2. JDM -0 .0 4 9 -0 .0 4 4 -0 .0 4 2 -0 .0 5 0 -0 .0 6 3 -0 .0 6 0 -0 .0 4 8 -0 .0 6 9
3. GW -0 .0 5 0 -0 .061 -0 .0 5 8 -0 .0 6 7 -0 .0 5 1 -0 .0 5 2 -0 .0 7 4 -0 .1 2 4
4. AR -0 .0 4 8 -  0.066 -0 .0 5 8 -0 .0 6 6 -0 .0 4 8 -0 .0 4 8 -0 .0 6 9 -0 .0 7 2
5. RO -0 .0 7 0 -0 .0 8 5 -0 .0 9 0 -0 .0 8 3 -0 .0 6 0 -0 .0 7 5 -0 .0 8 3 -0 .0 7 7
6. JM I -0 .0 5 0 -0 .061 -0 .0 6 0 -0 .0 5 9 -0 .0 4 3 -0 .0 6 9 -0 .0 8 8 -0 .0 7 6
7. H M D -0 .0 5 2 -0 .0 7 3 -0 .0 6 7 -0 .0 5 9
8. RR -0 .0 5 3 -0 .0 7 4 -0 .0 8 8 -0 .0 8 0 -0 .0 6 0 -0 .0 6 7 -0 .0 9 3 -0 .0 6 9
9. DQ -0 .0 6 0 -0 .0 4 3 -0 .0 5 9 -0 .0 8 1
10. SON -0 .0 4 5 -0 .0 5 9 -0 .071 -0 .0 8 5 -0 .0 6 4 -0 .0 6 8 -0 .0 8 2 -0 .0 7 5
11. LCC -0 .0 5 0 -0 .0 5 8 -0 .0 6 4 -0 .0 7 3
12. VK -0 .0 4 7 -0 .0 5 5 -0 .0 7 6 -0 .0 9 3
C and G -0 .0 4 8 -0 .0 5 6 -0 .0 6 0
R, S and M -0 .0 6 4 -0 .0 9 3
Units: log units per cycle per degree.
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Quantitative analysis
In order that these measurements might be of practical value in 
predicting contrast sensitivity at this CRT luminance of 1.4 cd/m^, the 
best fitting multiple regression equations were derived taking into 
account pupil diameter, defocus and spatial frequency. To simplify the 
analysis the CSF was separated at the peak of 3 c/deg into low and high 
spatial frequency limbs.
The derived equation expressed logarithm contrast sensitivity (y) 
as a linear function of spatial frequency (xF, in c/deg), pupil diameter 
(Xp, in ran) and defocus (x^ , in dioptres). The equations derived for the 
natural and homatropinised eyes are shown below.
Homatropine
0.5-3 c/deg, y = 0.80 + 0.29xF + 0.021xp - 0.092^,
SDy = 0.15, r = +0.924 (P< 0.001)
3-38 c/deg, y = 1 .99 - 0.055xF + 0.009 xp - 0.313^,
SDy = 0.11, r = -0.981 (P< 0.001).
Natural
0.5-3 c/deg, y = 0.78 + 0.33xF + 0.024xp - 0.05x q , 
SDy = 0.15, r = +0.926 (P< 0.001)
3-38 c/deg, y = 2.05 - 0.057xF + 0.016xp - 0.26xD, 
SDy = 0.15, r = -0.972 (P< 0.001).
Neither logarithmic nor square functions of the x variables in the 
equations resulted in a better fit with the exception of the natural eye 
at 3-38 c/deg where a very marginal improvement was obtained by taking 
the logarithm of the spatial frequency term. Analysis of the 0.5-1.0 
c/deg data (i.e. excluding 3 c/deg) in the homatropinised eye gave 
coefficients for pupil diameter and defocus of +0.017 and -0.08,
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respectively. These are similar to those obtained when 3 c/deg was 
included in the lew spatial frequency limb and indicated that the 
3 c/deg data had not biased these coefficients. To take account of a 
possible increase in negative slope with defocus, the latter term was 
incorporated as a function of spatial frequency. The best fitting 
regression for the hematropinised eye over 3-38 c/deg thus obtained was 
y = 1.93 - 0.052xp + 0.006xp - 0.15xDlog^qXf 
SDy = 0.10, r = -0.980 (P< 0.001)
As the correlation coefficient was almost exactly the same for 
this equation there was no reason to prefer this equation over the more 
simple form originally computed.
To summarise the findings of these computations, at all spatial 
frequencies, changes in pupil diameter had only very marginal effects, 
tending to increase contrast sensitivity as pupil diameter increased. 
The effects were somewhat greater at 0.5-3 c/deg than over the 3-38 
c/deg segment of the CSF. By contrast, the effects of defocus were 
profound, being greater in the homatropinised eye than in the natural 
eye. At 0.5-3 c/deg, contrast sensitivity was reduced by 19% and 11% per 
dioptre in the homatropinised and natural eye respectively While at 3-38 
c/deg, the reduction was 51% and 45% per dioptre respectively.
Contrast sensitivity to the laser display
The shape of the CSF for the laser display was generally more 
flattened at the peak than that for the CRT display. Attenuation of 
contrast sensitivity did occur at low and high spatial frequencies as 
shown for the mean CSF for all 12 subjects (Fig. 11). The peak contrast 
sensitivity was 148 units (range 43-692) and also occurred at 3 c/deg as 
for the CRT display but the peak was more noticeably flattened. Spatial 
frequencies as high as 50 c/deg were observed without difficulty. The
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Fig. 11. Contrast sensitivities (on logarithmic scale) to laser 
interference fringes showing the geometric mean + S.D. for 12 subjects 
for viewing with natural 6 mm pupil.
high frequency fall-off was fitted by a logarithmic-linear plot as shown 
in Fig. 11 and the regression equation obtained is given below. However, 
the relationship may be more curvilinear at very high spatial 
frequencies for omitting the 45 and 50 c/deg points from the regression 
resulted in a slightly better fit to the regression line as also shown 
below.
The regression for the laser display obtained over 2.5-50 c/deg was 
y = 2.34 - 0.043x 
SDy = 0.12, r = -0.983 (P< 0.001)
The best fitting regression obtained over 2.5-41.5 c/deg was 
y = 2.41 - 0.047x 
SDy = 0.10, r = -0.986 (P< 0.001)
The standard deviation bars of Fig. 11 show that there was a great 
deal of variation between subjects in the absolute contrast sensitivity 
values, nevertheless the general shape of the CSF was the same for all 
subjects. The contrast sensitivity measurements to the laser 
interference fringes were always greater than those for the CRT at 
corresponding spatial frequencies, since the contrast of the fringes is 
not degraded by the ocular media. The ratio of CRT to laser contrast 
sensitivities should represent the modulation transfer of the ocular 
media. The continuous line uppermost in Fig. 12 which has been obtained 
from the two best-fitting lines for CRT and laser displays represents 
the derived MTF. From a peak value of 0.5 (which represents 50% 
transmission of contrast) at 3 c/deg, the modulation transfer declines 
to 0.3 at 10 c/deg above Which it remains fairly level over the range of 
spatial frequencies studied. The mean slope of the MTF was less steep 
than that for the laser display, indicating, for the higher spatial 
frequencies, that greater loss of contrast sensitivity arises in the
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Fig. 12. Contrast sensitivities to CRT (filled circles) and laser 
displays (open circles), showing the mean + S.E. for 12 subjects (as in 
Figs. 7 and 11 respectively). Uppermost continuous curve is the MIF 
derived from the two lower curves.
retina-brain which must ultimately set the limit to resolution. Below 
3 c/deg, the fall in the MTF which arose in all subjects, is clearly 
anomalous because theoretical considerations predict an increase in the 
transmission to unity as spatial frequency decreases (Hopkins, 1955).
This relationship was further investigated by an honours student 
working in our laboratory. By carefully matching field size and 
luminance of the two displays she found that for very low spatial 
frequencies the MTF did in fact increase from 0.2 to 0.6 over the range 
of 3 bo 0.2 c/deg, but never approached unity as predicted for a simple 
optical lens. Her results are reproduced in Fig. 13. On the left are the 
results obtained for a typical subject and on the right those of a group 
of 7 subjects others showing means and range of values. The mean values 
reflect the general shape of the individual CSFs, although the numerical 
range of values was fairly wide. The MTF obtained from these results is 
shewn at the top of the figure.
Part 2; The effects of a single oral dose of pyridostigmine bromide on 
contrast sensitivity
Contrast sensitivity to CRT and laser displays 
Individual results
The CSF was of the same general form for each subject both for 
each experimental day (pyridostigmine and lactose control) and for each 
display (CRT and laser). Contrast sensitivities to the laser display 
were generally greater than to the CRT display; however there was some 
variation between subjects and Fig. 14 shows some representative 
results. Subject 7 is one of a group of five subjects for whom contrast 
sensitivity to the laser display always exceeded that to the CRT 
display. Subject 8 is one of a group of six subjects in whom laser
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Fig. 14. Effects of ingestion of 60 mg of pyridostigmine bromide (boxed 
symbols) compared with 60 mg lactose on contrast sensitivity 
(logarithmic scale) measured to CRT and laser displays. The results of 
four individual subjects are shown, repeat measurements for the CRT 
display made at the end of the experiment are indicated.
contrast sensitivity generally exceeded that to the CRT at most spatial 
frequencies except for those at the peak of the CSF where much closer 
overlap occurred. This may have been due, in part, to an overestimation 
of threshold to the laser display as the precision of measurement was 
poorer at small angles of rotation than at larger angles. Hie responses 
of the two other subjects tested in this experiment are shown in the 
bottom half of this figure as they did not fit into either of the 
categories just described. Subject 6 only showed a greater sensitivity 
to the laser display at high spatial frequencies above 25 c/deg. Subject 
11 shewed greater sensitivity to the laser display than to the CRT on 
the first day he was tested (11A), but on the second day (11B) which was 
after pyridostigmine, the laser and CRT results overlapped over the 
complete range of spatial frequencies tested. This seemed to be due to 
an increase in performance to the CRT display (when comparing the 
results to those in 11 A). While both subjects 6 and 11 were naive 
subjects, five others wsre also being tested for the first time in this 
study and they did not produce any unusual results.
By inspection of the individual CSFs following physostigmine, 
three subjects showed slightly greater, three showed slightly reduced 
and five showed no change in contrast sensitivity for the CRT display. 
Similarly, for the laser display, three subjects showed slightly 
greater, two showed slightly reduced and six showed no change in 
contrast sensitivity following pyridostigmine.
The CSF for both stimulus displays consisted of a peak at 3-5 
c/deg with a decline at lower and higher spatial frequencies. Each 
individual's high frequency fall-off (3 c/deg and above) was best fitted 
by a logarithmic-linear plot, the correlation coefficient of which was 
always better than r = -0.92 (P<0.001). Since it is highly improbable 
that any one spatial frequency would be affected in isolation, these
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regression equations were statistically compared between pyridostigmine 
and lactose control for each individual. No significant differences were 
present between the slopes of the pyridostigmine and control results, or 
between their intercepts to either stimulus display. Statistical 
comparisons at low spatial frequencies for each subject were not 
feasible since this involved comparing the five contrast sensitivity 
measurements used to compute the mean value. However, at 1 c/deg and 3 
c/deg it was apparent by inspection that overlap occurred between 
pyridostigmine and control results for both stimulus displays, 
indicating the absence of a discernible change.
Repeat measurements were made for the CRT display at 10, 20 and 30 
c/deg at the end of the experimental period and were compared with those 
obtained for the same spatial frequencies at the start of the 
experiment. Paired t-tests revealed no significant changes between the 
two sets of measurements for either the pyridostigmine or control 
experiment. The significance levels are given in Table 5 below. Thus, 
no change in the subject's criterion of threshold had occurred during 
the course of the experiment.
Table 5. Comparison of contrast sensitivity measurements to CRT display 
at start and end of the experiment by paired t-test for 13 subjects.
Spatial Frequency
(c/deg)
10
Pyridostigmine
P » 0.87 P = 0.81
Control
20 P = 0.68 P = 0.23
30 P = 0.54 P = 1.00
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Mean Results
A mean CSF was calculated for the 13 subj ects under the two 
different experimental conditions for the two displays used. The mean 
value and standard error of the mean for each spatial frequency are 
shown in Fig. 15. For the CRT display, the peak of the CSF had a mean 
value of 93 units after pyridostigmine and a mean value of 91 units for 
the control experiment (Fig. 15A). The high frequency fall-off was best 
fitted by a logarithmic-linear plot with a cut-off frequency of 39.8 
c/deg for the pyridostigmine results and 39.6 c/deg for the control 
results. The laser display CSF had a mean value of 126 units at peak 
for both the pyridostigmine and control experiments (Fig. 15B). The 
regression of the linear part of the CSF gave a predicted cut-off 
frequency of 53.5 c/deg for the pyridostigmine and 53.4 c/deg for the 
control. The regression equations are given below, where y is 
logarithm^q contrast sensitivity and x is the spatial frequency (c/deg). 
CRT display
Control (lactose) y = 2.06 - 0.052x
SDy = 0.11, r = -0.983 (P< 0.001)
Pyridostigmine y = 2.11 - 0.053x
SDy = 0.09, r = -0.988 (P< 0.001)
Laser display
Control (lactose) y = 2.19 - 0.041x
SDy = 0.08, r = -0.988 (P< 0.001)
Pyridostigmine y = 2.30 - 0.043x
SDy = 0.12, r = -0.978 (P< 0.001)
Comparison of the regression equations for the mean results for 
each display for the pyridostigmine and control experiments revealed 
that neither the slopes nor the intercepts were significantly different
102
A B
1000 -i
JU
10
a
V)
o
E 100 £
‘C(0
o>o
£*
>
8 10
coo
1.0 —1
% Si
f
4
§ ■
n 1 r~
5 10 20
1000 '
100 -
10
“i---1
50 100
1.0 J
i j
X
-i r-
10 20
—I---1
50 100
Spatial frequency (c/deg) (logarithmic scale)
Fig. 15. Effects of ingestion of 60 rag of pyridostigmine bromide 
compared with 60 mg lactose on contrast sensitivity (logarithmic scale) 
to CRT display (A) and laser display (B). Each point shows the mean + 
S.E. for 13 subjects, o, lactose; a , lactose repeat; •, pyridostigmine; 
a , pyridostigmine repeat.
E
E
0)
Ere
'■5 5 -
a3
a.
42 30
B
7t
6-
5 -
l—
Hours
Fig. 16. Effects of ingestion of 60 mg pyridostigmine bromide on pupil 
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For comparison, pupil diameter measured on subject's first or second 
visit to the laboratory, a , first visit; a , second visit (B). These 
are the mean results + S.E. of 10 subjects.
(P>0.25). Paired t-tests were also performed for the mean logarithm 
contrast sensitivity data. Contrast sensitivity for all spatial 
frequencies above peak showed a mean improvement of 0.031 log units, 
S.D., 0.042 (viz. a 7% improvement) after pyridostigmine for the CRT 
display only (P=0.02). Below the peak spatial frequency no significant 
differences occurred with either display (CRT, P>0.25; laser, P>0.10).
Pupil diameter was also measured during the course of this 
experiment for 10 subjects for whcm satisfactory photographs had been 
obtained. The mean values and standard errors are shown in Fig. 16. A 
small reduction in pupil diameter occurred after pyridostigmine (Fig. 
16A) though this was rather less than the decrease occurring between 
first and second visits to the laboratory (Fig. 16 B).
Part 3: The effects of topical application of 0.25% physostigmlne 
sulphate on visual performance.
Twelve subjects (18-28 years) completed the experiments in this 
part of the study. They comprise! of 7 males and 5 females, though no 
differences in performance were seen (by inspection) between the two 
sexes. Each subject completed 3 experimental trials on well spaced days, 
so that no cumulative effects would be possible. Application of the 
eyedrops produced a stinging sensation and stimulated some tear 
formation. The amount of tears produced was quite variable and was noted 
for each subject. Twitching of the eyelids also occurred in several 
subjects during the first few minutes after administration.
All 12 subjects showed a marked and long lasting pupillary 
constriction in response to the eyedrops. This usually began at about 10 
min and was maximal after 30 min, by which time the pupil had 
constricted from a mean of 5.7mm to 2.2mm in diameter. The pupil
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remained constricted for the duration of the experiment, though the 
mean pupil diameter increased slightly to 2.7mm at the end of the 3 hour 
period. Pupil diameter then slowly returned to normal by 24-36 hours. 
Hie mean pupil diameters, calculated for each of the three experimental 
trials are shown in Fig. 17. The control eye did not show any evidence 
of constriction from possible systemic absorption of physostigmine, or 
any consensual response and remained fairly constant at a diameter of 
circa 6mm throughout.
The physostigmine eyedrops caused an- increase in amplitude of 
voluntary near point accommodation (i.e. brought the near point closer) 
and also an increase of involuntary accommodation which caused a defocus 
of all distant objects (in fact all objects beyond the near-point 
distance). The increase in accommodation began between 5 and 10 min 
after administration and the resulting defocus was maximal by 30 min and 
then subsided by some 2 hours. The mean defocus for all 12 subjects is 
shown in Fig. 18. There was, however, a great deal of variation in the 
magnitude of this response as shown by the peak values for all subjects 
given in Table 6. Following physostigmine eyedrops, on Trial 1 three 
groups of responses were observed. Subjects 1-6 were all severely 
defocused by some 7-9D, and Snellen acuity was reduced to less than 
5/60. Three subjects (subjects 7,8 & 9) were only moderately defocused 
(1.5-4.5D) with Snellen acuity being reduced to 5/35, 5/18 and 5/6
respectively. The remaining three subjects (10-12) were only slightly 
defocused (0.5-0.75D) with Snellen acuity at worst being 5/5. Subject 
12, in fact, maintained 5/4 acuity throughout. This large variation in 
response was not associated with eye colour or to the amount of tears 
produced.
To demonstrate the two extremes in response seen for each of the 
parameters measured, the individual results for subjects 1 and 12 are
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Table 6. Effect of 0.25% physostigmine eyedrops on the amplitude of 
involuntary accommodation.
Subject Sex Age Peak increase in accommodation (dioptres)
(yr) Trial 1 Trial 2 Trial 3
1. SW M 28 9.0 10.0 6.0
2. DO M 20 9.0 8.5 7.5
3. CK F 24 8.0 9.0 8.0
4. GM M 24 8.0 8.5 7.5
5. AB F 25 7.0 8.5 9.0
6. SO M 23 7.0 1.25 6.0
7. AM F 20 4.5 4.0 6.0
8. LM F 22 3.0 3.5 -
9. CH M 23 1.5 6.0 4.5
10. JG F 20 0.75 1.5 3.5
11. JR M 24 0.5 4.0 1.5
12. MF M 22 0.5 0.75 0.5
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shown along with the mean results. Fig. 19A & B shows that the pupil 
constricted equally for subjects 1 and 12 whilst the increase in 
accommodation shown in Fig. 20A & B was quite different, being 9.0D for 
subject 1 at the peak of the response compared to only 0.75D for subject 
12.
Those subjects who were most severely defocused on the first 
experimental trial generally were so on each of the two repeats (Table 6 
and shown in Fig. 20A for subject 1). The only exception to this was for 
subject 6 who showed a very much smaller response on the second trial. 
This may however have been due to poor delivery of the drug for 
excessive twitching of the eyelids was noted (which did not occur for 
this subj ect on either Trial 1 or 3). If excessive drug was absorbed 
through the skin, a smaller amount may have been available for 
absorption through the cornea. However, the drug was still reaching the 
iris in sufficient concentration to constrict the pupil to a similar 
extent as Trials 1 and 3. Those subjects who were moderately defocused 
gave somewhat variable responses as did two of the subj ects (10 & 11) 
who were only slightly defocused on the first trial. Subject 12 was 
consistently not defocused to any great extent (Fig. 20B).
The increase in accommodation caused a certain amount of 
discomfort with pain felt in and around the eye which led to headaches 
in some cases. The severity of the pain seemed related to the degree of 
defocus response and increased when an accommodative effort was made to 
focus on a close object, as in near point measurements. One subject, on 
the second occasion tested, experienced a delayed reaction to the 
eyedrops in that severe headache and nausea were experienced later that 
day. She was therefore not asked to complete the third trial.
An increase in voluntary near point accommodation was seen which 
peaked at 30 minutes after the eyedrops were given and then gradually
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Fig. 19. Effect of 0.25% physostigmine eyedrops on pupil diameter of 
test (closed symbols) and companion eye (open symbols) for three trials. 
Individual results of subject 1 (A) and subject 12 (B).
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declined, but an additional 2D of accommodation remained at the end of 
the experiment (Fig. 21). Some of this increase in accommodative 
amplitude would be due to the increased depth-of-focus obtained from the 
small pupil. To take account of this, control measurements prior to 
physostigmine were also made viewing through a 2mm artificial pupil - 
these data are shown in Fig. 22. This approach had varying degrees of 
success due to the problem which subjects experienced in alignment of 
the artificial pupil with the chart of the RAF rule. In the case of 
Subject 1, no difference in near point accommodation occurred (Fig. 22A) 
while Subject 12 showed an increase of 2D in near point accommodation 
viewing through the 2mm artificial pupil in control measurements. This 
was similar to the increase measured for the constricted pupil following 
physostigmine (Fig. 22B).
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Fig. 21. Effect of 0.25% physostigmine eyedrops in causing an increase 
in near point accommodation. Mean + S.E. for 12 subjects.
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Contrast sensitivity to stationary grating patterns
The mean contrast sensitivity to stationary gratings of 3, 10, 20 
and 30 c/deg also declined with a time course similar to that of 
defocus. The curves in Fig. 23A show logarithm contrast sensitivity 
plotted against time for each spatial frequency measured. At each 
spatial frequency, there was a large fall in contrast sensitivity which 
peaked at about 30 min and then subsided by 2-2.5 hours. The curves in 
Fig. 23B show the change in contrast sensitivity expressed as a 
percentage of the second control value (at -30 min). The time course and 
minimum contrast sensitivity were approximately the same for each 
spatial frequency, though the contrast sensitivity at 3 c/deg remained 
at only 75% control at the end of the experiment.
The peak decline in contrast sensitivity, for the grouped data, 
was proportional to the degree of defocus as shown in Fig. 24. At 
3 c/deg a clear correlation exists between the decline in contrast 
sensitivity (expressed as logarithm of test/control value) and the 
amount of defocus (r=-0.71, P=0.009). A similar relationship was seen at 
10 c/deg (r=-0.74, P=0.006). At both 20 and 30 c/deg, many observers 
were unable to detect the pattern at all when the drug's effect was 
maximal (represented as open triangles in Fig. 24). However, the 
relationship between peak decline in contrast sensitivity and defocus 
still applies at 20 and 30 c/deg as the same downward trend is apparent.
While the time course of reduction in contrast sensitivity shown 
in Fig. 23 generally applied to all subjects, the actual amplitude of 
change showed considerable variation between individuals. The extreme 
range is illustrated in Fig. 25 in which Subject 1 showed the usual 
transient fall in contrast sensitivity while Subject 12 instead showed a 
small improvement which was attributed to improved ocular quality 
following the physostigmine induced miosis.
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frequencies of 3 a; 10b; 20 o  and 30 • c/deg.
3 c/deg 10 c/deg
Defocus (dioptres) Defocus (dioptres)
+0.2
-1.0-
r = -0.71 
P = 0.009i— i
o
L_
-Mcroos
4-»tocu
4-J
-2.0 J
20 c/deg
+0.2
-1.0-
r = -0.74 
P = 0.006
-2.0 J
30 c/deg
oF‘ 'i
+0.2>»+j
>
4-J
o-
(O1c;
cuto
-M
totol_
4-»cr
oo
-1 .0-
-2.0 J
+0.2
0-
-1.0 -
Fig. 24. Maximum reduction in contrast sensitivity from control value 
C2 (logarithmic scale) for stationary grating patterns plotted against 
maximum defocus caused by 0.25% physostigmine eyedrops, for the spatial 
frequency indicated. Correlation coefficient (r) and significance 
level (p) of the linear regression are shown. Readings which were off- 
scale are shown by open triangles; statistical analysis was not 
performed in these cases.
A
3.00-t
2.00-
10
201.00-
30
g 3.00-]
O)o
-1 2.00-
10
20
1.00-
30
-60 -30 30 120 
Time (mi 11)
150 18060
Physostigmine
eyedrops
Fig. 25. Effect of 0.25% physostigmine eyedrops on log contrast 
sensitivity to stationary grating patterns generated on CRT display for 
spatial frequencies of 3, 10, 20 and 30 c/deg. Individual results of 
subject 1 (A) and subject 12 (B).
Contrast sensitivity to "moving" grating patterns
In Fig. 26A an appreciable decline in contrast sensitivity at 2 
and 3 c/deg with a somewhat smaller change at 1 and 0.5 c/deg is shown. 
This variation in response is more clearly seen in Fig. 26B, with the 
lower spatial frequencies being less affected. The contrast 
sensitivities to these moving gratings were again related to the degree 
of defocus and the relationship between the peak decline in contrast 
sensitivity and the degree of defocus for the mean results is shown in 
Fig. 27. The decline in contrast sensitivity seen for a 3 c/deg moving 
grating was very similar to that for a 3 c/deg stationary grating, and 
indeed paired t-tests for each series of measurements after 
physostigmine revealed no significant differences (P>0.14). Thus, the 
fact the grating was moving does not seem to be important. A point to 
note, was that contrast sensitivity to each of these low spatial 
frequency moving gratings remained significantly reduced (at 
approximately 70 % of control) at the end of the experimental session 
(Fig. 26B, P<0.05). The amplitude of the change in contrast sensitivity 
to the moving grating patterns also varied between subjects. The 
extreme range is illustrated in Fig. 28 in which Subject 1 showed the 
usual fall in contrast sensitivity whereas Subject 12 showed no change 
at all.
Contrast sensitivity to laser interference fringes
The mean contrast sensitivities to laser interference fringes of 
spatial frequencies 4, 15 and 25 c/deg were calculated for the 11 
subjects Who completed this part of the study (Fig. 29A). At 4 c/deg 
there was a small though significant decline in contrast sensitivity 
(P=0.02, paired t-test) for the first measurement (on average 17 min) 
after physostigmine and a small but significant increase in contrast 
sensitivity (P=0.05) by the third measurement (some 70 min after
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Fig. 26. Effect of 0.25% physostigmine eyedrops on log contrast 
sensitivity for grating patterns generated on CRT display with contrast 
phase-reversed at 5.5z (A) and the change in contrast sensitivity 
(logarithmic scale) from control value C2 (B). The contrast of the 
gratings was phase-reversed at 5.5 Hz. Each point shows the mean + S.E. 
for 12 subjects at spatial frequencies of 0.5 A ; 1 • ; 2 o and 
3 a c/deg.
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sensitivity for phase-reversed (at 5.5 Hz) grating patterns generated 
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Fig. 29. Effect of 0.25% physostigmine eyedrops on log contrast
sensitivity to laser interference fringes (A) and the change in contrast
sensitivity (linear units) from control value C2 (B). Mean data + S.E. 
for 11 subjects at spatial frequencies of 4 • ; 15 0 and 25 A c/deg.
** denotes significant reduction from control value (p < 0.05).
physostigmine). At 15 and 2-5 c/deg a larger, more consistent, decline in 
contrast sensitivity m s  seen with a similar time coarse to defocus. At 
15 c/deg, this fall in contrast sensitivity to 75% control had recovered 
by the third series of measurements some 78 min after physostigmine 
whereas the fall to 50% control at 75 c/deg recovery was not complete 
until some 90 min (Fig. 29B). The two extremes of response to 
physostigmine as shown by the individual results for subjects 1 and 12 
are presented in Fig. 30A and B.
These results therefore indicate that physostigmine was adversely 
effecting retinal contrast sensitivity. Since the loss in contrast 
sensitivity followed the time course of defocus but not that of 
pupillary constriction which was much more sustained, an effect of 
defocus as the cause of this loss was investigated. One possibility was 
while the interference fringes themselves would not be affected by the 
increase in acconrnodation, the aperture surrounding the fringes would be 
defocused. To investigate this contrast sensitivity was measured to 4, 
14 and 25 c/deg interference fringes for both optimal focus and 
defocused vision. This was achieved by a myopic subject viewing the 
fringes wearing his normal correcting lens or with his unaided eye (i.e. 
7.0D defocus). The mean threshold was measured twice for each spatial 
frequency for both optimal focus and defocused vision, in a random 
order: no significant differences were found between the two sets of 
mean contrast thresholds (P>0.20), which closely overlapped as shown in 
Fig. 31. This therefore, excludes defocus of the aperture as the cause 
of the decline in contrast sensitivity after physostigmine. By 
exclusion, physostigmine appeared to be exerting its deleterious effect 
through a direct action on the retina.
110
Lo
ga
rit
hm
 
co
nt
ra
st
 
s
e
n
s
it
iv
it
y
3.00i
2.00-
1.00 -
V N r
'Si-
c/deg
-Os
“6 15
* 25
0 I------r
3.00-
•-
o-
2.00- ■o-
■ 1
-I—  —  O
O— — O 15
1.00-
° Jr
-60
"T”
30 3o" 95 i5o iio i5 o
Time (min)
Physost igmine 
eyedrops
Fig. 30. Effects of 0.25% physostigmine eyedrops on log contrast 
sensitivity to laser interference fringes at spatial frequencies 
indicated. Individual results of subject 1 (A) and subject 12 (B).
3n
&
\ >
‘co
c
0
CO
- 4-J
CO
o
L_
c
o
o
E
x:
-M
‘ l.o
cn
o
2 -
I
1 -
o J
0  1 0  2 0
Spatial frequency (c /d e g )
30
Fig. 31 • Contrast sensitivity to laser interference fringes of spatial 
frequencies 4, 14 and 25 c/deg measured for one observer; -f- , viewed 
with optimal focus and O  , viewed with unaided eye, -7.0 D myopia.
Further evidence to support a retinal effect of physostigmine is 
that there was also a transient fall in the mean critical fusion 
frequency vrfiich was also measured for 11 subjects (Fig. 32). The small 
fall in fusion frequency after 10 min was not significant (P>0.10) but 
the reduction from 44 to 42 Hz attained significance after 37 min 
(P=0.03). Subsequent measurements were not significantly different from 
the control value (P>0.50). The individual results for subjects 1 and 12 
however, do not shew any marked differences in response (Fig. 33).
At the end of the experimental period most subjects reported 
tiredness although the unpleasant side-effects such as headaches and 
tension had subsided. Subjects generally did not go back to normal work 
immediately after the experiment and usually went home to rest. All 
were fit and well the following day, though in some cases partial 
constriction of the pupil was still noted.
Possible genetic factors involved in sensitivity of accommodation to 
physostigmine
Two groups of siblings were involved in this part of the study 
(Table 7). Family 1 consisted of two of the original subjects who 
received physostigmine (subjects 1 and 3 in this table) and a third 
brother. All three members of Family 1 were markedly defocused on their 
first exposure to 2 drops of 0.25% physostigmine sulphate eyedrops and 
the maximal increase in accommodation ranged from 7 to 12 D. Pupil 
diameter was constricted to less than 2mm for each subject. Family 2 
consisted of one of the original subjects (Subject 3 in this table) who 
was only slightly affected by physostigmine eyedrops of his first 
exposure and two of his siblings. These were twins, male and female and 
they both experienced an increase in involuntary accommodation of 4.5 D 
which although larger than that of their brother's response (0.5D) on
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frequency. Individual results of subject 1, S.W. and subject 12, M.F.
his first exposure to physostigmine was similar to the 4.0D response 
observed for this subject on his second exposure to physostigmine. Hence 
there is some reason to suppose that there may be a genetic disposition 
to the action of physostigmine on accommodation but not pupil diameter. 
Further investigations would, thus, be desirable.
Table 7. Comparisons between families.
Family 1 Family 2
Sex Age Minimum pupil Peak Sex Age Minimum pupil Peak
diameter (mm) defocus diameter (mm) defoci
1. DO M 20 ,1-8 9.0 SR M 17 1.9 4.5
2. KO M 21 1.6 12.0 DR F 17 1.9 4.5
3. SO M 23 1.9 7.0 JR M 25 1.8 0.5
Results are for first exposure to 2 drops of 0.25% physostigmine sulphate eyedrops.
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Part 4; The effect of an intramuscular dose of 2mg atropine sulphate on 
visual performance
Experiment 1, which assessed the effects of atropine on a variety 
of visual measurements, was completed by 7 male volunteers, aged 19-24 
years and one volunteer age 35 years. Experiment 2, which looked 
specifically at the effects of atropine on contrast sensitivity measured 
for both CRT and laser displays, was completed by 13 male volunteers 
aged 22-42 years, 3 of Whan had also completed Experiment 1. In each 
person, Snellen acuity was 5/4, wearing spectacles if necessary. The 
results were examined on both an individual and group basis. The 
significance of any changes in measured values was assessed by paired t- 
tests between control measurements prior to the atropine injection and 
test measurements. The convention used throughout is that control 
periods are denoted as C and post-atropine periods as A followed by the 
hourly interval.
General Effects of Atropine
The most common effect of the i.m. injection of 2mg atropine 
sulphate was dryness of the mouth with difficulty in swallowing. The 
degree of discomfort varied from person to person. For three subjects 
Who completed both parts of the study, less discomfort was felt on the 
second occasion. Two subjects expressed some difficulty in 
micturition. Several subjects reported dry hands, as sweating was 
inhibited, and one subject described the blocking of sweating even on a 
long training run later the same day. Central effects in the form of 
lightheadedness, slight ataxia (unsteadiness in wallcing) and difficulty 
in concentrating were reported in 10 out of the 21 experiments. Two 
subjects reported a headache during the course of the experiment, Which
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had disappeared before completion of the tests. All subjects expressed 
tiredness by the end of the session.
A transient bradycardia occurred in 17 of 21 experiments within 
the first five minutes, followed by a more pronounced tachycardia, 
rising to within pre-injection levels by 10 min (Fig. 34A). Heart rate 
increased significantly above control levels by 15 min post-injection 
(P<0.05). The tachycardia became pronounced by 20-40 min post­
injection, consisting of an approximately 50% increase in resting heart 
rate. For Experiment 1, the peak increase in heart rate averaged 35.4 
beats/min and 28.4 beats/min for Experiment 2, thereafter declining 
slowly to within control levels by 4.5 hours post-injection. Heart rate 
was still significantly elevated (P<0.01) at the end of Experiment 2. 
The most extreme case in an individual was an initial slowing from 60 to 
46 beats/min, followed by an increase to 120 beats/min at 60 min post­
injection.
Pupil diameter and accommodation
The ocular effects followed a slower time course than the heart 
rate response. In Experiment 1, atropine produced a gradual mydriasis 
of 0.3mm at 30 min (not significant), 1.2mm at 2 hours (P<0.05) and a 
maximum dilation of 1.5mm at 2.5 hours (P<0.01) (Fig. 34B). After 5 
hours, the mean increase in pupil diameter was 1.0mm, but was no longer 
significantly different from control levels (P>0.10). In Experiment 2, 
similar results were obtained though the maximum dilation of 1. 5mm was 
reached after between 1 and 2 hours (P<0.001).
Following atropine, the amplitude of accommodation, measured as 
the near point, had declined by 0.7D after 1 hour (P<0.04), with a 
maximum fall of 1.8D after 4 hours (P<0.001) (Fig. 34C). Some recovery 
of accommodation had occurred by 6 hours post-injection, though the
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Fig. 34. Effects of injection of atropine sulphate (2 mg, i.m.) on (A) 
heart rate, (B) pupil diameter and (C) near point accommodation. Each 
point shows the mean + S.E. for 8 subjects measured in Experiment 1. The 
significance levels indicated are for paired t-tests between the test 
period and the period immediately preceding the injection. ** P < 0.01;
deficit of 1.5D was still significant (P<0.01 Experiment 1). Similarly 
in Experiment 2, accommodation was reduced on average by 1.2D after 1 
hour (P<0.01), 1.3D after 2 hours (P<0.001) and 1.2D after 3 hours
(P<0.01).
Experiment 1_
Reaction time and choice reaction time
Atropine did not significantly affect either reaction time or 
choice reaction time to a visual stimulus (Table 8), as no significant 
differences were present between any given test period and the second 
control period (C2) (P>0.20). This experiment was completed in 7 
subjects.
Extraocular muscle balance
The results of these tests, performed on the Visual Function 
Tester are shown in Figure 35. For the grouped data, horizontal 
heterophoria changed significantly from a mean of 3.7 prism dioptres 
(C2) to 2.8 prism dioptres at 1 hour (P<0.05, Fig. 35A). Seven out of 8 
subjects became less esophoric after atropine while the remaining 
subject became more exophoric, i.e. the common direction of change of 
alignment m s  tcwards exqphoria by seme 0.8 prism dioptres. Vertical 
heterophoria remained unchanged (P>0.05, Fig. 35B). Cyclophoria 
declined significantly from a mean of 1.94 deg (C2) to 1.06 deg at 2 
hours (P<0.05, Fig. 35C).
Colour-matching
Colour-matching was not affected by atropine as the red-green 
matching range remained constant throughout (Table 9). The readings 
which are the positions of the right hand slide of the anomaloscope give
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Table 8. Effect of atropine on reaction time and choice reaction time 
to a visual stimulus. Mean + S.E. for 7 subjects.
Reaction Time (msec)
C1 C2 A1 A2 A3 A4 A5 A6
491.3 452.1 467.5 452.8 472.8 464.4 469.7 452.9
+40.0 +43.3 +39.4 +41.7 +43.4 +51.6 +39.2 +40.0
Choice Reaction Time (msec)
ci C2 A1 A2 A3 , A4 A5 A6
651.2 590.7 622.7 630.1 629.1 635.4 601.1 591.3
+39.1 +46.4 +32.4 +29.9 +38.8 +35.8 +45.8 ±45.9
Table 9. Effect of atropine on red-green colour perception.
Interval Mean Red-Green Matching Range + S.E. (n=8)
ci 38.5 + 0.3 - 39.4 + o • to
C2 39.0 + 0.3 - 39.7 + 0.2
A1 38.9 + 0.2 - 39.5 + 0.2
A2 38.7 + 0.2 - 39.6 + 0.3
A3 38.7 + 0.4 - 39.2 + 0.3
A4 38.9 + 0.3 - 39.6 + 0.3
A5 38.7 + 0.2 - 39.4 + 0.3
A6 38.6 + 0.4 - 39.2 + 0.3
(Normal range 33.6 to 41.2, with 99% confidence limits)
C: control measurements, A: measurements after atropine at hourly 
intervals.
116
Horizontal 
heterophoria 
(prism dioptres)
B
Vertical 
heterophoria 
(prism dioptres)
Cyclophoria 
(degrees) i —
2mg atropine
~T~
A3
~ r
A5C1 C2 A1 A2  A4 
Trial number (hourly intervals)
l
A6
Fig. 35. Extraocular muscle balance as measured with the Visual 
Function Tester (see text for details). Mean + S.E. for 8 subjects. 
Significance levels are for paired t-tests against the control 
measurement C2: * p < 0.05 and + N.S.
the proportion of red and green needed for matching with the yellow 
reference half-field. In all test periods there were no significant 
differences from the second control period in either the individual or 
the grouped results (P>0.10).
Stereoacuity
(i) Stereoacuity was measured to extended line stimuli in a 
demanding series of determinations which involved many judgements of 
exceedingly fine discrimination. These judgements were not significantly 
affected by atropine since line stereoacuity remained at around 3 
seconds of arc throughout the experiment (P>0.18). A small decline in 
overall performance of the test which represented the percentage of 
correct responses, occurred but was not significant (P>0.28; Table 10).
(ii) A measurement of stereoacuity based on discrimination of the 
disparate dot out of a pattern of 4 dots was made with the Visual 
Function Tester. This represents a different measure to that in part 
(i) since it assesses global stereopsis and in fact gives a value of 
stereoacuity appreciably less than in the above method. The smallest 
disparity available on the Visual Function Tester was 10 seconds of arc. 
Subjects were always able to identify the disparate dot before and after 
atropine.
These experiments were completed in 8 sub) ects but one subj ect 
experienced such difficulty in performing both parts of the test that 
his results were discarded.
Visual acuity.
Individually, 2 subjects showed a slight fall in cut-off frequency 
after atropine, whereas the other 5 individuals showed a slight increase 
or no change. Examination of the mean data showed that atropine did
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not significantly affect visual acuity, as the cut-off frequency 
remained within normal limits throughout the experiment (P>0.20) (Table 
11). This experiment m s  completed in 7 subjects.
Table 10. Effect of atropine on line stereoacuity and overall 
performance on the test. Mean ± S.E. for 7 subjects.
Stereoacuity
Visual Angle (seconds of arc)
ci C2 A1 A2 A3 A4 A5 A6
2.9 2.8 2.6 2.6 2.4 3.1 2.9 2.2
+0.4 +0.3 +0.5 ±0.2 ±0.2 ±0.1 ±0.3 ±0.2
% Overall Performance
Cl C2 A1 A2 A3 A4 A5 A6
71.1 71.1 70.7 67.0 69.6 65.9 69.2 68.9
±4.7 +4.5 ±4.1 ±1.9 ±2.3 +3.1 ±2.3 ±1.9
Table 11. Effect of atropine on visual acuity. Mean ± S.E.
subjects.
Visual Acuity (c/deg)
ci C2 A1 A2 A3 A4 A5 A6
42.4 43.7 43.9 43.5 42.3 42.7 43.3 43.1
±1.5 ±1.3 ±0.9 ±1.1 ±1.0 ±1.0 ±0 •8 ±0•8
C: control measurements, A: measurements after atropine at hourly 
intervals.
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Contrast sensitivity to a moving grating pattern.
Atropine caused a decline in contrast sensitivity to a grating 
pattern which m s  phase-reversed at 5.5 Hz (Fig. 36). In 4 out of the 8 
subjects tested this decline in sensitivity occurred at the 4 spatial 
frequencies tested and 3 subjects showed a decline in sensitivity for 3 
of the 4 spatial frequencies tested. The eighth subject showed no change 
at any spatial frequency.
The mean contrast sensitivity values at 1, 2 and 3 c/deg were 
significantly reduced by atropine by 20-35% at 1-2 hours post-injection 
which persisted at 5-6 hours post-injection (Table 12 and Fig. 36). At 5 
c/deg, a smaller reduction was observed which was significant only at 5 
and 6 hours post-injection. Thus, the detection of moving grating 
patterns was adversely affected by atropine with a time course which was 
more sustained than that of either heart rate or pupil diameter.
Experiment 2
Contrast sensitivity to a stationary grating pattern; CRT display
The contrast sensitivity curve was of the same form for each 
subject. There was a peak at 3-5 c/deg with a linear fall in logarithm 
contrast sensitivity with increasing spatial frequency. First, the data 
were examined against time for each spatial frequency on both an 
individual and combined basis (Fig. 37). Two factors had to be 
considered: first, an appraisal of the reproducibility of results in the 
1 dummy1 run of 4 hours without atropine; and second, the effects of 
atropine with respect to the preceding control measurement.
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Fig. 36 Effects of atropine on contrast sensitivity (logarithmic scale) 
to sinusoidal grating patterns phase-reversed at 5.5 Hz at the spatial 
frequencies indicated. Each point shows the mean + S.E. for 8 subjects. 
Significance levels are for paired t-tests between the test period and 
the control period C2: ** p < 0.01; * p < 0.05; + N.S.
Table 12. Effect of atropine on contrast sensitivity to sinusoidal 
gratings phase reversed at 5.5 Hz for the spatial frequencies stated. 
Change in contrast sensitivity at the periods indicated is expressed as 
a percentage of C2. Significance levels are for paired t-tests.
1 c/deg 2c/deg 3c/deg 5c/deg
change P changei P change P change P
ci +2% 0.97 -4% 0.63 +9% 0.46 -4% 0.41
A1 -17% 0.05 -17% 0.009 -13% 0.08 -22% 0.12
A2 -22% <0.001 -17% 0.01 -19% 0.04 -2% 0.81
A3 -19% 0.07 -22% 0.005 -24% 0.02 -19% 0.09
A4 -22% 0.02 -26% <0.001 -26% 0.003 -19% 0.17
A5 -26% <0.001 -21% 0.01 -35% <0.001 -21% 0.006
A6 -21% 0.05 -26% <0.001 -34% <0.001 -17% 0.04
C: control measurements A: measurements after atropine at hourly
intervals.
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Fig. 37. Effects of atropine on contrast sensitivity (logarithmic 
scale) at spatial frequency stated. Left, a series of four control 
measurements (C1-C4) repeated at hourly intervals: each point shows the 
mean + S.E. for 13 subjects. Right, one control measurement (AC) 
followed by post-atropine measurements (continuous line). Contrast 
sensitivity at 1 and 3 c/deg are displaced 'upwards (x 10) for clarity. 
Significance levels are for paired t-test against the first measurement 
in each series (Cl or AC). ** P < 0.01; * P < 0.05; + N.S.
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Reproducibility of measurements.
Reproducibility was expressed as a percentage of the first control 
run for all spatial frequencies for 13 subjects. (Fig. 38). Overall, a 
7% improvement in sensitivity occurred on the first repeat, a further 
4% on the second, and a further 5% on the third. However, when shown on 
the conventional logarithmic scale, these changes are minimal (Fig. 38).
Paired t-tests between periods C2-C4 with respect to Cl generally 
revealed no significant differences except at 1 and 30 c/deg at C3 and 
C4 and 5 c/deg at C4 when a significant improvement occurred (Fig. 37). 
However on day 2, the control prior to atropine (CA) was significantly 
higher than C4 of the previous day at 5, 8, 15, 20 and 25 c/deg (P<0.05) 
(Fig. 37).
Thus, measurements of contrast sensitivity are generally 
reproducible on the same day, with a small time-related improvement in 
performance. There is a likelihood of a much larger increase in 
contrast sensitivity on a second day perhaps representing a resetting of 
criterion.
Effect of atropine.
Given that the expected response in a series of repeated 
measurements should lead to a gradual improvement in contrast 
sensitivity with testing, only three or possibly four of the 13 subjects 
showed a deleterious effect following atropine administration. In the 
remaining 9 subjects either no effect or a marked improvement occurred. 
For the grouped data for all 13 subjects, there was generally a lack of 
effect of atropine. Most post-atropine contrast sensitivity values were 
not significantly different from C2 (P>0.10); however for 5 c/deg a 
significant reduction occurred at 2 hours post-atropine (P<0.05) and for 
8c/deg at 1 and 2 hours post-atropine (P<0.05). After 3 hours, however,
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Fig. 38. Consistency of contrast sensitivity measurements to the CRT 
display for all spatial frequencies expressed as a percentage of the 
first reading. Each point is the mean + S.E. for 13 subjects at 10 
spatial frequencies.
contrast sensitivity at both 5 and 8 c/deg was not significantly 
different from control levels (P>0.05).
It is unlikely that any one spatial frequency would be depressed 
in isolation vhile adjacent spatial frequencies were unaffected since 
spatial frequency channels have a finite bandwidth of about an octave 
(Blakemore & Campbell, 1969). The contrast sensitivity data were, 
therefore, collectively tested by regression analysis. As mentioned 
earlier, contrast sensitivity (logarithmic scale) was inversely linearly 
related to spatial frequency over the range 3-30 c/deg. For the pre­
atropine control and the three post-atropine periods (Fig. 37, right), 
the correlation coefficients were at least -0.985 with significance of 
P<0.001. Comparison between pre- and post-atropine regression equations 
for each subject showed an absence of a significant difference in both 
intercept and slope (P>0.25). A one-way analysis of variance also showed 
that atropine had no effect (P>0.10). These results are consistent with 
the lack of effect of atropine on visual acuity which remained at 42-43 
c/deg (Table 11).
Contrast sensitivity to the laser display.
Contrast sensitivity was measured at three spatial frequencies on 
the linear part of the CSF, corresponding to medium and fine object 
detail. First, the data were examined against time on an individual 
basis and on a group basis as shown in Figure 39. Individually, 2 out 
of the 13 subjects showed an increase in sensitivity as they repeated 
the measurements in the control experiment whilst all other observers 
showed no effects at all. Likewise the grouped data generally showed no 
significant changes between C1 and any of the repeat measurements C2-C4 
(P>0.10) except at 7-9 c/deg where a gradual improvement in contrast 
sensitivity occurred which became significant at C4 (P<0.01). When the
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Fig. 39. Effects of atropine on contrast sensitivity (logarithmic 
scale) to laser interference fringes of the spatial frequency stated. 
Left, a series of four control measurements (C1 - C4) repeated at hourly 
intervals: each point shows the mean + S.E. for 13 subjects. Right, one 
control measurement (AC) followed by post-atropine measurements 
(continuous line). Significance levels are for paired t-tests against 
the first measurement in each series (C1 or AC). ** p < 0.01; + N.S.
effects of atropine were considered with respect to the preceding 
control measurement, 5 subjects showed a deleterious effect following 
atropine administration, three showed an increase in contrast 
sensitivity following atropine and the remaining five showed no change 
at all. The grouped data showed no significant changes between the pre­
atropine control and any of the test measurements after atropine 
(P>0.10).
It is, therefore, concluded that atropine had no measurable effect 
on the detection of stationary grating patterns over the range of 
spatial vision studied.
Part 5: The effectiveness of prior administration of intramuscular 
injection of atropine sulphate or instillation of hcmatropine eyedrops 
against physostigmine eyedrops.
Pre-treatment with atropine sulphate
Those 6 subjects whose accocmiodation was most markedly increased 
by physostigmine in Part 3 of this study (subjects 1-6 of Table 6) 
participated in the first of these experiments. In the second, subject 
5 was unavailable and was replaced by another subject. This subject 
first underwent a single control experiment with physostigmine eyedrops 
alone prior to the atropine experiment. This necessitated the 
calculation of two different sets of control data for physostigmine 
alone (from part 3) for comparison with the results of prior injection 
of atropine, which was made with the paired t-test.
In the first set of experiments an i.m. injection of 2mg atropine 
sulphate m s  given approximately 2 hours prior to physostigmine eyedrops 
(mean time interval = 124 min) to allow the ocular effects to develop 
fully (Fig. 34). The effects of physostigmine eyedrops were followed
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for only 2 hours post-administration because of the long duration of the 
control measurements. In the second set of experiments the injection 
was given just prior to the eyedrops (mean time interval = 8 min) so 
that the peak plasma atropine as reflected by the peak heart rate (Fig. 
34) would coincide with the peak effect of physostigmine (Fig. 18). The 
effects of physostigmine were then followed for 3 hours.
The data were first analysed on an individual basis and then on a 
group basis. As all subjects showed a qualitatively similar response, 
the mean data shown are representative of the individual results. Most 
of the figures shewn in this part of the study are of the same format. 
Each measurement made is plotted against time with the administration of 
2 drops of 0.25% physostigmine sulphate shown as time 0. Injection of 
the pre-treatment of 2mg atropine sulphate (i.m.) is indicated by an 
arrow. Control measurements obtained prior to the administration of 
atropine are also shown. For comparison, the mean results (for the same 
6 subjects) for physostigmine alone are shown. The upper portion of 
each figure (A) shows the results obtained for a pre-treatment of 
atropine sulphate given 8 min prior to the physostigmine eyedrops. The 
lower portion of each figure (B) shews the results obtained for a pre­
treatment of atropine sulphate given 124 min prior to physostigmine 
eyedrops.
Pupil diameter
Pre-treatment with atropine sulphate did not prevent the marked 
pupil constriction following physostigmine eyedrops. The mean changes 
in pupil diameter are shown in Fig. 40 along with those previously 
measured for physostigmine alone.
Following atropine 8 min prior to physostigmine, the pupil of the 
test eye which received the eyedrops constricted to 1. 9mm by 30 min and
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then gradually dilated to 2.4mm at the end of the 3 hour experimental 
period. By comparison, in the experiment in which the subjects received 
only physostigmine, the pupil of the test eye constricted to 2.1 mm by 
24 min after physostigmine. The maximal constriction of 1.9mm was seen 
after 50 min thereafter the pupil gradually dilated to 2.7mm by 3 hours 
(Fig. 40A). Thus, the maximal pupil constriction was the same following 
physostigmine whether preceded by atropine or not and the constriction 
appeared slightly longer lasting after the pre-treatment. Paired t- 
tests, however, at each time period showed no significant difference in 
the time course or extent of pupil constriction between atropine pre­
treatment and physostigmine alone (P>0.08). The pupil of the control 
eye which did not receive physostigmine, gradually dilated from 5.3mm to 
7.1mm by 3 hours post-atropine.
Atropine given 124 min prior to physostigmine caused a dilatation 
of both pupils from 5.0 to 7.0mm before the physostigmine was 
administered. After physostigmine, the pupil of the test eye 
constricted to 2.1mm by 30 min, dilating to 2.2mm by 2 hours (Fig. 40B). 
The mean results for these subjects for physostigmine alone showed a 
constriction of the pupil to 2.1mm by 37 min and to 2.0mm by 51 min then 
a gradual dilatation to 2.4mm by 2 hours (and to 2.7mm by 3 hcurs). Once 
again the pre-treatment seemed to slightly prolong the pupillary 
constriction. However, paired t-tests again showed no difference in 
time course or extent of pupil constriction (P>0.16) except at the first 
time interval after the eyedrops (P=0.01) which may be attributable to a 
difference in sampling times (6 and 10min). The pupil of the control 
eye remained dilated at circa 7mm throughout.
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Fig. 40. Effect of injection of atropine sulphate (2 nig i.m.) at 8 min 
(A) and 124 min (B), prior to 0.25% physostigmine eyedrops (broken 
lines) on pupil diameter for test eye A and companion eye A . Control 
data for physostigmine eyedrops alone are also shown (continuous line) 
for test eye o and companion eye • . Mean results + S.E. for 6 
subjects.
Accommodation
Physostigmine eyedrops produced a large increase in involuntary 
accommodation despite administration of atropine 8 min earlier (Fig. 
41 A). Hie increase in accommodation amounted to 1.8 D after 7 min and 
was maximal at 6.5 D after 30 min, then declining gradually over 2 
hours. Physostigmine alone had caused a somewhat larger increase in 
accommodation of 4.5 D after 5 min but the peak effect after 30 min was 
similar at 7.1 D and the response had also declined by 2 hours. Indeed, 
no significant difference was detected between the increase in 
accommodation caused by physostigmine alone or when preceded by 
atropine, at any of the time periods measured (P>0.10).
Atropine given 124 min prior to physostigmine slightly reduced the 
increase in involuntary accommodation measured after physostigmine 
eyedrops (Fig. 41B). An increase of 1.1 D was seen after 5 min, rising 
to a maximum increase of 6.0 D after 26 min then declining to 0.3 D by 
105 min after physostigmine. In comparison, physostigmine alone had 
caused an increase of 2.1 D after 5 min, which rose to a maximum 
increase of 7.6 D after 29 min and declined to 0.8 D by 110 min, with 
some effect still detected until 3 hours after physostigmine. However, 
paired t-tests showed that the peak increase in accommodation was not 
significantly different from that for physostigmine alone (P>0.10). 
The increase in accommodation was less after 5 and 45 min although this 
was only of marginal significance (0.05<P<0.10) and significantly less 
than that obtained for physostigmine alone after 105 min (P<0.05).
The change in near point accommodation (i.e. the mean control 
value for near-point accommodation subtracted from each test value) is 
shown in Fig. 42. Pre-treatment with atropine 8 min prior to 
physostigmine resulted in, if anything, a slightly larger increase in 
near point accommodation after physostigmine (Fig. 42A). A peak
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Fig. 41. Effect of injection of atropine (2 mg i.m.) at 8 min (A) and 
124 min (B) prior to 0.25% physostigmine eyedrops (O, broken lines) on 
amplitude of accommodation. Significance of differences from control 
data for physostigmine eyedrops alone (#, continuous line) are shown:
** p < 0.05; * 0.05 < p < 0.1; + N.S., p > 0.1. Mean results + S.E. for 
6 subjects.
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Fig. 42. Effect of injection of atropine (2 mg i.m.) at 8 min (A) and 
124 min (B) prior to 0.25% physostigmine eyedrops (O, broken lines) on 
near point accommodation. Control data for physostigmine eyedrops alone 
also shown (#, continuous line). Mean results + S.E. for 6 subjects.
increase of 5.8 D was measured 30 min after physostigmine which then 
gradually declined to 2.5 D at the end of the experiment (3 hours); 
physostigmine alone had previously caused a peak increase of 5.4 D after 
34 min which had declined to 2.2 D by 3 hours. However, these small 
differences were not significant at any time interval (P>0.10).
Atropine given 124 min prior to physostigmine resulted in a loss 
of near point accommodation of 0.8 D immediately prior to physostigmine 
administration. Following physostigmine, a peak increase of 4.7 D was 
observed at 45 min after physostigmine and an increase of 3.6 D remained 
at the end of this experiment (105 min; Fig. 42B). Physostigmine alone 
had previously caused a peak increase of 5.3 D after 34 min and an 
increase of 2.7 D had remained at 110 min after physostigmine. Again 
however, prior administration of atropine made no significant difference 
at any time period (P>0.35) to the effect of physostigmine on near point 
accommodation.
Critical fusion frequency
A transient fall in the mean critical fusion frequency occurred at 
36 min for physostigmine alone (P=0.03). After the pre-treatment with 
atropine 8 min prior to physostigmine, this effect was no longer seen 
and no significant differences were found between any of the test 
measurements and the second control measurement C2 prior to atropine 
administration (P>0.20; Fig. 43). The critical fusion frequency was not 
measured for the 124 min atropine pre-treatment.
Contrast sensitivity
Irrespective of atropine given 8 min or 124 min beforehand, 
application of physostigmine still resulted in a large decline in 
contrast sensitivity at 10, 20 and 30 c/deg for a stationary pattern and
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Fig. 43. Effect of injection of atropine (2 mg i.m.) at 8 min prior to 
0.25% physostigmine eyedrops (O, broken line) on critical fusion 
frequency. Control data for physostigmine eyedrops alone also shown 
(•, continuous line). Significance of difference from control period C2; 
* p = 0.03; all other periods N.S., p > 0.20. Mean results + S.E. for 6 
subjects.
at 3 c/deg for a phase-reversed pattern. First, the data were examined 
against time on an individual basis and then as a group. All 6 subjects 
showed a transient fall in contrast sensitivity at each spatial 
frequency measured which peaked at about 30 min and then subsided by 
some 2 hours after physostigmine, despite both atropine pre-treatments.
(a) Atropine 8 min prior to physostigmine
The grouped data for contrast sensitivity for atropine at 8 min + 
physostigmine are shown in Fig. 44. Paired t-tests between the two 
control measurements prior to atropine showed no significant differences 
at any of the spatial frequencies measured (P>0.09). The test 
measurements following physostigmine were then compared to the second 
control measurement (C2). After physostigmine there was a transient fall 
in contrast sensitivity at each spatial frequency measured. Contrast 
sensitivity to a 10 c/deg grating pattern was significantly depressed 
until 108 min after physostigmine, contrast sensitivity to a 20 c/deg 
grating pattern had recovered to within control levels by 81 min and 
that to a 30 c/deg grating pattern by 143 min after physostigmine. 
However, contrast sensitivity to a 3 c/deg phase-reversed grating 
pattern remained significantly depressed at the end of the experimental 
period (P<0.05). The significance levels for the t-tests are shown in 
Table 13.
The factor to be considered was whether the pre-treatment was 
having any effect at all. In order to compare the contrast sensitivity 
measurements obtained for the same subject on different days each 
individual's results were normalised by expressing contrast thresholds 
as a percentage of C2. Paired t-tests were then performed at 
corresponding time periods between the physostigmine + atropine and 
physostigmine alone data.
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Fig. 44. Effect of injection of atropine (2 mg i.m.) at 8 min prior to 
0.25% physostigmine eyedrops on contrast sensitivity (logarithmic scale) 
to stationary sinusoidal grating patterns of 10, 20 and 30 c/deg and a 
3 c/deg grating phase-reversed at 5.5 Hz. Mean data + S.E. for 6 
subjects.
The reduction in contrast sensitivity following physostigmine for 
a 10 c/deg grating pattern is shown in Fig. 45A. Pre-treatment with 
atropine 8 min prior to physostigmine resulted in a fall to 11% of 
control after 17 min which was not significantly different from a fall 
to 13% of control after 13 min for physostigmine alone (P>0.80). By 170 
min contrast sensitivity had recovered to 92% of control compared to 
105% of control after 170 min for physostigmine alone (which again was 
not significantly different, P>0.20). Indeed* there was no significant 
difference between the physostigmine + atropine and physostigmine alone 
data at any time period measured (P>0.10; Fig. 45A)
The reduction in contrast sensitivity at 20 and 30 c/deg after 
physostigmine is shown in Figs. 46A and 47A respectively. In general, 
there was no significant difference in the reduction of contrast 
sensitivity seen after the 8 min atropine pre-treatment compared with 
that for physostigmine alone, nor in the recovery of contrast 
sensitivity (P>0.16). The only exception was for 20 c/deg at 170 min 
after physostigmine (P<0.05).
For the 3 c/deg phase-reversed grating pattern, the loss of 
contrast sensitivity after physostigmine was slightly greater with the 
8 min atropine pre-treatment where the maximal reduction was to 13% of 
control compared to 26% of control after physostigmine alone (Fig. 48A). 
However this difference was not significant (P>0.50). As with the 
physostigmine alone experiment contrast sensitivity to the 3 c/deg 
moving grating pattern returned to only 70% of the control level by the 
end of the experimental period.
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Table 13, Atropine 8min prior to physostigmine. Significance levels 
(paired t-tests) of the difference in logarithm contrast sensitivity 
between the test period and the control period C2, at the spatial
frequencies indicated.
Period ci P1 P2
Time (min) - (21) (39)
10 c/deg 0.09 <0.001 0.001
20 c/deg 0.35 0.001 0.006
30 c/deg 0.88 <0.001 0.01
3c/deg * 0.94 <0.001 0.002
P3 P4 P5 P6 P7
(60) (83) (113) (114) (173)
0.02 0.05 0.61 0.63 0.63
0.05 0.54 0.30 0.56 0.17
0.04 0.02 0.009 0.26 0.51
0.001 <0.001 0.01 0.008 0.01
C: control measurements and P: measurements after physostigmine at the 
mean time indicated. * grating pattern phase-reversed at 5.5 Hz.
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Fig. 45. 10 c/deg stationary grating pattern: effects of injection of
atropine sulphate (2 rag i.m.) at 8 rain (A) and 124 min (B) prior to 
0.25% physostigmine eyedrops (O, broken line) compared with 
physostigmine alone (•, continuous line) on contrast sensitivity. None 
of the values was significantly different; + p > 0.1; * 0.05 < p < 0.1. 
Mean + S.E. for 6 subjects.
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Fig. 46. 20 c/deg stationary grating pattern: effects of injection of 
atropine sulphate (2 mg i.m.) at 8 min (A) and 124 min (B) prior to 
0.25% physostigmine eyedrops ( O, broken line) compared with 
physostigmine alone (•, continuous line) on contrast sensitivity. 
Significance levels of difference are indicated next to the points 
compared; + N.S., p > 0.1; ** p < 0.05. Mean + S.E. for 6 subjects.
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Fig. 47. 30 c/deg stationary grating pattern: effects of injection of 
atropine sulphate (2 mg i.m.) at 8 min (A) and 124 min (B) prior to 
0.25% physostigmine eyedrops ( O, broken line) compared with 
physostigmine alone (•, continuous line) on contrast sensitivity. 
Significance levels of difference are indicated next to the points 
compared; + N.S., p > 0.1; ** p < 0.05. Mean + S.E. for 6 subjects.
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Fig. 48. 3 c/deg grating pattern phase-reversed at 5.5 Hz: effects of
injection of atropine sulphate (2 mg i.m.) at 8 min (A) and 124 min (B) 
prior to 0.25% physostigmine eyedrops (O, broken line) compared with 
physostigmine alone (#, continuous line) on contrast sensitivity. None 
of the values was significantly different; + p > 0.1. Mean + S.E. for 6 
subjects.
(b) Atropine 124 min prior to physostigmine
The mean contrast sensitivity data for atropine at 124 min + 
physostigmine compared with that for physostigmine alone are shown in 
Fig. 49. Paired t-tests between the two control measurements prior to 
atropine showed no significant differences at 20 and 30 c/deg nor for 
the 3 c/deg phase-reversed grating pattern (P>0.30) but at 10 c/deg the 
second control measurement was significantly greater than the first 
(P<0.01). Contrast sensitivities were also measured at approximately 60 
and 90 min after atropine administration and were compared with the 
control measurement just prior to atropine administration. Following 
atropine, contrast sensitivity to a 3 c/deg phase-reversed grating 
pattern was significantly less at 60 and 90 min (P<0.05) which confirms 
the results in part 4 of this study on another group of subjects. 
Contrast sensitivity to grating patterns of 10 and 20 c/deg were also 
significantly reduced but only at 60 min post-atropine (P<0.01). 
Contrast sensitivity at 30 c/deg was not significantly different from 
control at either 60 or 90 min post-atropine (P>0.35). Following the 
administration of physostigmine, there was a large and transient fall in 
contrast sensitivity at each spatial frequency measured. Contrast 
sensitivity to a 10 c/deg grating pattern did not recover completely to 
within control levels until 109 min, whereas at 20 and 30 c/deg recovery 
was complete at about 80 min after physostigmine. Contrast sensitivity 
to the 3 c/deg phase-reversed grating pattern remained significantly 
depressed compared with control levels at the end of the experimental 
period (2 hours in this case, P<0.01). The significance levels for the 
paired t-tests are shown in Table 14.
To compare the fall in contrast sensitivity after atropine 124 min 
before + physostigmine, with that seen after physostigmine alone, the 
data were normalised by expressing contrast thresholds as a percentage
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Fig. 49. Effects of injection of atropine (2 mg i.m.) at 124 min prior 
to 0.25% physostigmine eyedrops on contrast sensitivity (logarithmic 
scale) to stationary sinusoidal gratings of spatial frequencies 10, 20 
and 30 c/deg and a 3 c/deg grating phase-reversed at 5.5 Hz. Mean data 
+ S.E. for 6 subjects.
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Table 14. Atropine 124 min prior to physostigmine. Significance 
levels (paired t-tests) of the difference in logarithm contrast 
sensitivity between the test period and the control period C2, at the 
spatial frequencies indicated.
Period c i A1 A2 P1 P2 P3 P4 P5
Time (min) - (60) (90) (14) (36) (54) (81) (112)
10 c/deg 0.004 <0.001 0.29 0.005 0.002 0.008 0.05 0.27
20 c/deg 0.31 0.006 0.24 0.006 0.003 0.05 0.21 0.27
30 c/deg 0.51 0.67 0.36 <0.001 <0.001 0.01 0.33 0.18
3c/deg * 0.58 0.01 0.05 <0.001 0.001 0.005 0.01 0.008
C: control measurements A: measurements post-atropine and P:
measurements post-physostigmine. * grating pattern phase-reversed at
5.5 Hz.
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of C2. Hie reduction in contrast sensitivity for a 10 c/deg grating 
pattern is shewn in Fig. 45B. Pre-treatment with atropine 124 min 
prior to physostigmine resulted in a fall to 12% of control by 31 min 
with a recovery to 89% of control by 109min after physostigmine. In 
comparison, physostigmine alone had caused a reduction in contrast 
sensitivity to 8% of control by 39 min, gradually recovering to 102% of 
control by 167 min. Again there were no significant differences between 
the physostigmine + atropine and physostigmine alone data at any time 
period (P>0.07; Fig. 45B).
The reduction in contrast sensitivity at 20 and 30 c/deg after 
physostigmine is shown in Figs. 46B and 47B respectively. In general, 
there was no significant difference in the reduction of contrast 
sensitivity seen for the physostigmine + atropine data compared with 
those for physostigmine alone, nor in the recovery of contrast 
sensitivity (P>0.10). The only exception was for 30 c/deg at 110 min 
(P<0.05).
For the 3 c/deg phase-reversed grating pattern, the loss of 
contrast sensitivity was slightly greater after the 124 min atropine 
pre-treatment which resulted in a maximal reduction to 11% of control 
compared with 21% of control for physostigmine alone (Fig. 48B). 
However these differences were not significant (P>0.10). As with the 
physostigmine alone experiment, contrast sensitivity to the 3 c/deg 
moving pattern returned to only 70% of the control level by the end of 
the experimental period (P<0.01).
In summary, neither of the pre-treatments with atropine 
significantly affected the amplitude or time course of the effects of 
physostigmine eyedrops, followed over 3 hours, on pupil diameter, 
accommodation and contrast sensitivity, as shewn by the peak effects of 
physostigmine in Ihble 15.
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Table 15. Comparison of effects of 0.25% physostigmine eyedrops 30min 
after instillation, when given alone or preceded by atropine at 8 min 
and 124 min. Mean data for 6 subjects.
Pupil diameter Defocus Mean reduction in contrast sensitivity (%)
(mm) (dioptres) 3c/deg 10c/deg 20c/deg 30c/deg
Physostigmine 2.0 7.0 77 92 96 98
+ 8min atropine 2.0 6.5 87 86 95 100
+ 124min atropine 2.1 6.0 86 88 91 95
Pre-treatment with homatropine hydrobromide eyedrops
Five of the six subjects who had taken part in the previous two 
experiments also completed this third test with physostigmine eyedrops. 
Each subj ect had shown a large increase in accommodation following 
physostigmine eyedrops on five previous occasions.
Pupil diameter
Following homatropine hydrobromide, all 5 subjects showed a 
dilatation of the pupil to ~8mm. This was followed by pupillary 
constriction after physostigmine to only 6mm in diameter instead of the 
value of 2mm to physostigmine alone. Table 16 shows the individual 
responses, expressed as the difference in pupil diameter between the 
test eye and the control eye. Constriction of the pupil following 
physostigmine was sufficient to bring the diameter of the test eye to 
belcw that of the control eye for only two of the five subjects tested.
The mean data for the homatropine pre-treatment on the pupil 
diameter response to physostigmine eyedrops are shown in Fig. 50.
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Homatropine initially caused a pupil dilatation from about 5.5mm to 
about 8.6mm. To ensure that the homatropine effects were fully 
developed, physostigmine eyedrops were not given until, on average, 112 
rain after homatropine. Physostigmine then caused a constriction of the 
pupil to about 6mm, at 60-80 min when the pupil diameter was not 
significantly different from the pre-homatropine control for that eye 
(C3, P>0.35). Thereafter, the pupil diameter was significantly greater 
than the pre-homatropine control (P<0.05), as if the physostigmine- 
induced miosis was declining. After physostigmine, paired t-tests 
between the control and test eyes, however, showed no significant 
differences (P>0.10) except at 10 min when that of the test eye was 
still significantly larger than control (P<0.001).
Accommodation
Pre-treatment with homatropine resulted in a slight loss of 
accommodation which required a correcting lens (of the order of +0.25D) 
to be worn for optimal Snellen acuity at 5m. Administration of 
physostigmine then caused a small increase in involuntary accommodation 
with the result that the subject now had optimal Snellen acuity without 
additional refraction or needed a negative spherical lens to compensate 
for the increased accommodation. The individual results are given in 
Table 17 and the grouped data are shown in Fig. 51. Thus, administration 
of physostigmine causes a slight increase in accommodation. However, 
when compared with the effect of physostigmine alone, the changes are 
very small (e.g. -0.4 D change at 30 min as compared with -7.5 D).
Following application of homatropine eyedrops, all 5 subj ects 
experienced a marked loss of near point accommodation (to less than 2 D, 
the limit of our measurements; Table 18). Physostigmine then caused an 
almost complete recovery of near point accommodation, but the effect was
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transient as near point accommodation started to diminish by the end of 
the experiment. Indeed, in one subject this had again resulted in a 
complete loss of near point accommodation. The mean changes in near 
point accommodation are illustrated in Fig. 52. Physostigmine caused 
near point accommodation to return to pre-homatropine control levels 
(P>0.13). However, later there was an apparent loss of near point 
accommodation which attained significance by 3 hours post-physostigmine 
(P=0.04).
Contrast sensitivity
Contrast sensitivity was measured at 10, 20 and 30 c/deg for 
stationary grating patterns and at 3 c/deg for a grating phase-reversed 
at 5.5 Hz. Three control series of measurements were made prior to 
administration of any drugs. Following homatropine eyedrops, three 
further series of measurements were made. After administration of 
physostigmine eyedrops, measurements were made for a further 3 hours.
Individually, two out of five subjects showed little or no change 
in contrast sensitivity, at each spatial frequency measured, after 
homatropine and physostigmine and their results are shown in Fig. 53. 
These two subject's accommodation was also least affected (see Table 
17). In another two subjects contrast sensitivity remained constant 
after homatropine eyedrops but a transient fall in contrast sensitivity 
was present mainly at 10, 20 and 30 c/deg after physostigmine (Fig. 54). 
The fifth subject showed a marked fall in contrast sensitivity after 
homatropine at 10, 20 and 30 c/deg, with a smaller reduction at 3 c/deg. 
Physostigmine administration then increased this subject's contrast 
sensitivity to about control levels (Fig. 55). The reason for the fall 
in contrast sensitivity following homatropine is not readily apparent, 
though homatropine nevertheless annulled the effect of physostigmine.
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Fig. 53. Individual results of tvro subjects who showed little change in 
contrast sensitivity at the spatial frequencies indicated after 2% 
homatropine and 0.25% physostigmine eyedrops.
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The grouped data for all 5 subjects were calculated and the mean 
contrast sensitivity measurements are shown in Fig. 56A. For comparison, 
Fig. 57 shows the mean contrast sensitivity measurements after 
physostigmine alone for the same 5 subjects. Pre-treatment with 
homatropine eyedrops prevented the large decrease in contrast 
sensitivity normally seen after physostigmine eyedrops. Although there 
was a small transient fall in contrast sensitivity, particularly for the 
10, 20 and 30 c/deg grating patterns with less effect at the 3 c/deg 
phase-reversed grating pattern, contrast sensitivity was not 
significantly different from the control measurement prior to 
homatropine administration (C3) at any of the spatial frequencies 
measured (paired t-tests, P>0.12). Homatropine per se did not 
significantly affect contrast sensitivity at any spatial frequency 
measured, including the phase-reversed grating pattern (P>0.10).
The changes in contrast sensitivity have also been shown as a 
percentage of the pre-homatropine control value in Fig. 56B. Immediately 
after physostigmine, a 20% fall in contrast sensitivity was seen at 10, 
20 and 30 c/deg and a 12% fall was seen for the 3 c/deg phase-reversed 
grating pattern. By 30 min after physostigmine, however, contrast 
sensitivity had returned to, or exceeded the control level. This is 
compared with a peak fall in contrast sensitivity of 92% at 10c/deg; 
95% at 20 c/deg; 97% at 30 c/deg and 78% at 3 c/deg (phase-reversed) 
after physostigmine alone. Overall, the deleterious effect of 
physostigmine eyedrops on contrast sensitivity was very effectively 
prevented by homatropine.
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Assessment of visual performance mainly by measurement of contrast 
sensitivity has provided several new findings with respect to the action 
of anticholinesterases and cholinergic antagonists. By far the most 
important finding was the profound deleterious effect caused by defocus 
in contrast to the minimal effects caused by the changes in pupil 
diameter. In addition, evidence has been presented for neural actions 
of atropine and physostigmine. Intramuscular injection of atropine had 
a deleterious effect on motion sensitivity at lew spatial frequencies. 
Physostigmine eyedrops caused a transient reduction in contrast 
sensitivity at higher spatial frequencies with an additional sustained 
action on lew spatial frequency channels. Thus, as far as the visual 
system is concerned it is most undesirable for there to be a premature 
injection of atropine in the face of anticipated anticholinesterase 
poisoning. Even in the presence of the anticholinesterase, atropine has 
no beneficial effects in protection of visual function and may actually 
exacerbate perception difficulties by impairing motion sensitivity.
Contrast sensitivity to the CRT display
In the present study, the mean CSF for 12 subjects measured for 
the CRT display (Fig. 7), viewing with the natural pupil of 6 mm 
diameter, had a peak of 81 units (S.D., 0.20) at 3 - 5 c/deg. This mean 
CSF is very similar to the individual data of Campbell & Green (1965) 
and Charman (1979). It can also be directly compared to the
measurements of Morrison & McGrath (1985) (which were made using the 
same apparatus), for a group of young subjects, the range of contrast 
sensitivity they found was similar to that in the present study.
Contrast sensitivity at low spatial frequencies was measured from 
1.0 m in the first part of the present study, where the display 
subtended 4.5 deg. McCann et al., (1974) showed that the viewing of low
142
spatial frequencies is unaffected by distance, but one factor which may 
limit contrast sensitivity at low spatial frequencies is the number of 
cycles of the grating visible. At least three cycles should be present 
for our screen luminance (Hoekstra et al., 1974). Thus some additional 
attenuation of contrast sensitivity may have been present at 0.5 c/deg 
as just under three cycles of the grating were visible. Howell & Hess 
(1978) found that the angular length of the bars of a grating was also 
important at lew spatial frequencies. In absolute terms the contrast 
sensitivity measurements at the lowest spatial frequencies may not be 
entirely normal, but any effect wculd be present for all subjects under 
each of the test conditions; therefore, the measurements are acceptable 
for making comparisons. The presence of a dark surround also reduces 
contrast sensitivity, especially at low spatial frequencies (Estevez & 
Cavonius, 1976). The reduction would, however, not be constant 
throughout the present work since the action of the defocusing lenses 
would be to reduce the gradient of luminance between display and 
surround. Again, this factor should be constant between subjects, 
allowing comparisons to be made.
Contrast sensitivity to the laser display
Contrast sensitivity measurements to laser interference fringes 
observed in the Maxwellian view provide a measure of the transfer 
characteristics of the retina/brain portion of the visual system. The 
contrast sensitivity measurements to laser interference fringes made in 
the present study (Fig. 11) are, in general, comparable to those of 
Campbell & Green (1965), in that peak contrast sensitivity of similar 
magnitude occurred at 5-10 c/deg. High spatial frequency resolution was 
also comparable to Campbell & Green since spatial frequencies as high as 
50 c/deg could be detected without difficulty, as was also found by
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Morrison & McGrath (1985) for a group of young subjects. These results 
are higher than those from earlier studies before gas lasers were 
available, using partially coherent light (Arnulf & Dupuy, 1960; 
Westheimer, 1960). Higher contrast sensitivities, particularly at high 
spatial frequencies were reported by Williams (1985a), in a study which 
employed a constant fraction of coherent light. In the present study 
and that of Campbell & Green (1965), the fraction of coherent light 
varied since a polariser was used to modulate the contrast of the 
interference fringes. Williams (1985a) has suggested that the presence 
of coherent spatial noise both from the apparatus and from 
irregularities in the eye itself, such as vitreal floaters, can have a 
masking effect. This reduces contrast sensitivity to interference 
fringes and is especially marked when a greater proportion of coherent 
light is present i.e. when the contrast threshold is high, as for high 
spatial frequency fringes in the present study. At spatial frequencies 
above 60-70 c/deg, the individual bars of the interference fringes are 
no longer visible as aliasing due to the spacing of the foveal cones 
distorts the image and a low spatial frequency moire pattern is seen 
(Williams, 1985b). Aliasing, however, should not have been a problem in 
the present study.
The method of presentation of the stimulus can also influence the 
contrast threshold to high spatial frequency interference fringes. These 
fringes can only be seen at the macula and disappear with steady viewing 
due to adaptation. To prevent this, subjects were instructed to make 
rapid determinations of threshold and to look away from the display then 
return to it if necessary. The range for normal subjects was 
considerable and generally greater than that for the CRT display but was 
similar to that found for the six subjects tested by Williams and in the 
study with subjects of different ages by Morrison & McGrath (1985).
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This emphasises the need for relatively large samples of subjects 
wherever possible.
The ocular modulation transfer function
Comparison of contrast sensitivity measurements to laser 
interference fringes with those made for conventional CRT generated 
grating patterns allows the ocular MTF to be calculated. This method of 
comparing contrast sensitivity for the two displays has the advantage 
that light must pass through the optics of the eye only once. Methods of 
determining the ocular MTF from measurements of the linespread function 
require the light to pass through the eye twice (Westheimer & Campbell, 
1962; Campbell & Gubisch, 1966; Charman & Jennings, 1976) and may be 
confounded by backscattered illumination (Kerker, 1969). However, one 
disadvantage of the method used in the present study is that it does not 
allow for intraocular scatter of light. This will degrade the modulation 
of the image of both the laser interference fringes and the CRT grating 
patterns and may, therefore, lead to an overestimation of the ocular MTF 
(Charman, 1983). The fact that the two displays used in the present 
study (and also by Campbell & Green) were of different wavelength 
emissions should not be a problem, for contrast sensitivity to 
monochromatic gratings does not change with wavelength, providing the 
mean luminance is constant (van Nes & Bouman, 1967).
The mean ocular MTF (shown as the continuous line uppermost in 
Fig. 12) shows that image contrast was reduced to 50% at 3 c/deg with a 
further fall to 30% at 20 c/deg. Over 10-38 c/deg, it remained fairly 
constant whereas the retinal transfer characteristics (i.e. contrast 
sensitivity to the laser interference fringes) declined at a much faster 
rate, indicating that the high frequency cut-off (i.e. the resolution 
limit) would be set by the retina/brain rather than by the ocular media.
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This is in agreement with the results of Campbell & Green (1965) and 
also those from a study with subjects of different ages (Morrison & 
McGrath, 1985). While at first it may seen that the present results 
which measured down to 1 c/deg extend the data of Campbell & Green 
(1965) which measured down to 4 c/deg, this was not the case. Due to 
the failure to anticipate certain methodological problems, and the fact 
that it was thought more objective to analyse the data after all the 
experiments had been completed, this was discovered only later. For 
spatial frequencies less than 3 c/deg the MTF, for all 12 subjects 
measured, fell due to a greater difference between the CRT and laser 
contrast sensitivities. This was due to three factors: first, the
luminances of the two displays were not exactly matched (difference of
1.3 log units) although this should have least effect at low spatial 
frequencies (van Meeteren & Vos, 1972). Second, there was a difference 
in field size which would have had greatest effect for low spatial 
frequency grating patterns generated on the CRT display (Howell & Hess,
1978). Third, the shape of the two displays was different (CRT, 
rectangular; laser, circular) and edge effects due to the truncation of 
the grating pattern would have influenced contrast sensitivity only for 
the CRT display since they average out for circular apertures (Kelly, 
1970). When field size, shape and luminance of the two displays was 
carefully matched, the ocular MTF was found to increase towards unity at 
lew spatial frequencies (Fig. 13; Fraser & Morrison, 1987), in agreement 
with conventional physical optics.
Reproducibility of the measurements
In order to be able to use contrast sensitivity as a monitor of 
visual performance throughout an experimental session consisting of 
repeated sets of measurements, the measurements themselves must be
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reproducible. This is especially important if one wishes to detect any 
small changes in performance which may occur, for example, following 
administration of a drug. The reproducibility of the contrast 
sensitivity measurements made in the present study was assessed in Part 
4 when a full "dummy" run of experiment 2 of the atropine study was 
performed. This consisted of four consecutive hourly series of 
measurements to both CRT and laser displays (shown on left of Figs. 37 & 
39 respectively). There was a gradual trend for contrast sensitivity to 
increase on each repeat session over the four hour experimental period. 
However, these changes were relatively rather small as seen in Fig. 38 
which shows the consistency of contrast sensitivity for the CRT display, 
for all spatial frequencies measured. Contrast sensitivity was 
generally not significantly different from that determined on the first 
session for either stimulus display (Figs. 37 & 39). Contrast 
sensitivity on the second day (prior to atropine administration) was, 
however, significantly greater than the last series of control 
measurements cn the first day. Thus, a significant practice effect or 
change in criterion for judgement of threshold had occurred between 
days. If the effect of some drug was to be examined by contrast 
sensitivity measurements, it would be necessary to at least randomise 
the sessions or preferably to establish a series of controls on the same 
day prior to administration of the drug. De Valois (1977) reported that 
two highly practised subjects showed a large increase in sensitivity as 
a result of repeated testing, but this was for almost daily testing over 
a period of 1.5 years. In contrast to the present work, Kelly & 
Tomlinson (1987) for a group of 20 subjects, showed that no significant 
practice effects occurred over a five day training period. They 
concluded that the technique was suitable for longitudinal studies of 
visual performance. Throughout the present study, an initial set of
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practice measurements m s  made for each display used at a low, medium 
and high spatial frequency. These results though analysed were not 
used. After practice at a high spatial frequency the subject usually 
became attuned to the method of determining threshold and then a full 
series of measurements could be taken with confidence.
Part 1; A quantitative investigation of the effects of defocus, pupil 
diameter and spatial frequency on contrast sensitivity.
Pupil Diameter
i b l *
In general, change in pupil diameter from 2mm to 8mm was without 
significant effect on contrast sensitivity as compared with the natural 
pupil of 6mm (Fig. 8). There was a tendency for contrast sensitivity 
over 3-38 c/deg to be reduced at 2mm compared with 3mm pupil diameters, 
but the reduction was not significant (Fig. 8A). The only significant 
reduction in contrast sensitivity observed was at 0.5 and 1.0 c/deg for 
a 2mm pupil.
It has been established that, when retinal illumination is 
arranged to be constant, optical quality increases as pupil diameter 
decreases until a critical pupil diameter is reached below which 
diffraction degrades image quality. The optimal pupil diameter has been 
demonstrated by psychophysical measurements of the MIF (Amulf & Dupuy, 
1960; Campbell & Green, 1965; Charman, 1979; Bour, 1980), objective 
measurements of the line spread function (Campbell & Gubisch, 1966; 
Charman & Jennings, 1976) and measurements of visual resolution 
(Campbell & Gregory, 1960; Jenkins, 1963; Tucker & Charman, 1975) to be 
around 3mm. Thus, in the present study, the theoretical improvement to 
be gained by reducing the pupil diameter appears to be annulled by the 
reduction in retinal illumination. Indeed, it has been previously shown
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that at lew light levels, a small fixed pupil leads to a large loss in 
visual resolution giving rise to the proposal that the pupil diameter 
resulting naturally from a given level of illumination is optimal for 
visual acuity at that illumination (Woodhouse, 1975). The results of the 
present study are in agreement with the findings of Morrison & McGrath 
(1985) who showed no difference in contrast sensitivity for young 
subjects viewing with either their natural pupil (8mm) or through a 3mm 
artificial pupil and have since been confirmed by Tobimatsu, Oelesia & 
Cone (1988) for natural, constricted and dilated pupils.
In the present work, a significant reduction in contrast 
sensitivity was found for 0.5 and 1 c/deg gratings when viewed through a 
2mm pupil but not a 3mm pupil. This result is unlikely to be due to the 
reduction in retinal illumination alone for this should have least 
effect on lew spatial frequency gratings (van Meeteren & Vos, 1972). A 
possible explanation is that increased diffraction effects from a 2mm 
pupil, in combination with lower retinal illumination, significantly 
degrades contrast sensitivity at low spatial frequencies. This also 
leads to the tendency for contrast sensitivity to be reduced for the 2mm 
pupil compared with the 3mm pupil over the 3-38 c/deg range. The effect 
becomes significant at low spatial frequencies due, perhaps, to the 
involvement of other factors. It is known that at low spatial 
frequencies, subjects scan the grating in order to aid detection of the 
pattern (Kulikowski & Tolhurst, 1973) as eye-movements increase contrast 
sensitivity at low spatial frequencies (Kelly, 1977). With the 
introduction of a small artificial pupil in a fixed position relative to 
the orbit, this scanning could result in compromising of central 
fixation. Perhaps more likely, the significant reduction seen at 0.5 and 
1 c/deg is related to the number of cycles being close to the minimum 
limit for normal contrast sensitivity.
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Defocus
Defocus had a profound effect on contrast sensitivity, each 
increment in defocus causing a further decrement in contrast 
sensitivity. All spatial frequencies were affected by defocus but those 
belcw the peak of the CSF less so than those above. Spatial frequencies 
above the peak were all affected to the same extent, as a downwards 
parallel shift of the CSF was observed with increasing defocus, i.e. 
there was no significant change in the slope of the regression of the 
CSF above the peak. If increasing defocus were having a more detrimental 
effect on the higher spatial frequencies, the slope of the regression 
would be expected to increase with increasing defocus.
Campbell & Green (1965) showed an increase in slope with +1.0D 
defocus, as also shown in a brief study by Regan et al., (1977). 
Although no significant changes in slope were found in the present 
study, a fairly consistent finding was that between OD (optimum focus) 
and +1.0D, a slight (but insignificant) increase in slope occurred, 
thereafter the slope remained the same or decreased (Table 3). At 
optimum focus for high spatial frequencies, the image is situated at the 
hyperopic point of the depth-of-focus (Kasai et al., 1971). The fact 
that at large pupil diameters, there is a difference of -0.8 to -0.9D 
between optimal focus for high and low spatial frequencies (Green & 
Campbell, 1965), offers a possible explanation for the change of slope 
caused by +1.OD of defocus. Assuming a -0.8D difference in optimal 
focus between high and lew spatial frequencies, this would mean that the 
image of a high spatial frequency grating would be situated at the 
hyperopic point of the depth-of-focus whereas the image of a lew spatial 
frequency grating would be 0.8D in front of this point. By adding a 
+1 .OD lens, the image of the high spatial frequency grating would be 
shifted by 1D behind the hyperopic point (effectively defocused by 1 .OD)
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whilst the image of a low spatial frequency grating would be shifted by 
1D from its original position (i.e. through the depth of focus range to 
a point +0.2D behind the hyperopic point) and therefore only effectively 
defocused by 0.2D. For further increases in defocus (i.e. for +2.0D and 
+4.0D) both low and high spatial frequencies would then be defocused by 
the same amount and hence the slope of the CSF would remain constant. 
Although a difference in optimal focus was not seen when viewing through 
a 2mm pupil (Green & Campbell, 1965), which was attributed to a 
reduction in spherical aberration, some effect may possibly be present 
at the 3mm pupil used in this study. Indeed, pupils of 5.4 and 3.8mm 
diameters also show a spatial frequency dependence of optimal focus 
(Charman & Heron, 1979). Perhaps if the effects of defocus cn contrast 
sensitivity had been investigated for larger pupil diameters in the 
present study, +1.0D may have caused a significant increase in slope.
The conclusion of Campbell & Green (1965) that higher spatial 
frequencies were disproportionately affected compared with lower spatial 
frequencies was based largely on contrast thresholds of one subject, 
viewing through a 2mm artificial pupil, at spatial frequencies of 1.5, 
9, 22 and 30 c/deg (Fig. 6 in their original paper). However, when they 
examined contrast sensitivity over a wider range of spatial frequencies 
for 0, +0.5, +1 and +2.0 dioptres of defocus (Fig. 7 in their paper) 
contrast sensitivity was seen to decrease at all spatial frequencies 
from peak upwards, with some apparent tailing-off at the very highest 
spatial frequencies. However, calculation of the linear regression of 
the CSF greater than peak for each amount of defocus, revealed no 
increase in slope with increasing defocus (P>0.25). With a 7mm pupil, a 
parallel downward shift in contrast sensitivity occurred (Green & 
Campbell, 1965) in agreement with the present work. Charman (1979) also 
showed a basically parallel fall in contrast sensitivity over 5-30 c/deg
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for +0.25, +0.5 and +1.0D of defocus measured for a range of pupil 
diameters from 1 to 6mm. Marmor & Gawande (1988) also found a parallel 
loss of contrast sensitivity over 3 to 18 c/deg for +0.5, +1.0 and +1.7D 
of defocus.
From theoretical predictions of the effect of defocus on the MIF 
of the human eye, considered as a diffraction limited optical system 
(Hopkins, 1955), one would expect a steep increase in the effect of 
defocus with increasing spatial frequency and with increasing defocus 
(as shown in Fig. 2); this was not seen in this study. Also "zero 
minima" would have been expected where the grating would appear to 
reverse in contrast, but were not found in this study, nor in the work 
of Campbell & Green (1965). Charman (1979) did find some modulation but 
not always at the predicted spatial frequency (i.e. for +1 .OD of defocus 
minima occur at 6.6 and 10 c/deg in the diffraction-limited eye, Smith, 
1982). Thus, the refractive media of the eye perform in a way that 
cannot be predicted by the characteristics of a simple diffraction- 
limited optical system.
In the present study, contrast sensitivity to low spatial 
frequencies below the peak of the CSF was also degraded by defocus 
though to a lesser amount than spatial frequencies above the peak. The 
decrease in contrast sensitivity for these lew spatial frequencies was, 
however, only statistically significant when viewing through a 3mm 
pupil, not a 2mm pupil. The difference between the two conditions is 
most probably due to the greater depth-of-focus available with a 2mm 
pupil. Also a reduction in retinal illumination itself is also known to 
increase the depth-of-focus (Campbell, 1957).
Campbell & Green (1965) had concluded that lew spatial frequencies 
were not degraded by defocus, since the results for one subject, viewing 
a 1.5 c/deg grating through a 2mm pupil were not affected by increasing
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positive or negative lenses (Fig. 6 in their original paper). However, 
if cne examines the more complete CSF (their Fig.7) there does seen to 
be some decline in contrast sensitivity, with defocus, for spatial 
frequencies less than peak. With a 7mm artificial pupil, low spatial 
frequencies were markedly reduced (Green & Campbell, 1965). Also, in 
Charman's work (1979), contrast sensitivity at 1, 2 and 5 c/deg was 
reduced for a range of pupil diameters between 1 and 6mm.
In the repeat experiments of this study, which entailed viewing 
with the natural eye, several subjects noticed that their accommodation 
was fluctuating, presumably as their accommodative mechanism sought to 
bring the blurred image into focus. Regardless of this, viewing with 
the natural eye produced very similar results to the original study for 
the homatropinised eye. One exception was that +1.0D of defocus did not 
significantly reduce contrast sensitivity as it had done previously for 
the homatropinised eye. For 6 of the 8 subjects, a reduction in contrast 
sensitivity was found (though this was not significant) with +1.0D 
compared to optimal focus, but for 2 subjects contrast sensitivity was 
indistinguishable on the two occasions. Differences between individuals 
of this nature had been described by Reese & Fry (1941) who showed that 
not all individuals respond to defocusing lenses in the same manner. 
Some observers relax their accommodation when viewing through a 
defocusing lens (as for the 2 subjects above) whereas many observers1 
accommodation remains unchanged. Some others will, in fact, increase 
their level of accommodation in response to the external lens. Only a 
small relaxation of accommodation would be necessary to compensate for 
the external lens (0.25D for viewing from 3m and 0.75D for viewing from 
1m) because there is already a considerable amount of depth-of-focus 
(0.6D for a 3 mm pupil, Campbell, 1957) in addition to a tolerance of 
defocus blur of some 0.2-0.25D (Whiteside, 1957; Campbell & Westheimer,
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1958). This emphasises the fact that even a very small amount of 
defocus degrades the CSF, for the same depth-of-focus and tolerance of 
blur would also be present for the homatropinised eye with a 3 mm pupil, 
where +1 .OD did significantly degrade the CSF. Indeed, this is as 
predicted from optical theory, for Hopkins (1955) calculated that the 
optical transfer function would be appreciably reduced for only 0.125D 
of defocus (which corresponds to n=1 in Fig. 2) for a 3mm pupil viewed 
in green light.
The reproducibility of the contrast sensitivity measurements made 
in these long experiments was very good; repeat measurements at optimum 
focus made at the end of the session were not significantly different 
from those made at the start.
Quantitative analysis
To predict contrast sensitivity at the CRT luminance used in the 
present study, the best-fitting multiple regression equations were 
derived to incorporate terms for pupil diameter, defocus and spatial 
frequency. Pupil diameter was found to have only a small effect on 
contrast sensitivity, vhereas defocus had a profound effect particularly 
over 3 - 3 8  c/deg where it reduced contrast sensitivity by 51% and 45% 
per dioptre in the homatropinised and natural eyes, respectively. At 
0.5 - 3 c/deg, the reduction was only 19% and 11% per dioptre 
respectively. The relative insensitivity of low spatial frequencies 
will mean that the visual system will at least be able to rely on this 
information when defocus has reduced fine detail recognition. Thus, 
object detection should be relatively unimpaired as this has been 
correlated with the peak of the CSF (Ginsburg et al. 1982). Stereopsis 
should also be spared, for fusion of the two images can occur in the 
presence of low spatial frequency information only (Julesz, 1971).
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Stereoacuity, however, requires the full range of spatial frequencies to 
be present and has been shown to be degraded by defocus to a greater 
extent than visual acuity itself (Westheimer & McKee, 1980). Also, in 
the absence of high spatial frequency information, the accommodative 
mechanism will not be able to attain a sharp focus (Charman & Heron,
1979).
To summarise the findings of this part of the work, pupil diameter 
had such a small effect on contrast sensitivity that it can effectively 
be ignored. Therefore, in the mesopic range of illumination, for 
defocus of up to 4 dioptres, contrast sensitivity will be halved for 
each dioptre of defocus, for all but the very lowest of spatial 
frequencies.
Part 2; The effects of a single oral dose of pyridostigmine bromide on 
contrast sensitivity.
The principal finding of this study was that a 60mg oral dose of 
pyridostigmine bromide was without significant effect on the CSF 
measured for either the CRT or laser display. Borland et al., (1985) 
stated without elaboration that a 30mg dose of pyridostigmine, repeated 
at 8 hourly intervals for 3 days, had no effect on contrast sensitivity 
at several spatial frequencies between 0.5 and 25 c/deg. In the present 
study, a small (7%) but significant improvement of the mean contrast 
sensitivity, for the CRT display was seen over 3 - 4 0  c/deg after 
pyridostigmine. The mean contrast sensitivity for the laser display, 
which gives an entirely neural assessment of visual function, over the 
same range showed no such improvement. Below the peak of the CSF, no 
significant difference in contrast sensitivity was seen for either 
display. Thus, the small improvement in visual performance for
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externally viewed grating patterns in the absence of an effect on neural 
sensitivity may be attributed to an increase in ocular quality which was 
presumably due to the small reduction in pupil diameter (Fig. 16 A). 
However, the actual change in pupil diameter was very small. It was 
interesting that a larger difference in pupil diameter was present 
between the first and second tests (Fig. 16 B). It may be that the 
effect of the sympathetic nervous system on the first visit, perhaps due 
to the stress of performing tests in a strange laboratory environment 
or of taking an unknown tablet (anticipating possible ill-effects), were 
having a greater effect on pupil size than the actions of the 
anticholinesterase. Borland et al., (1985) noted that pyridostigmine
caused an increase in arousal. Therefore, it may even have been that 
any decrease in pupil diameter, expected from direct action of an 
anticholinesterase agent on the sphincter pupillae, was counteracted by 
an increase in pupil diameter associated with increased central arousal 
(Hess & Polt, 1964) due to a central action of the drug. However, 
pyridostigmine is a qua ternary compound and should not readily cross 
the blood brain barrier. This is supported by the constancy of contrast 
sensitivity to laser interference fringes in the present study.
There is evidence, from electrophysiological studies in the cat, 
that pyridostigmine alters visual cortical cell activity; approximately 
half of the cells studied were excited and half inhibited by 
pyridostigmine (DeBruyn & Bonds, 1987). Furthermore, physostigmine 
depressed visual cortical function, measured by the VER, to moving 
grating patterns of low spatial frequencies (0.1 - 1 c/deg), whereas 
high spatial frequencies were unaffected (Harding et al., 1983). Since 
contrast sensitivity in the cat is shifted down ten-fold with respect 
to human vision (Campbell, Maffei & Piccolino, 1973), these spatial 
frequencies may be analagous to spatial frequencies of 1 - 10 c/deg in
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man. Interestingly, in part 4 of the present study, atropine sulphate 
(2mg, i.m.) was found to have a deleterious effect specifically on
movement sensitivity at low spatial frequencies (1 - 5 c/deg). This 
being so, for completeness it would be desirable to undertake further 
experiments to assess the effect of pyridostigmine on visual performance 
to moving stimuli.
In any future experiments, the double blind protocol would not be 
used, for although one can depend on good reproducibility of contrast 
sensitivity measurements on any one day, this is not necessarily so 
between days. Therefore, both tests should be performed on the same day 
with control followed by test (in case of persistence if performed the 
other way round), though subjects must not know this.
To conclude, the present study demonstrates that a 60 mg dose of 
pyridostigmine does not significantly affect contrast sensitivity for 
stationary grating patterns. This suggests that this dose may be used 
as a pre-treatment against organophosphorus anticholinesterases without 
fear of impairment of stationary visual function, though a possible 
effect on movement function remains to be resolved.
Part 3; The effects of topical application of 0.25% physostigmine 
sulphate on visual performance.
In accordance with the established literature, physostigmine 
sulphate eyedrops caused a marked and long lasting pupillary 
constriction and an increase in the amplitude of accommodation. The 
extent of pupil constriction was greater than that caused by a single 
drop of 0.25% physostigmine salicylate (Ogle, Whisnant & Hazelrig, 
1966), but of a similar time course. Systemic absorption by way of the 
conjunctival vessels or the nasal mucosa was unlikely in the present
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study, as there was no effect on the contralateral eye. Aside from the 
predominant muscarinic effects on the smooth muscle of the sphincter 
pupillae and the ciliary body, some physostigmine must also have passed 
through the palpebral conjunctiva and prolonged the action of 
acetylcholine at nicotinic receptors of the orbicularis oculi palpebral 
muscle. This caused involuntary twitches of the eyelids.
An interesting finding of the present study was that While all 
subjects showed a similar degree of miosis there was wide variation in 
the amplitude of the increase in involuntary accommodation, ranging from 
practically zero to +10 dioptres (Table 6). Several factors were 
explored to try to account for this variation.
It is well known clinically that dark irises dilate very slowly 
with mydriatic agents. It is believed that darkly pigmented irises show 
a prolonged drug absorption phase (Shell, 1982), due to drug binding to 
melanins, the drug is then released slowly from this store prolonging 
the duration of the response (Nagataki & Mishima, 1980; Patil, 1984). 
However, the variation in the degree of defocus found in the present 
study was not related to any particular eye colour.
A significant amount of topically applied drugs is lost via 
drainage through the lachrymal apparatus, the rate of drainage 
increasing as the volume of instilled drug increases (Chrai et al.,
1973). Similarly, if excess tears were formed on administration of the 
eyedrops, increased washout of the drug solution may have occurred. 
However, in the present study, there appeared to be no relation between 
the amount of tear formation and the extent of the defocus.
Wide variation in the extent of defocus after physostigmine, up to 
a maximum of +7.5D, was also found by Rengstorff (1970). He found the 
visual task which he set his subjects, immediately following 
instillation of the eyedrops, influenced the amount of defocus
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experienced. Those subjects who performed near tasks produced 
significantly larger increases in accommodation than those subjects
performing far visual tasks, presumably because more acetylcholine 
accumulates at the endplates of an active muscle. However, the visual 
tasks performed immediately after instillation of the eyedrops can not 
account for the variation in the amplitude of defocus in this present 
work. All subjects followed the same sequence of tests involving both 
near and far visual tasks.
The possibility that some genetic factor may be involved in the 
degree of defocus caused by physostigmine was also investigated in the 
present study. Two groups of siblings were tested. One family all 
showed large increases in accommodation and the other showed only 
moderate or small increases in accommodation. Both families showed the 
same miosis (Table 7). These results are consistent with a genetic 
trait affecting the response of the ciliary body, but further
experiments would, of course, be necessary to establish this point.
In the present study, the effect of physostigmine on visual 
performance was initially assessed by a Snellen test which is the only 
assessment that has in the past been made (Mattila et al., 1967; 
Rengstorff, 1970). A more extensive assessment of visual function was 
then made by measuring contrast sensitivity.
Contrast sensitivity to oscilloscope-generated stationary grating 
patterns declined transiently in response to physostigmine with a time- 
oourse similar to that of the increase in accommodation. Since the 
miosis did not recover during the experimental period, it seems that 
only defocus of the image contributes substantially to the decline in 
contrast sensitivity, which is consistent with the findings of part 1 of 
this study. Indeed, at the peak of the response, the decline in
contrast sensitivity was proportional to the degree of defocus
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(P < 0.01) as shown in Fig. 25. At this time, contrast sensitivity to 
each spatial frequency measured (3, 10, 20 and 30 c/deg) was similarly 
reduced. However, contrast sensitivity at 3 c/deg did not fully 
recover within the time period of the experiment (Fig. 23).
Gontrast sensitivity to oscilloscope-generated moving patterns 
also declined, spatial frequencies of 2 and 3 c/deg were more severely 
affected than those of 1 and 0.5 c/deg, as vould be predicted from the 
present study with defocusing lenses. The decline in contrast 
sensitivity to these moving gratings was also proportional to the 
degree of defocus (P < 0.001 at 1, 2 and 3 c/deg gratings) as shown in 
Fig. 28. A point of particular interest was that for each of these low 
spatial frequency moving gratings, as well as for the 3 c/deg stationary 
grating, full recovery of contrast sensitivity was not seen during the 
experiment. Contrast sensitivity for the higher spatial frequencies, 
however, recovered to control levels by 90 - 120 min post­
administration. Since diffraction effects, arising from the small pupil 
would be present for all spatial frequencies and the reduced retinal 
illumination should, if anything, have less effect at low spatial 
frequencies (van Meeteren & Vos, 1972), this may represent some 
prolonged neural effect of physostigmine on the lew spatial frequency 
channels. This may also be related to the present finding of a 
reduction in movement sensitivity following atropine administration.
Contrast sensitivity measurements made for laser interference 
fringes also showed a transient reduction following physostigmine. 
Again, since the miosis outlasted the fall in contrast sensitivity, the 
reduction in retinal illumination could not account for this change. 
Although the interference fringes themselves, which were formed by 
coherent light and observed in the Maxwellian view, would not be 
defocused by an increase in accommodation, the aperture surrounding the
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fringes would be defocused. This would reduce the luminance gradient 
between the interference fringes and the surround and produce a blur 
circle around the edge of the display which may alter the phase of 
truncation of the waveform, both of which can influence the contrast 
threshold (Estevez & Cavonius, 1976; Kelly, 1970). However, a defocus 
of +7.0 D due to myopia, which would cause a similar defocus of the 
aperture, did not significantly change contrast sensitivity to the 
interference fringes (Fig. 31). Thus, defocus of the aperture seems not 
to be the cause of the decline in contrast sensitivity to the laser 
display. Since the control eye showed no miosis, systemic absorption of 
physostigmine which may have led to an effect on the central nervous 
system seems improbable. This suggests that there may be a direct 
effect from trans-comeal absorption of physostigmine on the retinal 
neurones. Further evidence to support a retinal/central effect of 
physostigmine was the transient reduction in mean critical fusion 
frequency measured with a constant entrance pupil, as also shown by 
Alpern & Jampel (1959). The transient time course of both these 
effects, while mirroring the time course of the defocus response, may, 
instead, represent the time course of the presence of physostigmine at 
the retina.
Large contractions of the ciliary muscle, however, are known to 
cause forward movement of the choroid and retina. Enoch (1973) has 
calculated that +10D accommodation results in a 2.5% increase in retinal 
area. This is not confined to the anterior margins of the retina as the 
central retina also stretches during marked accommodation (Hollins,
1974). Blank & Enoch (1973), found that large increases in 
accommodation induced significant distortions of horizontal spatial 
perception which may have altered the spatial frequency of the 
interference fringes in the present study. However, subject 12, who
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showed very little increase in accommodation following physostigmine, 
also showed a small decline in laser contrast sensitivity, but only for 
the 25 c/deg pattern (Fig. 30). This again suggests that the decline in 
laser contrast sensitivity is not related to the ciliary muscle 
contraction but a direct effect of physostigmine on the retina.
Physostigmine may also have some general vascular effect on the 
retinal neurones which affects visual function, since contraction of the 
ciliary muscle also contracts the ciliary arteries, but, at the same 
time, outflow from the vorticose veins is facilitated. This leads to a 
reduced volume of blood in the eye and hence, a reduced intra-ocular 
pressure (O'Connor Davies, 1981).
The cholinergic cells in the retina have been identified as a 
population of amacrine cells which, in the monkey retina have been shown 
to contact other amacrine cells, bipolar cells and ganglion cells 
(Mariani & Hersch, 1988). Both nicotinic and muscarinic receptors have 
been demonstrated in the inner plexiform layer. The consensus of opinion 
seems to be that nicotinic receptors are found on ganglion cells in 
rabbit, chick and rat retinae (Masland & Ames, 1976; Morgan & Mundy, 
1984; Redbum et al., 1984 respectively) and on "transient" ganglion 
cells in the cat (Ikeda & Sheardown, 1982), whereas muscarinic receptors 
are found on amacrine cells (Morgan & Mundy, 1984; Redbum et al., 
1984). However, Schmidt et al., (1987) have suggested that both 
"sustained" and "transient" ganglion cells in the cat possess muscarinic 
receptors. The inhibitory effect of physostigmine on the retinal 
contrast sensitivity found in the present study is consistent with the 
enhancement of the effect of acetylcholine on muscarinic receptors of 
amacrine cells which are inhibitory to the retinal ganglion cells. This 
action must be stronger than any potentiation of cholinergic 
transmission to the nicotinic receptors on the "transient" ganglion
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cells which subserve movement detection since the effect of 
physostigmine on the low spatial frequency grating patterns which will 
be detected by the movement-dependent channels (Tolhurst, 1973) showed a 
sustained loss of contrast sensitivity which was not apparent at higher 
spatial frequencies.
The main findings of this part of the work were: (1 ) that
physostigmine caused a transient reduction in contrast sensitivity to 
externally viewed grating patterns which was correlated with the 
increase in the amplitude of accommodation, (2) physostigmine had a 
direct effect, of transient time course, on contrast sensitivity to 
laser interference fringes particularly at higher spatial frequencies 
which was not affected by defocus of the image, and (3) physostigmine 
caused a prolonged reduction in contrast sensitivity to low spatial 
frequency grating patterns indicating an additional action on the 
movement-dependent channels of the visual system.
Part 4: The effect of an intramuscular dose of 2mg atropine sulphate on 
visual performance.
In the present study, a 2 mg i.m. injection of atropine sulphate 
produced the well known effects of a general antagonism of muscarinic 
receptors throughout the body (Martindale, 1982). The overall degree 
of discomfort expressed by each subject was quite variable, although all 
three subjects who completed both parts of the study experienced less 
discomfort (in particular, dryness of the mouth and throat) on the 
second day, as was also noted by Cullumbine et al., (1955). Atropine 
caused a transient bradycardia during the first five minutes after the 
injection which has been previously reported following low doses (0.5-
2.4 mg) of atropine i.m. (Cullumbine et al., 1955; Chamberlain, Turner &
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Sneddon, 1967; Kaiser & McLain, 1970; Holland, Parkes & White, 1975). 
It is believed to be due to either a slight central stimulant action of 
atropine on the nucleus ambiguus - the source of cardiac vagal fibres, 
or to an agonist action of atropine on muscarinic receptors of cardiac 
muscle, since 1 cm  doses of antagonists can act as partial agonists, 
before the antagonist action develops (Bowman & Rand, 1980). As the 
bradycardia was not found at higher i.m. doses of atropine (Mirakhur, 
1978) nor for a 1 mg i.v. dose (Cullumbine et al., 1955), the second 
explanation may be the more probable. The- more pronounced effect on 
heart rate was a tachycardia which then rapidly developed, due to 
inhibition of the vagal inputs to the heart. Resting heart rate 
increased by approximately 50% at the peak of the response (30 min - 1 
hour post-injection) and then declined gradually to normal by 4 - 5 
hours post-injection.
Atropine's effects on the ocular smooth muscle developed more 
slowly and were more prolonged than its effect on heart rate. 
Differences in the initial time course of the action of atropine are due 
to differences in regional blood flew and the rate of diffusion of the 
drug into the various tissues (Mayer, Melmon & Gilman, 1980). The 
prolonged duration of the effect on the ocular smooth muscle is related 
to binding of the drug to proteins in the muscle (notably to pigments in 
the iris). In the present study, a maximum pupil dilation of 1.2 - 1.5mm 
was seen between 2 - 2.5 hours post-injection and the pupil remained 
significantly dilated for up to 4 hours, as also found by Herxheimer 
(1958) and Rozsival & Ciganek (1978). The reduction in the amplitude of 
accommodation was sustained in the present study for 6 hours post­
injection, as previously found by Mirakhur (1978). A small amount of 
this reduction may be due to the decreased depth-of-focus available with 
a dilated pupil but as only 0.6 D is available with a 3mm pupil, its
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contribution must be minimal (Campbell, 1957). The loss of ability to 
focus on near objects was large enough that most subjects noted 
difficulty in reading, even though they still had a reserve 
accommodation of around 8 D. Near visual acuity was not measured in 
this study but Haegerstrom-Portnoy et al., (1987), reported deficits of 
about one and a half lines on a Bailey near acuity chart.
The effect of atropine on the extraocular muscles which caused a 
change in horizontal heterophoria and cyclophoria was rather short 
lasting. It seemed to coincide with the change in heart rate, which 
reflects plasma concentration of atropine (Kaiser & McLain, 1970), 
rather than with the changes in pupil diameter and accommodation. This 
may be due to a non-specific membrane effect at the motor end plate 
(Wray, 1980). However, there is evidence for muscarinic receptors which 
are blocked by atropine in the superior oblique muscle of cat (Sanghvi & 
Smith, 1969). The present change in muscle balance is, therefore, 
consistent with the presence of muscarinic receptors on human 
extraocular muscle fibres.
In general, atropine did not affect the performance of any 
stationary visual tasks in the present study. Atropine did not 
significantly affect reaction time or choice reaction time to a visual 
stimulus, followed for 6 hours post-injection, despite subjective 
complaints of lightheadedness and an inability to concentrate from many 
subjects. Red-green colour balance was unchanged by atropine as also 
reported by Baker et al., (1983). Stereoacuity, the ability to
discriminate between features at different distances in space, was a 
particularly demanding task for the subject which, if anything, should 
reflect any cerebral effects of the drug. However, stereoacuity was 
unaffected by atropine in the present study. Since stereoacuity has been 
shown to be more markedly affected than visual acuity by a given amount
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of defocus (Westheiraer & McKee, 1980), it was not surprising therefore, 
that visual acuity was also unaffected by atropine. Similarly, Rozsival 
& Ciganek (1978) reported no change in distant vision, Baker et al.,
(1983), found no change in acuity to a Landolt C chart and Haegerstrom- 
Portnoy et al., (1987) found no change in distant acuity to either high 
or lcw contrast test charts.
In case, by measuring only visual acuity, we were perhaps missing 
some more subtle effects of atropine on spatial vision, a full 
examination of its effect on the CSF was performed. However, atropine 
had no significant effect on contrast sensitivity to stationary grating 
patterns of spatial frequencies 1 - 3 0  c/deg, generated on a CRT. This 
is in accord with the absence of an effect of pupil size on contrast 
sensitivity and with Baker et al., (1983) who also found contrast 
sensitivity to be mainly unaffected by atropine. Also, Haegerstrom- 
Portnoy et al., (1987) found no change in sensitivity to contrast 
differences on a "Border contrast sensitivity" test following 2 and 4 mg 
atropine. Contrast sensitivity to stationary laser interference fringes 
was similarly unaffected by atropine confirming an absence of any neural 
effect on stationary visual function.
An important finding of this study was that an i.m. injection of 
atropine sulphate had an adverse effect on contrast sensitivity to low 
spatial frequency moving grating patterns. Detection of moving gratings 
of 1, 2 and 3 c/deg was significantly impaired by some 25 %, with a 
smaller reduction at 5 c/deg. The time course of the adverse effect on 
contrast sensitivity to these grating patterns was sustained, spanning 
the whole of the experimental period (6 hours). Since contrast 
sensitivity to stationary grating patterns of the same spatial 
frequencies was unaffected by atropine, this must reflect a specific 
effect on movement sensitivity. An adverse effect on movement
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sensitivity is consistent with the recently reported impairment of 
visual tracking of a moving stimulus (Penetar & Beatrice, 1986; 
Haegerstrom-Portnoy et al., 1987) after atropine. In both studies, the 
subject aligned the cross-hairs of an eyepiece on the centre of a moving 
target and tracking scores were computed. A 4 mg dose produced a 
significant increase in tracking errors under dim and bright lighting 
conditions, but a 2 mg dose only reduced performance under dim 
illumination. Topical application of hyoscine has also been shown to 
selectively depress contrast sensitivity, by 30 - 50%, to lew spatial 
frequency grating patterns (Morrison & Reilly, 1989).
Cholinergic inputs are present throughout the visual system, in 
the LGN and visual cortex, but are often not involved in the 
transmission of visual information (Phillis et al., 1967). The 
cholinergic input to both the LGN and visual cortex seems to originate 
from neurones of the reticular formation (Singer, 1979). Ionophoresis of 
acetylcholine has a predominantly excitatory action on neurones of the 
dLGN (Sillito et al., 1983; Crunelli et al., 1988) but some cells may 
also be inhibited (McCormick & Prince, 1987). Little difference between 
"Y" and "X" dLGN cells' response to acetylcholine has been reported 
except for one study where a specific enhancement of a peripheral 
response of "Y" cells was seen (E^sel et al., 1987). Cortical cells are 
also influenced by ionophoresis of acetylcholine, an effect which can 
be antagonised by atropine (Sillito & Kemp, 1983). Firing of cells in 
layer 4 of the cortex was depressed by acetylcholine and their dominance 
of the VER would explain its depression at lew spatial frequencies after 
physostigmine (Harding et al., 1983) mentioned earlier. Also, in man, 
i.m. injections of lew doses of the muscarinic antagonist hyoscine (0.25 
- 0.75 mg) caused some amplitude and latency changes to flash and 
pattern (2.4 c/deg reversing checkerboard) VERs, while simultaneously
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recorded electroretinograms were unaffected, suggesting that the effect 
was central and not retinal (Sannita et al., 1988).
However, the specific effect of atropine on movement sensitivity 
found in the present study may reflect an effect on the cholinergic 
cells in the retina as they are known to be particularly responsive to 
flickering or moving stimuli (Masland & Livingstone, 1976; Ariel & Daw, 
1982b). In the previous section, it was argued that physostigmine 
enhanced the efficacy of amacrine cells which were surmised to have 
cholinergic inputs and released inhibitory transmitters onto the 
ganglion cell. This effect outweighed any potentiation of the direct 
excitatory cholinergic inputs onto the ganglion cell. It is at the 
latter synapse which the action of atropine is now surmised to have its 
dominant effect in selectively depressing movement sensitive ganglion 
cells. The present results are partially in agreement with the results 
of Ikeda & Sheardown (1982) who described in cat retina, excitatory 
cholinergic inputs to transient or "Y" ganglion cells, but they found 
dH pE antagonised the effect while atropine was described as having a 
non-specific depressant effect, when applied in high concentration. 
Thus, they suggested that "YM cells possessed nicotinic rather than 
muscarinic receptors. The present results are also in partial agreement 
with the work of Schmidt et al., (1987). These authors found that 
acetylcholine was excitatory to both "X" and "YM cells and that the 
response was antagonised by hyoscine, whereas dH p E blocked the effect 
of acetylcholine only on OFF-cells, suggesting the presence of 
muscarinic receptors on the ganglion cells, but on both "X" and MY" 
types. Given that the central actions of hyoscine are generally 
recognised to be more potent than those of atropine in man (Herxheimer, 
1958; Mirakhur, 1978), it may be that atropine especially in low dosage 
may discriminate between the ganglion cells underlying the movement-
168
dependent (MY"-like) and movement-independent (MX"-like) mechanisms 
which have also been described in man (Tolhurst, 1973), whereas hyoscine 
is more non-selective.
In conclusion, stationary pattern functions viz. contrast 
sensitivity to stationary grating patterns, visual acuity, stereoacuity 
and colour perception are unaffected by atropine administration. 
However, contrast sensitivity to lew spatial frequency moving gratings 
is adversely affected by atropine indicating an impairment of movement 
detection.
Part 5; The effectiveness of prior administration of an intramuscular 
injection of atropine sulphate or instillation of homatropine eyedrops 
against physostigmine eyedrops.
Intramuscular injection of 2 mg atropine sulphate was ineffective 
in antagonising the effects of physostigmine eyedrops on vision whether 
given 8 min or 124 min previously. Whereas, prior instillation of 2% 
homatropine hydrobromide eyedrops effectively blocked the marked miosis, 
the increase ih near point accommodation, the increase in amplitude of 
accommodation for distance and the accompanying decrease in contrast 
sensitivity, induced by physostigmine. Thus, neither peak plasma 
concentration of atropine which occurs at 30 min after injection 
(Berghem et al., 1980) nor atropine bound to muscarinic receptors of the 
ocular smooth muscle, which was maximal at 124 min, was sufficient to 
antagonise the effects of physostigmine eyedrops.
Atropine, during the 124 min period prior to physostigmine 
administration, significantly reduced contrast sensitivity to the 3 
c/deg phase-reversed grating pattern, but not to the higher spatial 
frequency stationary gratings (Table 14). Furthermore, the loss of
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contrast sensitivity for the 3 c/deg phase-reversed grating was, if 
anything, greater after both atropine pre-treatments although the 
difference was not significant (Fig. 48). This therefore confirms the 
result of part 4 of the present study that a 2 mg i.m. injection of 
atropine sulphate per se has a deleterious effect on contrast 
sensitivity to lew spatial frequency channels which are sensitive to 
movement. In addition, contrast sensitivity to a 3 c/deg phase-reversed 
grating pattern had returned to only 70 % of the control level by the 
end of the experiment, indicating a prolonged inhibition of the low 
spatial frequency channels by physostigmine. This confirms the result 
of part 3 of this study that physostigmine has an additional prolonged 
action, presumably at the retina, on the movement-dependent mechanism of 
the human visual system.
Atropine sulphate i.m. has been reported to prevent the proposed 
central elevation of the absolute scotopic threshold induced by exposure 
to Sarin vapour (Rubin & Goldberg, 1958). This is interesting because 
the only variable which atropine sulphate antagonised in the present 
study was the physostigmine-induced reduction in critical fusion 
frequency at 30 min post-administration (Fig 43), which was also thought 
to be a central effect.
Thus, it seems that the rate of delivery of atropine from an i.m. 
injection is insufficient to compete against the ocular effects of 
locally applied physostigmine. Although some of the muscarinic 
receptors of the ocular smooth muscle are occupied by atropine (shown by 
the dilatation of the control eye) this is overcome by the large 
quantities of acetylcholine which accumulate due to the inactivation of 
AChE by physostigmine. Ocular instillation of homatropine, however, 
occupies sufficient numbers of muscarinic receptors to render any build­
up of acetylcholine ineffective.
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Wood (1950) and Grob & Harvey (1953) briefly stated without 
elaboration that topical administration of 2% homatropine hydrobromide 
eyedrops was sufficient to relieve all the ocular symptoms in mild 
organophosphorus poisoning, but that the usual systemic dose of atropine 
was ineffective. In more severe cases, the administration of 0.5 or 1% 
atropine solution directly to the eye was necessary. Scholz & Wallen 
(1946) showed 5% hcmatropine was ineffective in reducing the miosis or 
the increase in accommodation for distance viewing, induced by DFP 
vapour. 0.25% atropine relieved the increased accommodation and 
returned distance vision to normal within 2.5 days, compared with an 
average of 5.3 days for the control eye. 1% atropine returned distant 
vision to normal in 3 hours. 5% homatropine only slightly relieved the 
intense pain experienced when focusing on close objects, while both
0.25% and 1.0% atropine gave complete relief in the treated eyes in 3 
hours. Thus, the antagonism produced by the three solutions is clearly 
concentration dependent which is in agreement with the present work.
It is difficult to relate the results obtained in this present 
study with physostigmine to the effects of the generally more potent 
organophosphorus anticholinesterases. Although these agents are known 
to cause a more marked and much longer lasting pupil constriction, the 
amplitude of any increase in accommodation as a result of exposure has 
yet to be firmly established. Certainly, blurred vision was one of the 
first symptoms ever noted by workers involved in the initial synthesis 
of dimethyl and diethylphosphorofluoridate in the 1930s in Germany 
(Holmstedt, 1963). Increased accommodation of between 1 and 6 D was 
reported after exposure to DFP, which came on within 3 hours of exposure 
and lasted from 2 to 7 days (Scholz & Wallen, 1946) and an increase in 
accommodation was also reported after exposure to TEPP (Upholt et al., 
1956). In contrast, other studies have reported little increase in
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accommodation after exposure to DFP (Aldridge et al., 1947) or Sarin 
(Rengstorff, 1985) despite a marked miosis. The lack of effect of 
organophosphorus anticholinesterases on accommodation may be explained 
if their binding potency was such that considerable binding to the iris 
occurs without substantial amounts reaching the ciliary muscles. 
However, Rubin et al., (1957) noted that Sarin applied direct to the eye 
was ineffective in raising the threshold of dark adaptation which was 
caused by the vapour. This implies that the cornea may constitute a 
barrier to absorption of appreciable amounts of Sarin. Hence, those 
amounts which do penetrate are sufficient to cause miosis but not 
accoainodative spasm. Finally, since relatively few subjects have been 
studied, the possible genetic disposition may be of relevance as 
suggested for physostigmine in the present study. Nevertheless, both 
Wood (1950) and Grab & Harvey (1953) state, without giving any detail, 
that exposure to traces of organophosphorus vapour causes constriction 
of the pupils within minutes, and slightly greater exposure induces 
ciliary muscle spasm. If the dose is sufficient to cause ciliary 
muscle spasm, it seems that a great deal of pain is felt on focusing and 
a headache and drawing sensation is felt behind and around the eyes. 
These symptoms were also experienced by subj ects who were severely 
defocused by some 8 - 10 D following physostigmine eyedrops in the 
present study.
In conclusion, if visual function were the sole consideration, the 
standard i.m. injection of 2 mg atropine sulphate would seem ineffective 
as a pre-treatment against anticholinesterase poisoning. This is due to 
delivery of insufficient atropine to counter the anticholinesterase in 
the ocular tissues. Atropine may also actually worsen the deleterious 
effect of the anticholinesterase on movement perception. Also, if the 
atropine was injected prematurely in what turned out to be a false alarm
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it would, in itself, have a deleterious effect on movement perception at 
low spatial frequencies and make close work requiring accommodation 
difficult. Homatropine eyedrops, given alone, have no deleterious 
effect on contrast sensitivity to stationary grating patterns, measured 
for a wide range of spatial frequencies (in part 1 of this study). 
Also, since contrast sensitivity to a 3 c/deg phase-reversed grating 
pattern was unaffected by hcmatropine eyedrops (Fig. 56), it would seem 
that, unlike i.m. atropine, homatropine eyedrops do not have a 
deleterious effect cm movement perception at lew spatial frequencies. 
Thus, a pre-treatment with homatropine eyedrops, prior to any exposure 
to anticholinesterase agents, would be far more effective, as far as the 
visual system is concerned.
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